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Transitt-tid blodstrømsmåling og analyse av skjærekrefter i bypass-graft  
ved koronar hjertekirurgi. En eksperimentell og klinisk studie. 
 
Bakgrunn 
Avhandlingen ”Transit-time flowmetry and wall shear stress analysis of coronary artery bypass grafts 
– A clinical and experimental study” er en studie av funksjonen i nye bypass-årer i ulike situasjoner, 
samt av skjærekrefter i disse under ulike eksperimentelle intervensjoner. I Norge utføres årlig ca. 3000 
bypass-operasjoner pga. koronar hjertesykdom (angina pectoris). Ved åpen hjertekirurgi sys da 
erstatningsårer forbi de trange partier på hjertets egne kransarterier. Korrekt vurdering av 
forsnevringen i kransarteriene og intraoperativ kvalitetskontroll av åreforbindelsen (anastomosen) er 
viktig for at bypass-årer holder seg åpne. Doktoravhandlingen er basert på fire arbeider som alle er 
publisert i anerkjente internasjonale tidsskrifter. Arbeidet er en blanding av studier på hjertekirurgiske 
pasienter og dyreeksperimentelle studier.  
 
Resultater 
I den første studien ble et stort pasientmateriale med 1390 blodstrømsmålinger analysert. Ulike typer 
bypass-graft til de forskjellige kransarteriene på hjertet ble sammenlignet. Hovedfunnet var økende 
blodstrøm ved økende antall anastomoser (opptil tre) fra den samme erstatnings-åre og når denne er 
vene. ”Pulsatility index”, som til en viss grad indikerer motstand i åresystemet, var uavhengig av antall 
anastomoser, men hadde høyere verdi på høyre side av hjertet sammenlignet med venstre side.  
I en annen klinisk studie ble de to mest anvendte transitt-tid blodstrømsmålere sammenlignet 
på samme bypass-åre. Undersøkelsen viste at MediStim flowmeter systematisk ga høyere pulsatility 
index-verdier enn Transonic flowmeter, selv om mengde blodstrøm per tidsenhet var lik. Årsaken var 
ulik filtrering av blodstrømssignalene i flowmetrene. Det bør derfor etableres retningslinjer for 
fortolkning og rapportering ved anvendelse av de respektive blodstrømsmålere.  
 Det er kjent at konkurrerende blodstrøm fører til at bypass-graft hyppigere går tett eller får 
mindre kaliber. Dette forekommer når innsnevringen av kransarterien er mindre uttalt enn forventet og 
ikke begrenser blodstrømmen i hvile. I en grisemodell ble transitt-tid blodstrømsmåling ved forskjellig 
grad av konkurrerende blodstrøm studert, med og uten innsnevring i anatomosen. Resultatet var at 
konkurrerende blodstrøm har en stor innvirkning på målingene, mens en innsnevring i anastomosen på 
inntil 75 % ikke ga noen begrensning av blodstrømmen i bypass-åren.  
 I den fjerde studien ble varierende grad av konkurrerende blodstrøm studert med avansert 
datasimulering, såkalt ”computational fluid dynamics”, på bakgrunn av en ny grisemodell. Her ble 
spesielt skjærekreftene (”shear stress”) mellom blodstrøm og årevegg beregnet. Resultatet var at full 
konkurrerende blodstrøm induserer ugunstige skjærekrefter i bypass-åren på grunn av redusert og 
retningsskiftende blodstrøm. Ved mindre grad eller fravær av konkurrerende blodstrøm var 
skjærekreftene gunstigere på grunn av høyere og mer retningsstabil blodstrøm. Ugunstige 
skjærekrefter kan føre til endotel-dysfunksjon, som er en viktig årsak til intima-hyperplasi og 
åreforkalkning. Disse funn indikerer at konkurrerende blodstrøm med ledsagende endotel-dysfunksjon 
er en negativ faktor i forhold til langtids holdbarhet av bypass-årer ved koronar hjertekirurgi.  
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4.   INTRODUCTION 
 
4.1 Coronary artery bypass grafting (CABG) 
CABG is one of the most frequently performed surgical procedures worldwide, with 
approximately 600,000 – 700,000 operations conducted annually. In Norway, 2859 
patients underwent CABG in 2008 [ Norsk Nasjonalt Hjertekirurgiregister 2008]. 
There has been a trend towards a decreased number of pure CAGB procedures over 
the last five years, after a maximum of 3430 operations in 2004. At the same time, 
there has been an increased number of combined CABG and aortic valve procedures. 
Since the mid-90s, percutaneous coronary intervention (PCI) has been done 
considerably more frequently than CABG worldwide. In 2008, a total of 11242 PCI 
procedures were performed in Norway, but this activity has also stabilised over the 
past five years (Figure 1) [ Norsk Nasjonalt Hjertekirurgiregister 2008]. 
 
 
 
Figure 1.  CABG and PCI in Norway 1995 – 2008. 
http://www.legeforeningen.no/thorax. Reproduced with permission from  
The Norwegian Association for Cardiothoracic Surgery.  
 
PCI with stenting has replaced CABG in most cases with one- or two-vessel 
disease and in patients presenting with acute coronary syndrome, whereas CABG is 
still considered as best practise in most patients with triple-vessel or left main vessel 
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disease and with impaired left ventricular function [Eagle et al 2004; Serruys et al 
2009; Patel et al 2009].  
Patients with complex coronary anatomy and calcified lesions are more often 
treated by CABG, as PCI in such cases are technically less feasible [Haaverstad 
2009]. Moreover, patients undergoing CABG nowadays often have a higher operative 
risk due to old age and comorbidities. On-pump CABG is still the technique most 
widely performed when surgical revascularisation is considered. In Norway, off-pump 
CABG is usually reserved for patients with a heavily calcified wall of the ascending 
aorta. The cannulation and cross-clamping may increase the risk of calcium emboli. In 
2007, only 20 off-pump coronary artery bypass (OPCAB) operations were performed 
in Norway [Haaverstad 2009]. 
The use of the left internal mammary artery (LIMA) and the great saphenous 
vein are still the most common procedures of surgical myocardial revascularisation. 
The LIMA-to-LAD has a superior long-term patency versus other conduits and 
improves long-term survival and freedom from reinterventions [Cameron et al 1996; 
Goldman et al 2004; Sabik et al 2005].  
Currently, vein grafting is often carried out by the sequential grafting 
technique, in which one or more side-to-side anastomoses are performed in addition 
to the distal end-to-side anastomosis. The obvious advantages of sequential vein 
grafting are shorter limb incisions and fewer proximal anastomoses with better 
utilisation of the vein graft segment. However, sequential vein grafts may also carry 
more blood flow to the myocardium compared to single vein grafts, although solid 
evidence for this is still warranted [Christenson et al 1998; Dion et al 2001; Vural et al 
2001; Kandemir et al 2007]. Furthermore, some data suggest that the long-term 
patency of side-to-side anastomoses are better than the patency of end-to-side 
anastomoses [Kieser et al 1986]. Sequential grafting may also optimise 
haemodynamic conditions like flow pattern and wall shear stress [Frauenfelder et al 
2007].  
Graft failure is a concern after CABG. Improvement of the early as well as the 
long-term graft patency is frequently addressed. Nowadays it is common to perform 
intraoperative quality assessment of the bypass grafts. Several technologies are 
available, but transit-time flowmetry is the most widespread method. The aim of 
intraoperative graft assessment is to detect and thereby to revise technical of grafts 
and anastomoses, thus improve clinical outcome and avoid re-interventions. 
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Table 1. Possible causes of early graft failure after CABG.  
Reported findings References 
Failure of prox. or dist. anastomosis [D'Ancona et al 2000] 
Overstretched graft [D'Ancona et al 2000; Tokuda et al 2007] 
Graft dissection [Walpoth et al 1998; Tokuda et al 2007] 
Obstructing intimal flap [Walpoth et al 1998; D'Ancona et al 2000; Tokuda et al 2007]  
Intramural haematoma [Walpoth et al 1998; D'Ancona et al 2000] 
Kinked or twisted graft [D'Ancona et al 2000; Tokuda et al 2007] 
 
In CABG, the flow within bypass grafts may be influenced by the function of 
native coronary arteries. Competitive flow may be seen when grafting is performed on 
coronary vessels with low-grade stenosis. Clinically, competitive flow is assumed to 
occur frequently in CABG, as coronary arteries with a luminal area stenosis of 50-70 
% are often grafted. Most studies on graft function have shown better long-term 
patency when they are directed distally to severe stenoses rather than beyond non-
significant lesions [Villareal et al 2000; Hirotani et al 2001; Sabik et al 2003; Bezon 
et al 2003; Berger et al 2004; Nakajima et al 2007; Botman et al 2007; Sabik et al 
2008; Kawamura et al 2008].  
The “string phenomenon” of the LIMA graft, which displays a threadlike 
structure on the angiogram, is assumed to be caused by competitive flow. However, 
there is limited knowledge of the underlining patho-physiological and biomechanical 
mechanisms of competitive flow in CABG. By addressing why grafts often fail during 
competitive flow conditions, essential information with great consequences may be 
achieved. This may subsequently facilitate the development of surgical, 
pharmacological and genetic interventions for improvement of coronary grafts 
patency.  
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4.2 Coronary haemodynamics 
Because this thesis deals with blood flow and wall shear stress in coronary bypass 
grafts, some basic fundamental anatomical and physiological concepts of the coronary 
circulation will be presented.  
 
 
Figure 2.  The coronary artery tree. LMS = left main stem; CX = circumflex artery; 
LAD = left anterior descending artery; OM = obtuse marginal; LIMA = left internal 
mammary artery; RCA = right coronary artery; PDA = posterior descending artery; 
PL = posterolateral artery. Modified figure from: 
http://www.meddean.luc.edu/lumen/meded/Radio/curriculum/Vascular/Coronary_art
ery.jpg 
 
Coronary blood flow, autoregulation and stenosis 
At rest, the total coronary flow is 180-250 ml/min, i.e. 5-10 % of the total 
cardiac output [Naidu et al 2001]. The primary regulatory mechanism of coronary 
blood flow is determined by the local myocardial metabolism by release of adenosine 
and other vasodilator mediators. At rest, the myocardium already has an extremely 
high oxygen extraction. The higher oxygen demand during increased cardiac work 
load or ischaemia is normally met by increased coronary blood flow. Thus, there is a 
nearly linear relationship between the myocardial metabolic demand and the coronary 
blood flow. Healthy individuals can increase coronary flow up to four-to-six fold 
[Naidu et al 2001; Spaan et al 2006]. Other important control mechanisms are the 
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neurogenic and hormonal systems, which are generally more vasoconstrictive than 
vasodilatory.  
The vascular endothelium acts as control system by determining the vascular 
tonus. The blood flow induced wall shear stress (WSS) increases the release of 
several mediators from the intact endothelium, particularly the vasodilatory molecule 
nitric oxide (NO). However, in damaged endothelium such as in patients with 
atherosclerosis, the release of NO is reduced and the release of the vasoconstrictive 
endothelin-1 is increased [Opie et al 2004].  
Coronary blood flow is inversely related to the peripheral vascular resistance. 
The vascular resistance is very low in the epicardial coronary arteries due to these 
large branches. Thus, only a minimal pressure drop exists between the ascending aorta 
and the distal end of healthy major coronary arteries. The smaller coronary branches 
are arterioles embedded deeply into the myocardium and are also called resistance 
arteries. They can adjust coronary blood flow according to the metabolic demands of 
the myocardium through the metabolic, neurogenic and vascular control systems 
(autoregulation).  
The coronary arteries provide stable myocardial perfusion when the systolic 
pressure ranges between 50 - 180 mmHg, allowing a relatively constant blood flow. If 
the systolic perfusion pressure drops below 50 mmHg, the vasodilatory effect 
controlled by the coronary autoregulation is gradually lost [Gould et al 1974; Opie et 
al 2004]. An estimated 70 % diameter reduction, equivalent to a 90–95 % decrease in 
luminal area, is required to decrease the basal, resting coronary blood flow [Gould et 
al 1974].  
Coronary flow varies considerably from rest to exercise. During exercise, the 
coronary flow is already impaired when the internal diameter is reduced beyond 30 % 
[Gould et al 1974]. The coronary flow is further influenced by the collateral blood 
flow, the vascular spasm and a multiple or extensive stenosis, as well as the degree of 
turbulence across the stenosis. 
The impact of a stenosis on blood flow cannot directly be explained in the 
context of Poiseuille's law due to the coronary autoregulation, the vessel tortuosity 
and the pulsatile flow that is present in-vivo. Moreover, the law was based upon a 
Newtonian fluid, i.e. an homogenous fluid with constant viscosity like water and not 
blood. The law relates the flow Q to the length of the internal radius r of the vessel, 
according to the following formula:  
  11 
neurogenic and hormonal systems, which are generally more vasoconstrictive than 
vasodilatory.  
The vascular endothelium acts as control system by determining the vascular 
tonus. The blood flow induced wall shear stress (WSS) increases the release of 
several mediators from the intact endothelium, particularly the vasodilatory molecule 
nitric oxide (NO). However, in damaged endothelium such as in patients with 
atherosclerosis, the release of NO is reduced and the release of the vasoconstrictive 
endothelin-1 is increased [Opie et al 2004].  
Coronary blood flow is inversely related to the peripheral vascular resistance. 
The vascular resistance is very low in the epicardial coronary arteries due to these 
large branches. Thus, only a minimal pressure drop exists between the ascending aorta 
and the distal end of healthy major coronary arteries. The smaller coronary branches 
are arterioles embedded deeply into the myocardium and are also called resistance 
arteries. They can adjust coronary blood flow according to the metabolic demands of 
the myocardium through the metabolic, neurogenic and vascular control systems 
(autoregulation).  
The coronary arteries provide stable myocardial perfusion when the systolic 
pressure ranges between 50 - 180 mmHg, allowing a relatively constant blood flow. If 
the systolic perfusion pressure drops below 50 mmHg, the vasodilatory effect 
controlled by the coronary autoregulation is gradually lost [Gould et al 1974; Opie et 
al 2004]. An estimated 70 % diameter reduction, equivalent to a 90–95 % decrease in 
luminal area, is required to decrease the basal, resting coronary blood flow [Gould et 
al 1974].  
Coronary flow varies considerably from rest to exercise. During exercise, the 
coronary flow is already impaired when the internal diameter is reduced beyond 30 % 
[Gould et al 1974]. The coronary flow is further influenced by the collateral blood 
flow, the vascular spasm and a multiple or extensive stenosis, as well as the degree of 
turbulence across the stenosis. 
The impact of a stenosis on blood flow cannot directly be explained in the 
context of Poiseuille's law due to the coronary autoregulation, the vessel tortuosity 
and the pulsatile flow that is present in-vivo. Moreover, the law was based upon a 
Newtonian fluid, i.e. an homogenous fluid with constant viscosity like water and not 
blood. The law relates the flow Q to the length of the internal radius r of the vessel, 
according to the following formula:  
  11 
neurogenic and hormonal systems, which are generally more vasoconstrictive than 
vasodilatory.  
The vascular endothelium acts as control system by determining the vascular 
tonus. The blood flow induced wall shear stress (WSS) increases the release of 
several mediators from the intact endothelium, particularly the vasodilatory molecule 
nitric oxide (NO). However, in damaged endothelium such as in patients with 
atherosclerosis, the release of NO is reduced and the release of the vasoconstrictive 
endothelin-1 is increased [Opie et al 2004].  
Coronary blood flow is inversely related to the peripheral vascular resistance. 
The vascular resistance is very low in the epicardial coronary arteries due to these 
large branches. Thus, only a minimal pressure drop exists between the ascending aorta 
and the distal end of healthy major coronary arteries. The smaller coronary branches 
are arterioles embedded deeply into the myocardium and are also called resistance 
arteries. They can adjust coronary blood flow according to the metabolic demands of 
the myocardium through the metabolic, neurogenic and vascular control systems 
(autoregulation).  
The coronary arteries provide stable myocardial perfusion when the systolic 
pressure ranges between 50 - 180 mmHg, allowing a relatively constant blood flow. If 
the systolic perfusion pressure drops below 50 mmHg, the vasodilatory effect 
controlled by the coronary autoregulation is gradually lost [Gould et al 1974; Opie et 
al 2004]. An estimated 70 % diameter reduction, equivalent to a 90–95 % decrease in 
luminal area, is required to decrease the basal, resting coronary blood flow [Gould et 
al 1974].  
Coronary flow varies considerably from rest to exercise. During exercise, the 
coronary flow is already impaired when the internal diameter is reduced beyond 30 % 
[Gould et al 1974]. The coronary flow is further influenced by the collateral blood 
flow, the vascular spasm and a multiple or extensive stenosis, as well as the degree of 
turbulence across the stenosis. 
The impact of a stenosis on blood flow cannot directly be explained in the 
context of Poiseuille's law due to the coronary autoregulation, the vessel tortuosity 
and the pulsatile flow that is present in-vivo. Moreover, the law was based upon a 
Newtonian fluid, i.e. an homogenous fluid with constant viscosity like water and not 
blood. The law relates the flow Q to the length of the internal radius r of the vessel, 
according to the following formula:  
  11 
neurogenic and hormonal systems, which are generally more vasoconstrictive than 
vasodilatory.  
The vascular endothelium acts as control system by determining the vascular 
tonus. The blood flow induced wall shear stress (WSS) increases the release of 
several mediators from the intact endothelium, particularly the vasodilatory molecule 
nitric oxide (NO). However, in damaged endothelium such as in patients with 
atherosclerosis, the release of NO is reduced and the release of the vasoconstrictive 
endothelin-1 is increased [Opie et al 2004].  
Coronary blood flow is inversely related to the peripheral vascular resistance. 
The vascular resistance is very low in the epicardial coronary arteries due to these 
large branches. Thus, only a minimal pressure drop exists between the ascending aorta 
and the distal end of healthy major coronary arteries. The smaller coronary branches 
are arterioles embedded deeply into the myocardium and are also called resistance 
arteries. They can adjust coronary blood flow according to the metabolic demands of 
the myocardium through the metabolic, neurogenic and vascular control systems 
(autoregulation).  
The coronary arteries provide stable myocardial perfusion when the systolic 
pressure ranges between 50 - 180 mmHg, allowing a relatively constant blood flow. If 
the systolic perfusion pressure drops below 50 mmHg, the vasodilatory effect 
controlled by the coronary autoregulation is gradually lost [Gould et al 1974; Opie et 
al 2004]. An estimated 70 % diameter reduction, equivalent to a 90–95 % decrease in 
luminal area, is required to decrease the basal, resting coronary blood flow [Gould et 
al 1974].  
Coronary flow varies considerably from rest to exercise. During exercise, the 
coronary flow is already impaired when the internal diameter is reduced beyond 30 % 
[Gould et al 1974]. The coronary flow is further influenced by the collateral blood 
flow, the vascular spasm and a multiple or extensive stenosis, as well as the degree of 
turbulence across the stenosis. 
The impact of a stenosis on blood flow cannot directly be explained in the 
context of Poiseuille's law due to the coronary autoregulation, the vessel tortuosity 
and the pulsatile flow that is present in-vivo. Moreover, the law was based upon a 
Newtonian fluid, i.e. an homogenous fluid with constant viscosity like water and not 
blood. The law relates the flow Q to the length of the internal radius r of the vessel, 
according to the following formula:  
  12 
L8
PrQ
4
K
'S ,  with viscosity Ș, length L and pressure difference ¨P [Opie et al 2004].  
The equation states that the dominant factor on the flow Q is the internal radius r of 
the vessel.  
The coronary flow pattern is pulsatile due to the myocardial contraction and 
relaxation. During systole, the subendocardial coronary branches are much more 
compressed than the epicardial branches [Yada et al 1993]. Hence, most of the 
coronary flow occurs in the diastolic phase of relaxation, most pronounced for the left 
coronary artery. The right coronary artery has a more equal volume flow both in 
systole and diastole. The heart rate also affects coronary blood flow as bradycardia 
extends the diastole, thus increases the coronary flow. Tachycardia prolongs the 
systolic phase of the cardiac cycle, thus reduces the coronary flow [Opie et al 2004].   
 
 
Wall shear stress and endothelial dysfunction 
The blood flow through arteries is mostly laminar with a parabolic profile: the highest 
blood velocity in the centre and the lowest velocities close to the vessel wall. The 
laminar blood flow may be considered as a series of layers that move with different 
velocities, but in the same direction. The friction between these layers generates the 
shear stress of blood. The WSS is the friction of blood flow against the vessel wall 
(Figures 3-5).  
For a Newtonian fluid, the WSS Ĳ is proportional to the wall shear rate (
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wP W .  The wall shear stress is defined as the shear stress at y = 0, i.e., at the 
vessel wall (Figure 3).  
The WSS may also be calculated in terms of volume flow Q and vessel radius 
R by applying Poiseuille’s law: 3R
Q4
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P W .  Thus, small changes in radius R greatly 
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flow and dimensions can be measured non-invasively, for instance by ultrasound 
imaging. However, as for Poiseuille’s law, the formula has several major 
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assumptions: a) stiff, straight and smooth vessels; b) Newtonian fluid; c) laminar, 
steady, non-pulsatile flow and d) zero velocity at the vessel wall. 
In healthy arteries at rest, the time-average WSS over a cardiac cycle typically 
varies within an approximate range of 1-7 Pa. A time-average WSS < 1-1.5 Pa is 
considered as low. Non-physiological elevated WSS is reported to be > 7 Pa and is 
usually seen in a narrowed lumen (Figure 4) [Malek et al 1999; Chatzizisis et al 
2007].  
 
 
 
 
Figure 3.  The wall shear stress is defined as the shear stress at y = 0.  
Y is the distance within the flow profile in relation to the vessel wall.  
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Figure 4.  (A) The frictional WSS acting on the endothelial surface. (B) Range of WSS 
magnitudes in different regions (1 Pa = 10 dyne/cm2).  
With permission: Malek et al, Hemodynamic shear stress and its role in 
atherosclerosis. JAMA 282 (1999): 2035-2042. Copyright © (1999) American 
Medical Association. All rights reserved. 
 
 
 
 
 
Figure 5.  Steady, high flow versus oscillatory, slow flow. The left panel shows a 
steady high blood flow,which  induces a high uni-directional shear stress, considered 
as athersclerosis-protective. The right panel shows a presumably atherogenic 
situation with slow, unsteady blood flow, inducing a bi-directional (oscillatory) shear 
stress. 
Modified figure with permission: Malek et al, Hemodynamic shear stress and 
its role in atherosclerosis. JAMA 282 (1999): 2035-2042. Copyright © (1999) 
American Medical Association. All rights reserved.  
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An established index for assessing the changes in direction and magnitude of 
WSS is the oscillatory shear index (OSI). It is given by the following equation:  
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where T is the time of an entire cardiac cycle, and Ĳ is the WSS vector [Ku et al 1985]. 
The numerator and the denominator display the total WSS (the sum of all positive and 
negative WSS vectors) and the sum of all absolute values of the same WSS vectors 
over a cardiac cycle, respectively. The OSI varies between 0 and 0.5, where 0 
indicates a completely unidirectional shear force, and 0.5 indicates a purely unsteady, 
oscillatory shear force with a net amount of zero WSS. Regions of high OSI are prone 
to endothelial dysfunction and atherogenesis [Ku et al 1985; Kassab et al 2006; 
Davies 2009]. 
Next to WSS, the other basic mechanical force acting within vessels is the 
transmural pressure. This acts perpendicular to the vessel wall and stretches the wall. 
Although there is a wide discrepancy between the extremely small force generated by 
the normal WSS (1-7 Pa) and the transmural arterial blood pressure (100 mmHg = 
13332 Pa), WSS has a major and well-documented influence on endothelial function 
[Malek et al 1999; Davignon et al 2004; Slager et al 2005; Chatzizisis et al 2007; 
Stone et al 2007; Katritsis et al 2007; Davies 2009; Koskinas et al 2009]. All 
endothelial cells throughout the cardiovascular system are constantly exposed to WSS 
generated by the blood flow. Further, WSS varies in magnitude and direction, 
depending upon the geometry of the vessel, blood viscosity and flow pattern. Healthy 
and intact endothelium is crucial for efficient control of vascular resistance and 
function [Opie et al 2004; Davignon et al 2004; Chatzizisis et al 2007]. WSS exerts its 
effects through the conversion of mechanical stress to biochemical response, also 
described as a mechano-transduction [Davies 1995]. Thus, the endothelium triggers 
the metabolic reactions by synthesising vasoactive mediators in response to WSS 
changes. 
The endothelium attempts to adapt to local flow conditions [Kassab et al 2006]. 
Vasoactive mediators regulate the adaptation to sudden changes in WSS, whereas 
sustained and prolonged changes of WSS induce a slow, structural wall remodelling 
that is mediated by the activation of several genes [Slager et al 2005; Kassab et al 
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5.  STUDY OBJECTIVES 
 
Paper I 
Routine TTFMs were performed in a large group of patients by the same surgeon. The 
grafts considered for analysis were LIMA-LAD, single saphenous vein grafts (SVGs), 
double sequential SVGs, and triple sequential SVGs. The aim was to study TTFMs of 
different sequential SVGs in relation to single grafts, and to investigate how graft 
flow is related to patient characteristics and haemodynamics. 
 
Paper II 
Nine pigs underwent off-pump coronary artery bypass surgery with the LIMA grafted 
to LAD. TTFMs of the LIMA graft were recorded under the following four flow 
conditions (Figure 6):   
A. No competitive flow; the proximal LAD totally occluded (the baseline condition), 
mimicking an ideal situation for placing the graft distal to a totally occluded 
coronary artery.  
B. Partial competitive flow; partial occlusion of the LAD to half its full flow,  
mimicking a situation in which the anastomotic site was placed distal to a 
significant stenosis, providing about half the volume flow compared to the full 
flow. 
C. Fully competitive flow; no occlusion of the proximal LAD, mimicking a situation 
in which a graft was placed distal to a moderate (or less than critical) stenosis. 
D. Stenotic anastomosis with no competitive flow; mimicking a typical site of surgical 
error (the toe of the anastomosis).  
 
 
Figure 6. A schematic layout of the four investigated flow conditions on each pig. 
 
The aim was to assess the influence on graft flows due to competitive flow and 
stenotic anastomosis in LIMA-LAD anastomoses. Sub-analysis of TTFMs was of 
particular interest in this project.  
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Paper III  
The objective was to compare the flow signals produced by the two most commonly 
used transit-time flowmeters, manufactured by MediStim ASA and Transonic Inc., 
both having the same guidelines regarding the level of Pulsatility index (PI).  
In the first part of the study a MediStim (VeriQ) or a Transonic (HT331) 
flowmeter were directly compared by applying two flow probes simultaneously on 
coronary bypass grafts. In the second part we aimed to investigate whether the PI is 
influenced by different technical characteristics with regards to variation of filter 
settings within the flowmeter.  
 
Paper IV 
In an experimental porcine model a LIMA-LAD anastomosis was performed to 
investigate wall shear stress (WSS) during competitive flow conditions. By applying 
computational fluid dynamics, WSS in a 3-D LIMA-LAD model were investigated 
during three different flow conditions (Figure 6):  
A. No competitive flow; simulation of an ideal situation  
B. Partial competitive flow; simulation of a significant LAD stenosis  
C. Fully competitive flow; simulation of a no-significant LAD stenosis  
The aim of the study was to explore the influence of competitive flow on WSS 
within the coronary grafts and vessels, and to analyse how different flow conditions 
may trigger endothelial dysfunction and subsequent graft failure.   
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6.  METHODOLOGICAL CONSIDERATIONS  
 
6.1  Transit-time flow measurements 
Almost every cardiac intervention, including valve repair and PCI, are routinely 
followed by a reliable assessment to ensure adequate technical results. However, in 
CABG, this kind of evaluation is not always a routine procedure, although technical 
failures is quite common even if the operation is performed by an experienced 
surgeons [D'Ancona et al 2000; Hol et al 2004]. 
 The intention of intraoperative graft assessment is to reduce the risk of early 
graft failure and thereby achieve optimal surgical results. Ideally, an intraoperative 
quality assessment has the following characteristics: 
x Simple and quick application 
x Easy interpretation 
x Surgeon or technician independent 
x Provision of both anatomical and physiologic information 
x Inexpensive 
x Applicable for all relevant vessels  
x Highly sensitive 
x Highly reliable and specific 
 
 TTFM of bypass grafts is the most commonly used method for 
intraoperative quality assessment in CABG. The theoretical basis of the transit-time 
method has been known for more than 40 years, but it has only been applied in 
clinical practice since the early 1990s. Initially, this delay was due to several technical 
difficulties, like the extremely short “transit-time” of a few nanoseconds and the 
complexity and stability of the electronic network. The progress in electronic 
technology solved these problems. The first commercial transit-time flowmeter was 
introduced by Transonic Inc. in 1983 (Personal communication with Arne Grip, 
former CEO, MediStim ASA, Oslo). Later, TTFMs were proven to be an accurate 
method for intraoperative verification of bypass grafts [Matre et al 1994; Beldi et al 
2000]. A common misunderstanding is that the TTFM method is based on the 
Doppler principle, as erroneously asserted by some authors [Wolf et al 2003]. TTFMs 
are based on the ultrasonic transit-time principle according to the following formula: 
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Figure 7.  The transit-time flow principle. 
 
The perivascular transit-time flow probes used in coronary surgery are 
composed of two transducers placed at a specific angle with a metal reflector on the 
opposite side of the vessel (Figures 7 and 8). The two transducers act as the 
transmitter and the receiver for the ultrasound beams. The ultrasound beam 
transmitted through the vessel is wide enough to cover the entire flow diameter. When 
the beams are transmitted through the blood, there is a difference between the 
upstream and downstream transit-time (time of flight or time difference), which is 
proportional to flow velocity. The average cross-sectional flow velocity is calculated. 
Larger time differences are correlated with higher flow velocities. 
 
Procedure 
The timing of TTFMs during the operation is dependent on the CABG technique 
employed:  
(1) In on-pump CABG, the measurements are usually done after 
discontinuation of the cardio-pulmonary bypass circulation. Measuring the LIMA-
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Figure 7.  The transit-time flow principle. 
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LAD flow is also recommended before removal of the aortic clamp because this time 
point has no collateral flow. Some cardiac surgery units register graft flow both before 
and after application of diluted papaverine, particularly within vein grafts. Some 
surgeons recommend repeated flow measurements as well as when the sternal edges 
are approximated during chest closing in order to assure correct graft position and 
absence of graft kinking.  
(2) In OPCAB, the arterial grafts are usually assessed both immediately after 
they have been constructed and before chest closure. For vein grafts, the assessment 
may be performed as with on-pump surgery.  
The final measurements should be carried out under stable haemodynamic 
conditions. The hook of the flow probe connected to the flowmeter is placed around 
the bypass graft. The graft should fit within the flow probe because the ultrasound 
beam must illuminate the entire graft.  
When assessing a pedicled LIMA graft, a short segment of the graft should be 
skeletonised to fit the probe hook. By measuring the graft both before and after 
application of papaverine into the vein graft, the flow reserve for the individual graft 
is also measured. For the LIMA graft, papaverine is usually applied only externally, 
which is not as efficient as when it is given intraluminally.  
In order to obtain a correct interpretation of the blood flow patterns, an ECG 
recording should be combined with flowmetry to differentiate systole from diastole.   
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Figure 8.  A transit-time flow probe is placed around a vein graft after weaning off 
the cardio-pulmonary bypass circulation. 
 
 
Interpretation  
There is a poor correlation between mean volume flow and the quality of the 
anastomosis [Jaber et al 1998; D'Ancona et al 2001; Nordgaard et al 2009]. At rest, 
the graft flow is not reduced until the luminal stenosis is severe.  
The flow pattern in a bypass graft should mainly be diastolic as in a coronary 
artery. Different indicators have been introduced for the quality assessment in CABG. 
The most important are: 
a) Diastolic filling %  (DF%), which is calculated as  
  %100VV
V
%DF
abs,Dabs,S
D  , 
where VD and VS is diastolic- and systolic volume flows, respectively. The DF% is 
only calculated when an ECG signal is connected to the flowmeter with sufficient 
quality for defining systole and diastole. The DF% is perhaps the most important 
indicator for TTFM interpretation [Morota et al 2002]. A DF % < 50 is suspicious of 
disturbed graft flow because it represents a systolic graft flow pattern [Becit et al 
2007].  
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b) Insufficiency % is the percentage retrograde flow:  
 
c) Pulsatility index (PI) is calculated according to the following formula: 
flowvolumemean
flowvolumeminflowvolumemaxPI    
The PI has been described as an indicator of peripheral vascular resistance 
[Louagie et al 1994; D'Ancona et al 2000; Becit et al 2007], although the sensitivity 
and specificity are unknown. Peripheral resistance is governed by many factors, and 
PI is not sufficiently specific to distinguish between stenoses of different severity. 
Only very severe stenoses may produce significantly higher PIs [Evans et al 1980].  
Several TTFM cut-off values have been suggested as indicators of adequate 
graft flow [D'Ancona et al 2001; Kim et al 2005; Di Giammarco et al 2006]. The 
largest prospective study on TTFMs was performed by Tokuda et al., who measured 
blood flow by the MediStim flowmeter in 261 bypass grafts, and correlated the results 
obtained with 3-month postoperative coronary angiography. They found that mean 
flow <15 ml/min, PI > 5 and insufficiency % > 4 % in grafts to the left coronary 
system had a higher incidence of graft failure. The failure of grafts to the right 
coronary artery was predicted with mean flow < 20 ml/min, PI > 4.7, and 
insufficiency % > 4.6 % [Tokuda et al 2007].   
The most commonly used transit-time flowmeters, manufactured by MediStim 
ASA (Oslo, Norway) and Transonic Systems Inc. (Ithaca, NY, USA), use a default 
low-pass filter at 20 Hz and 10 Hz, respectively. They filter the signals differently, 
which yields different wave forms (Figure 9) [Proakis et al 1995]. The different 
maximum and minimum peak flows that are registered may influence the PI value. 
Although several scientific papers have compared the available flowmeters 
and concluded that they are accurate and precise with regard to volume flow, the issue 
of different flow patterns has not previously been addressed [Laustsen et al 1996; 
Beldi et al 2000; Cikirikcioglu et al 2006]. However, the latter is important because 
smoother flow pattern and low PI are indications of good flow, in contrast to spiky 
flow pattern and higher PI, which are associated with poor flow [Jaber et al 1998; 
D'Ancona et al 2001; Kim et al 2005].  
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Figure 9.  A simplified scheme of signal processing in the flowmeter. The signal 
processing determines how the flow signals are visualised on the screen. The analog 
signal is digitally sampled at a sufficiently high frequency according to the Nyquist-
Shannon sampling theorem. Further, the flowmeters use a low-pass filter to smooth 
the signals and attenuate noise.  
 
Definitions:  Analog signal: A “real world” continuous signal in time and amplitude 
with total precision.  
Antialias Filtering: A low-pass filter of the analogue signal to reduce the 
aliasing-effect, so the sampling rate can beat least twice the maximum frequency of 
the signal. All signals above the cut-off frequency are totally attenuated. 
Sampling: To convert the continuous analogue signal to a "digital" form. The 
sampling rate (samples per second) must be sufficient to reproduce the same 
analogue signal as a digital signal. To reproduce the full information of the signal, it 
is necessary to sample at twice the maximum frequency in the signal of interest, 
known as the Nyquist-Shannon sampling theorem.  
Digital signal:
 
 A signal with limited precision defined by sampling of the 
analogue signal and discrete in both time and amplitude.  
 
Limitations  
The commercial success of TTFMs in coronary surgery is probably due to the clinical 
importance and interest of blood flow rate in coronary bypass grafts. The goal of a 
surgeon is to perform a revascularisation that will bring as much blood flow as 
possible to the ischaemic myocardium. Further, flowmetry is simple and quick to 
carry out. The measurements are angle- and vessel-size independent; thus, the flow 
assessment is not too biased by the operator. However, several important limitations 
should be acknowledged.  
The interpretation of TTFMs may be difficult in some cases and may generate 
confusion and uncertainty. It provides purely physiological information, which for 
many surgeons is less convincing than anatomical information. Also, it cannot point 
out where the problem is located. Flow values and curves cannot be standardised 
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because of the great variability among patients (sex, races, etc.). Thus, the 
interpretation of graft quality is to a large extent surgeon dependent.  
 
 6.2 Computational fluid dynamics (CFD) 
A CFD model may be applied to investigate the WSS distribution in arteries  [Krams 
et al 1997; Lei et al 2001; Boutsianis et al 2004; Frauenfelder et al 2007; Stone et al 
2007]. CFD is a subfield within fluid mechanics in which numerical methods and 
algorithms are used to analyse and solve problems that involve fluid flows; in 
particular, the Navier-Stokes equations govern how the motion of fluids is treated. 
The numerical tools can be used to obtain a better understanding of local 
haemodynamic and mechanical forces in arteries, including native coronary arteries 
and bypass grafts [Krams et al 1997; Lei et al 2001; Boutsianis et al 2004; 
Frauenfelder et al 2007].  
The CFD technique allows parameters, such as vessel wall conditions and inlet 
flow velocity, to be changed easily, so that they can simulate theoretical and realistic 
conditions. Additionally, the CFD technique may be use to estimate shear stress and 
other important haemodynamic factors. These characteristics make CFD to an 
appropriate tool for research of vessel disease aetiologies, for instance intimal 
hyperplasia, atherosclerosis and subsequent failure of coronary bypass grafts.  
Our study group developed 3-D CFD simulations of the LIMA-LAD model 
based on a geometric model and TTFMs (Figure 10). Details are presented in Paper 
IV [Nordgaard et al 2010]. 
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appropriate tool for research of vessel disease aetiologies, for instance intimal 
hyperplasia, atherosclerosis and subsequent failure of coronary bypass grafts.  
Our study group developed 3-D CFD simulations of the LIMA-LAD model 
based on a geometric model and TTFMs (Figure 10). Details are presented in Paper 
IV [Nordgaard et al 2010]. 
  25 
because of the great variability among patients (sex, races, etc.). Thus, the 
interpretation of graft quality is to a large extent surgeon dependent.  
 
 6.2 Computational fluid dynamics (CFD) 
A CFD model may be applied to investigate the WSS distribution in arteries  [Krams 
et al 1997; Lei et al 2001; Boutsianis et al 2004; Frauenfelder et al 2007; Stone et al 
2007]. CFD is a subfield within fluid mechanics in which numerical methods and 
algorithms are used to analyse and solve problems that involve fluid flows; in 
particular, the Navier-Stokes equations govern how the motion of fluids is treated. 
The numerical tools can be used to obtain a better understanding of local 
haemodynamic and mechanical forces in arteries, including native coronary arteries 
and bypass grafts [Krams et al 1997; Lei et al 2001; Boutsianis et al 2004; 
Frauenfelder et al 2007].  
The CFD technique allows parameters, such as vessel wall conditions and inlet 
flow velocity, to be changed easily, so that they can simulate theoretical and realistic 
conditions. Additionally, the CFD technique may be use to estimate shear stress and 
other important haemodynamic factors. These characteristics make CFD to an 
appropriate tool for research of vessel disease aetiologies, for instance intimal 
hyperplasia, atherosclerosis and subsequent failure of coronary bypass grafts.  
Our study group developed 3-D CFD simulations of the LIMA-LAD model 
based on a geometric model and TTFMs (Figure 10). Details are presented in Paper 
IV [Nordgaard et al 2010]. 
  26 
 
 
Figure 10.  The acquisition of the CFD simulation of the LIMA-LAD model.  
A: Resin cast of the vessel lumen. A methyl-methacrylat-based resin was injected into 
the LIMA graft and the surrounding tissue was removed with potassium hydroxide. 
B: 3-D micro-CT. The cast was scanned using a high resolution micro-CT. 
C: Geometric mesh. The cast was generated to a tetrahedral grid of 1 058 405 
elements.  
D: Simultaneous TTFMs of the LIMA and the LAD together with ECG and cardiac 
output. The TTFMs were used for calculation of the flow behaviour. 
E: CFD simulations  
 
 
 
  26 
 
 
Figure 10.  The acquisition of the CFD simulation of the LIMA-LAD model.  
A: Resin cast of the vessel lumen. A methyl-methacrylat-based resin was injected into 
the LIMA graft and the surrounding tissue was removed with potassium hydroxide. 
B: 3-D micro-CT. The cast was scanned using a high resolution micro-CT. 
C: Geometric mesh. The cast was generated to a tetrahedral grid of 1 058 405 
elements.  
D: Simultaneous TTFMs of the LIMA and the LAD together with ECG and cardiac 
output. The TTFMs were used for calculation of the flow behaviour. 
E: CFD simulations  
 
 
 
  26 
 
 
Figure 10.  The acquisition of the CFD simulation of the LIMA-LAD model.  
A: Resin cast of the vessel lumen. A methyl-methacrylat-based resin was injected into 
the LIMA graft and the surrounding tissue was removed with potassium hydroxide. 
B: 3-D micro-CT. The cast was scanned using a high resolution micro-CT. 
C: Geometric mesh. The cast was generated to a tetrahedral grid of 1 058 405 
elements.  
D: Simultaneous TTFMs of the LIMA and the LAD together with ECG and cardiac 
output. The TTFMs were used for calculation of the flow behaviour. 
E: CFD simulations  
 
 
 
  26 
 
 
Figure 10.  The acquisition of the CFD simulation of the LIMA-LAD model.  
A: Resin cast of the vessel lumen. A methyl-methacrylat-based resin was injected into 
the LIMA graft and the surrounding tissue was removed with potassium hydroxide. 
B: 3-D micro-CT. The cast was scanned using a high resolution micro-CT. 
C: Geometric mesh. The cast was generated to a tetrahedral grid of 1 058 405 
elements.  
D: Simultaneous TTFMs of the LIMA and the LAD together with ECG and cardiac 
output. The TTFMs were used for calculation of the flow behaviour. 
E: CFD simulations  
 
 
 
  27 
Limitations of CFD simulations 
There are several potential sources of errors that may cause simulations to 
differ from true conditions. The most common sources of error are as follows 
[Versteeg et al 2007]: 
x Input data error: If the geometry and the flow data that come from in vivo 
measurements are inaccurate. 
x Boundary conditions error: The model is simplified. All flow properties are 
generally not exactly known because they are estimated. For instance, flow data 
are needed at locations where the fluid enters and leaves the geometric model. 
x Discretisation error: Errors that occur when the entire numerical flow data are 
transferred into small discrete domain of space and time, known as grid or mesh, 
as algebraic expressions. These errors are intrinsic and of most concern to the 
CFD model. They are mainly dependent on the quality and distribution of the 
grids used in the simulation. 
x Modelling error: The real flow may involve complicated flow patterns that are not 
perfectly described by current scientific theories, for instance in turbulence 
modeling. 
 
In paper IV, we compared the flow pattern in the CFD model with the one seen 
by epicardial ultrasound imaging as a qualitative validation.  
 
 
6.3  Surgical procedures and experimental set-up 
 
CABG and experimental set-up in the clinical setting (papers I, III) 
A median sternotomy was performed in all cases and the LIMA was harvested with its 
pedicle. The greater saphenous vein was placed in a heparin solution with 0.05 % 
papaverine after harvesting. Cardio-pulmonary bypass circulation was instituted with 
moderate hypothermia (34 °C). The heart was arrested by infusion of antegrade 
crystalloid or cold blood cardioplegia. In OPCAB operations (paper I: n = 61, 11 % of 
all patients) the target vessel was snared with 4-0 Prolene (Ethicon, NJ, USA) 
proximal to the coronary arteriotomy. After 3-5 minutes of ischaemic preconditioning, 
the snare was released, and an epicardial stabiliser was applied to pull the heart and 
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immobilise the vessel site chosen for grafting. After arteriotomy, an intracoronary 
shunt (CardioThoracic System, CA, USA) was positioned into the vessel lumen. 
Grafting was attempted on all vessels measuring >1 mm and with >50 % 
stenosis on the angiogram. The surgical plan was to carry out sequential grafting any 
time it was considered feasible and the LIMA was always grafted end-to-side to the 
LAD. The single SVG anastomosis was constructed end-to-side. In the sequential 
SVG, the distal end-to-side anastomosis was constructed before the side-by-side 
anastomoses. All LIMA and vein anastomoses were sutured with 7-0 Prolene. The 
proximal anastomoses were generally performed after release of the aortic cross-
clamp and by applying a side-biting clamp on the ascending aorta.  
The final TTFMs were done at a stable haemodynamic condition 10-15 
minutes after weaning off CPB. In off-pump patients, the measurements were done 
after completion of all distal anastomoses and removal of the cardiac stabilizer. 
Three- or four mm flow probes connected to a transit-time flowmeter (Medi-Stim 
ASA, Oslo, Norway) were used. Both for single and sequential SVG, the flow probe 
was placed 2-4 cm below the proximal anastomosis. The LIMA flow was assessed by 
applying the probe around a skeletonised area. In all grafts both mean graft flow and 
PI were registered. 
 
CABG and experimental set-up in the animal model (papers II, IV) 
A total of 11 Noroc pigs (hybrid of ¼ Duroc, ¼ Yorkshire and ½ Norwegian 
landrace) were operated upon. Animals of 65-70 kg weight were chosen because at 
that size the dimensions of the coronary vessels are similar to humans, and the 
myocardium has a relatively good tolerance to ischaemia. One pig died due to 
ventricular fibrillation before completion of the investigation protocol. A second pig 
was excluded from the study because it was haemodynamically unstable, making 
measurements unreliable for statistical analysis.  
Details of anaesthesia and the animal instrumentation are presented in Paper II 
and 4 [Nordgaard et al 2009; Nordgaard et al 2010].  
Pigs are quite intolerant to myocardial ischaemia and prone to ventricular 
fibrillation. Ventricular fibrillation happened also during our experiments, especially 
when making the anastomosis. The heart was promptly defibrillated, and in most of 
the cases, the heart converted into sinus rhythm with a haemodynamically stable 
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condition. These events likely do not influence results because the pigs returned to 
haemodynamic stability long before and during all measurements.  
Amiodarone 150 mg and hexamethonium chloride 20 mg/kg 
(Hexamethonium, Sigma-Aldrich, MO, USA) were given to avoid arrhythmias. 
Hexamethonium chloride is a ganglionic blocker, which paralyses the autonomic 
nervous system (sympatholytic and parasympatholytic), thus contributing to a more 
stable pig model. This ganglion blocker provides a stable heart rate throughout the 
experiment and presumably avoids ventricular fibrillations [Nordhaug 2003]. 
The pig was chosen as an animal model because the anatomy and physiology 
of its cardiovascular system are very similar to humans. Nonetheless, the pig model 
has normal coronary arteries with good run-off and no collateral flow, a very different 
condition from patients with severe coronary disease. When planning the 
experimental studies, we concluded that non-animal research models were unsuitable 
to the purposes of our investigations. The minimum number of animals required for 
meaningful results was utilised, and we aimed to reduce any pain to the animals 
during the experiments. All experimental protocols were approved by the Norwegian 
Animal Experiments Authority. All animals received care in compliance with the 
European Convention on Animal Care, and the investigation conformed to the Guide 
for Care and Use of Laboratory Animals published by the US National Institutes of 
Health (NIH Publication No. 85-23, revised 1996).  
All pigs underwent OPCAB surgery with a LIMA-to-LAD anastomosis. After 
sternotomy, the LIMA was harvested with its pedicle. The LAD was identified and 
investigated visually and sometimes with ultrasound images to identify diagonal 
arteries. An epicardial stabiliser (Axius Vacuum Stabilizer, Guidant, CA, USA) was 
applied to immobilise the LAD. Proximal to the anastomotic site, approximately 15-
20 mm (dependent on diagonals/ anatomy), the LAD was dissected from the 
epicardial tissue in order to apply a 2-3 mm flow probe around the vessel. Adjacent to 
this flow probe, another short area was dissected in order to fit an adjustable vascular 
occluder (In Vivo Metric, CA, USA). A 16-mm flow probe was placed around the 
pulmonary trunk to monitor cardiac output. The flow through the pulmonary trunk 
was also used to define systole and diastole because the flowmeter was not always 
able to read and interpret the ECG from the pig (Figure 11). 
Prior to coronary arteriotomy, ischaemic preconditioning was performed. 
Then, the LAD was snared distally and proximally with 4-0 Prolene (Ethicon, NJ, 
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USA) to allow a coronary arteriotomy. An intracoronary shunt (CardioThoracic 
System, CA, USA) was positioned into the vessel lumen. Then, the LIMA was grafted 
to the LAD end-to-side and sutured with a continuous 7-0 Prolene to create patent 
anastomoses without technical failures. Patency of the anastomosis was confirmed 
with epicardial ultrasound imaging (Figures 12 and 13). Upon completion of the 
anastomosis, a short segment of the LIMA was skeletonised, and a flow probe was 
applied, at approximately 4-5 cm from the anastomosis, to assess graft flow. Another 
flow probe was placed around the proximal LAD to assess competitive flow (Figure 
11). All animals were stabilized for 30 min before the experimental protocol was 
carried out.  
 
 
 
Figure 11. A schematic layout of the positions of flow probes and the vascular 
occluder. Modified figure from Nordgaard et al. Eur J Cardiothorac Surg 36 (2009): 
137-142. 
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Epicardial ultrasound imaging 
A GE Vivid 7 scanner (GE Vingmed, Norway) with an i13L linear array mini-
transducer (GE Healthcare, WI, USA) was used. This scanner is capable of operating 
at frequencies 7-14 MHz. We applied ultrasound imaging extensively for visualisation 
of the anastomosis and the blood flow (Figure 12-13). In paper II, ultrasound imaging 
was used to calculate the stenosis at the toe of the anastomosis (Figure 14).  
We used a new imaging modality named “blood flow imaging” (BFI). It is 
based on conventional colour Doppler imaging, but, in addition, shows the speckle 
pattern of the blood flow with a very high frame rate. It visualizes the blood flow in 
any direction of the two-dimensional image plane without limitations imposed by 
aliases (the velocity aliasing or the angle-dependency). Using slow motion display of 
subsequent speckle images, the movement of speckle pattern can be tracked by the 
human eye. This new BFI provides a more intuitive display of the flow conditions, 
making interpretation easier than conventional colour Doppler imaging [Lovstakken 
et al 2008].  
In addition to the assessment of coronary graft anastomosis, ultrasound 
imaging may be useful to locate intra-myocardial coronary vessels, for evaluation of 
severity of coronary stenoses, identification of the arteriotomy site (to avoid plaques 
or stented segments), as well as assessment of the ascending aorta [Haaverstad et al 
2002; Dessing et al 2004; Budde et al 2006; Lovstakken et al 2008; Ibrahim et al 
2008; Budde et al 2009].  
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Figure 12.  Intraoperative photo of the pig heart with flow probes and occluder. 
Epicardial ultrasound imaging of the LIMA-LAD anastomosis is being performed 
with the stabiliser placed on the epicardial tissue. The geometry and blood flow were 
assessed before and after constructing a stenotic anastomosis, as well as with and 
without competitive flow. 
 
 
 
 
Figure 13.  Simultaneous TTFM and epicardial ultrasound imaging on a patent 
LIMA-LAD anastomosis.  
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Figure 14.  The luminal dimensions for estimating the extent of the stenoses were 
measured by epicardial ultrasound imaging. D1 = the vessel diameter of the stenotic 
toe; DA = diameter of the anastomotic inlet. A circular lumen was presumed. The 
formula for calculating the luminal stenosis: 
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6.5  Statistical analysis 
Data are presented as either the arithmetic mean ± one standard deviation for 
normally distributed data or the median with range for data that were not normally 
distributed. In paper III, the values are expressed as geometric mean and 95 % 
confidence interval after logarithmic transformation. P-values less than 0.05 were 
considered significant. Statistical analysis in Papers I-III was performed using SPSS 
for Windows version 15 (SPSS Inc., Chicago, IL, USA). In paper III, STATA for 
Windows version 10 (StataCorp, College Station, Texas, USA) and Excel were also 
used.  
In paper I, the flow values were compared utilising a linear mixed regression 
model. The pair-wise post-hoc comparisons were adjusted for multiple comparisons 
using the Bonferroni technique. Categorical variables were analysed using a chi-
square test, and continuous variables were analysed using a two-tailed Student's t-test 
with equal or unequal variances based on the findings of an initial F-test for equality 
of variance.  
In paper II, Friedman’s tests for non-normally distributed variables were 
applied. If the Friedman’s test revealed significant changes, post hoc analyses by 
Wilcoxon signed-ranks were performed without correction for multiple comparisons. 
Instead of using the Bonferroni correction for multiple comparisons, we chose to 
report uncorrected P-values for the Wilcoxon signed-ranks, so the readers may more 
easily assess the relevance of the statistical differences described [Perneger 1998].  
In paper III, a logarithmic transformation of the collected flow data was 
performed to achieve normal distribution. Two-sample t-tests were used on data with 
no repeated measurements, while a random effects model was used to account for 
repeated measurements on same individuals. The grafts were nested into LIMA-LAD, 
single SVGs and double sequential SVGs to the left and right coronary arteries. The 
comparisons between grafts from two different cardiac centres were performed using 
two sample t-tests except for the single SVGs to the left coronary artery, where a 
random effects model was used to account for repeated measurements. Wilcoxon 
signed ranks tests were used to compare the simultaneous flow assessments on the 
same grafts.  
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7.   SUMMARY OF RESULTS 
 
7.1 Paper I 
Within the single vein graft group there were no differences between flows within 
grafts to different target vessels except for diagonals, which had the lowest flow. The 
blood flow increased substantially from single to double and further to triple 
sequential vein grafts. Graft flow was higher in males versus females. Lower age and 
higher left ventricular ejection fraction were associated with higher mean graft flows. 
The aortic pressure did not influence on graft flow. The mean PI of vein grafts to the 
right coronary system was significantly higher than the mean PI of vein grafts to the 
left coronary system (PI ± SEM: 2.40 ± 0.06 and 2.00 ± 0.05, respectively). Similar PI 
values were found between gender and groups of vein grafts within each coronary 
system (Figure 15). 
 
 
 
Figure 15.  Left: Box-plot of the blood flows in different coronary bypass grafts. The 
bottom and top of the boxes show the 25th and 75th percentile, and bands near the 
middle of the box are the 50th percentile (the median). The ends of the vertical lines 
indicate the minimum and maximum values. Points outside the ends of the lines 
represent suspected outliers.  
Right: Mean PI ± 2 SEM in single SVGs, double and triple sequential SVGs, 
divided by right and left coronary system.  
Modified figure from Nordgaard et al. Ann Thorac Surg 2009; 87: 1409-1415 
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7.2 Paper II 
Competitive flow reduced the mean LIMA graft flow more than by a stenotic 
anastomosis, which was assessed to be 75 % ± 11 % luminal stenosis as measured by 
ultrasound. Reduction of the graft flow due to competition was particularly evident 
during diastole. The systolic flow remained unchanged. Competitive flow decreased 
both diastolic and systolic maximum peak flows, making the flow curve look 
smoother. Moreover, competitive flow increased retrograde flow. The PI and rate of 
insufficiency % (retrograde flow as a fraction of total flow) were more increased by 
competitive flow than by stenosis. Diastolic filling % was substantially reduced 
during competitive flow compared with both stenosis and baseline.  
 
7.3 Paper III 
The Transonic flowmeter calculated substantially lower PI values than the MediStim 
flowmeter. A systematic and constant increase of PIs occurred when the filter setting 
was raised from 5 Hz to 100 Hz. Under various filter settings (5 Hz, 10 Hz, 20 Hz, 30 
Hz, 50 Hz and 100 Hz) the proportion of the changes depended on the level of the PI 
values. Major changes were seen between the filter levels when the PI was high, 
typically seen when the flow curves were spiky with high and low peaks. Minor 
changes were observed when the PI was low, typically seen when the flow curves 
were smoother (Figure 16).  
Nineteen coronary bypass grafts were assessed simultaneously by the 
MediStim (VeriQ) and Transonic (HT331) flowmeters. The differences in calculation 
of PI between the two flowmeter increased as the flow pattern became more spiky. 
Thus, the differences between the flowmeters are more pronounced when the flow 
curve is spiky, typically seen in situations with poor graft flow and high resistance, 
situations where flow analysis is critical.  
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Figure 16. Simultaneous graft flow measurements with the MediStim and Transonic 
flowmeters [Nordgaard et al 2009].  
The upper panel shows a LIMA-to-LAD with flow pattern with sharp peaks. 
The PI values are 5.5 and 3.2 as calculated by the MediStim and Transonic 
flowmeters, respectively.  
The lower panel shows a single SVG to PDA with smoother flow pattern, thus 
similar PIs in both flowmeters; PI 1.3 and 1.2 in the MediStim and Transonic 
flowmeter, respectively.  
 
 
7.4 Paper IV 
High competitive flow resulted in substantial lower WSS and more oscillatory shear 
stress in the LIMA graft compared to the two other flow conditions. Partial 
competitive flow resulted in WSS and OSI values that were similar to the no-
competitive flow condition (Table 2; Figure 17 and 18).  
 
Table 2.  WSS and OSI in the LIMA graft found during one cardiac cycle.  
 
Competitive flow WSS [Pa] OSI 
High   0.3-0.6 0.15-0.35 
Partial 0.6-3.0 <0.05 
None 0.9-3.0 <0.05 
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Figure 17. The time-average distribution of the WSS in the LIMA–LAD model during 
one cardiac cycle. The upper and lower panels show the WSS in two different scales: 
0.1 – >1 and 1 – >19 Pa, respectively.  
(A) No competitive flow shows WSS > 1 Pa in the LIMA graft. In comparison, lower 
WSS is seen during partial reduced competitive flow (B). Substantial lower WSS in 
the LIMA graft is seen during high competitive flow (C). Higher WSS is shown at the 
toe of the anastomosis where a moderate narrowing of the vessel lumen had formed. 
 
 
 
 
Figure 18.  The time-average oscillatory shear index (OSI) distribution during one 
cardiac cycle. Higher OSI values are found in LIMA graft and within the anastomosis 
during high, unimpaired competitive flow (C), while reduced (B) and no competitive 
flow (A) lead to very low OSI values. 
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8.  DISCUSSION 
 
Transit-time flowmetry as intraoperative quality assessment 
Coronary bypass graft failure is a troubling complication that may cause various 
problems, including refractory angina pectoris, myocardial infarction, arrhythmia, 
heart failure, and premature death. Early graft failure is related to technical problems 
involving the bypass grafts and anastomoses, which are difficult to detect during 
surgery by visual assessment, palpation or conventional cardiac monitoring. Thus, to 
avoid early graft failure, intraoperative graft assessment is required. Late graft failure 
may be caused by both technical failures and other factors. We know that long-term 
patency is dependent on competitive flow, pathology of the target vessel, type of graft 
(venous or arterial) and time since CABG [Sabik et al 2005]. However, the exact 
pathophysiological reason for graft failure has been difficult to define.  
The first study of this thesis included flow measurements of 1390 coronary 
bypass grafts that were operated on and assessed by the same senior surgeon. Thus, 
operator-related biases were minimised due to all procedures being conducted by the 
same surgeon and the same protocol of flow measurements being applied to all 
patients. This continuity was essential for the statistical analyses.  
A detailed statistical analysis of the patient characteristics and all flow values 
gave important insights in the haemodynamic behaviour of different bypass grafts. 
Sequential vein graft flow was higher as compared to single bypass grafts, with flow 
substantially increasing from single versus double and triple sequential vein grafts. 
However, the differences were not two or three-fold higher, as one would expect if the 
resistance to flow were only determined by the peripheral coronary resistance. Other 
factors, such as the length of the grafts and the flow pattern in the anastomoses 
themselves, must contribute significantly to the total resistance.  
In terms of the Poiseuille's law, the flow resistance is proportional to the length 
of the conduit. Sequential bypass grafts are longer conduits, hence they produce more 
resistance. Another possible explanation may be the interaction between the two distal 
anastomoses. Flow disturbance caused by myocardial contractions or competitive 
flow close an anastomosis may impair the flow into the other anastomosis.  
The lowest flow was found in vein grafts to diagonals, which usually are small 
vessels with a limited peripheral vascular bed compared to other coronary branches.  
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Mean graft flows were higher in men vs. women, probably due to men having 
larger coronary arteries and larger ventricular mass [Levy et al 1987]. Higher graft 
flow was generally seen in younger patients and in patients with good left ventricular 
ejection fraction. A possible explanation may be that younger patients have larger and 
more dynamic coronary vessels than older patients, which may allow a better run-off. 
Reduced ejection fraction indicates congestive heart failure, which may reduce 
coronary flow due to the reduction of the coronary vascular bed caused by myocardial 
infarction, fibrosis and cardiomyopathy.  
The aortic pressure did not influence on graft flow. However, no patients had 
hypotension at the time of measurement. The mean blood pressure was around 90 
mmHg during the flow measurements suggesting that the coronary auto regulatory 
mechanism was intact.  
The LIMA-LAD grafts showed lower flow compared to vein grafts directed to 
the LAD. Lower flow is probably because of smaller dimensions and some degree of 
spasm in the LIMA grafts, since no vasodilators (e.g. papaverine) were used routinely. 
In study I similar PI values for single and sequential vein grafts were found. 
This observation was unexpected because the PI is thought to reflect peripheral 
resistance; hence, one would hypothesise that sequential grafts provide lower PIs 
compared to single grafts. Thus, flow pattern and thereby PI are determined by more 
factors than the run-off.  
Higher PIs were found in vein grafts directed to the right coronary system, 
which usually has higher systolic peaks and a more equal systolic and diastolic flow 
pattern as compared to the left coronary system. Although the difference in PI values 
reached statistical significance, the numeric difference was small. Our findings are in 
contrast to Kim et al who suggested cut-off values for insufficient graft flow of PI > 3 
to the left and > 5 to the right coronary artery  [Kim et al 2005].   
 
Graft flow alterations induced by competitive flow and stenotic anastomoses 
Firstly, the comparisons of the different levels of competitive flows revealed that 
competitive flow reduced the LIMA graft flow, mainly because of decreased diastolic 
flow, whereas the systolic flow remained unchanged.  Secondly, partial competitive 
flow induced the same effect as fully competitive flow on both mean and diastolic 
flow, although not to the same extent. Thirdly, retrograde flow and PI increased only 
under fully competitive flow. We also found that competitive flow caused a smoother 
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flow pattern with less sharp peaks compared with the flow pattern at no competitive 
flow.  
The LIMA graft flows were not significantly altered by a 75 % ± 11 % stenosis 
of the lumen of the anastomosis. Hence, our observations are in line with previous 
flow studies concluded that substantial hemodynamical effects at rest are seen only in 
a critical stenotic anastomosis [Jaber et al 1998; Jaber et al 1998].  
The question how to distinguish competitive flow from a severe stenotic 
anastomosis is an important issue because both conditions may alter the graft flow. In 
addition, numerous other causes may alter the graft flow, such as graft dissection, 
kinking, torsion and spasm, as well as high coronary resistance due to small target 
vessels [Walpoth et al 1998; D'Ancona et al 2000; Wolfe 2001; Tokuda et al 2007]. 
The consequences of even tighter stenotic anastomoses were not investigated. 
Naturally, the graft flow will abruptly decrease due to a tighter stenosis. In these 
situations, other studies have reported a systolic dominant flow pattern, similar to our 
findings with competitive flow conditions [Morota et al 2002]. 
TTFM of grafts flows and pattern may be difficult to interpret, especially in 
situations when graft flow is lower than expected. When competitive flow is 
suspected, one manoeuvre is to block the native flow while measuring the graft flow. 
Such block may be conducted by snaring the target coronary artery proximal to the 
anastomosis. If a significant competitive flow is present, the temporary occlusion of 
the native flow will induce an increase of graft flow [D'Ancona et al 2001]. However, 
there is concern that the temporary occlusion of a coronary artery proximal to an 
anastomosis may cause injury of the vessel [Hangler et al 2001]. Temporary clamping 
of grafts directed to collateral coronaries may also aid in the interpretation of graft 
flow. Another simple and practical technique to assess competitive flow in the LIMA 
graft is to measure the flow before and after removal of the aortic cross-clamp. If the 
LIMA flow decreases substantially following removal of the aortic clamp, 
competitive flow may be present.  
Alternatively, epicardial ultrasound may be used [Haaverstad et al 2002]. In 
our study, the Blood flow imaging (BFI) modality was applied to evaluate the patency 
of the anastomosis by looking at its geometry and function as well as the degree of 
stenosis [Lovstakken et al 2008]. We believe that this technique has a great potential 
for intraoperative assessment during CABG because it is non-invasive and can easily 
detect stenoses and competitive flow.  
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Comparison of the Transonic and the MediStim flowmeters 
The majority of published data regarding clinical TTFM have been obtained with the 
MediStim flowmeter [Goel et al 2003; Kim et al 2005; Hassanein et al 2005; 
Gwozdziewicz et al 2006; Nordgaard et al 2009]. 
In our clinical series, we found a trend towards lower PI values provided by 
the Transonic flowmeter versus the MediStim flowmeter. When we used both 
flowmeters simultaneously on the same grafts, the Transonic flowmeter gave 
systematically lower PI values. Furthermore, the difference was highly dependent 
upon the flow pattern: sharp peaks led to remarkable differences between the two 
flowmeters, while smoother flow pattern revealed similar PI values. In other words, 
the difference between the flowmeters became greater as PI increased (Figure 16).  
The graft flow assessment at different filter settings revealed a systematic and 
constant increase of PIs when the filter in the flowmeter was gradually raised from 5 
Hz to 100 Hz. Progressively higher filter settings led to a flow pattern with sharper 
peaks, which caused higher PIs. On the contrary, lower filter settings produced 
smoother flow pattern and lower PIs. The change of PI became greater when the flow 
curves had sharp peaks, and these peaks were filtered away at lower filter settings.   
 
Coronary bypass graft patency and failure 
Several studies with early postoperative coronary angiography demonstrate graft 
failure in the range of 4-14 % [Sanz et al 1990; Goldman et al 1991; Alderman et al 
1998; D'Ancona et al 2000; Desai et al 2006; Tokuda et al 2007]. Early graft failure is 
associated with low and disturbed graft flow, which is commonly related to technical 
problems with the graft or  anastomosis, both correctable if recognised 
intraoperatively [Nwasokwa 1995]. A post-mortem study of 517 coronary bypass 
grafts in 223 patients with fatal outcome within 30 days of CABG, discovered that 55 
% of the patients had technical failures in the grafts or anastomoses that were not 
recognised intraoperatively [Weman et al 1999]. 
 In a 10-year prospective study on graft patency in 1254 patients who were 
followed-up by repeated angiograms the most important predictors of long-term graft 
patency were the early patency as well as the size of the peripheral vascular bed 
[Goldman et al 2004]. Therefore, intraoperative evaluation of graft patency should be 
mandatory.  
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Ultimately, the majority of SVGs occlude or become substantially narrowed 
after 10-15 years [Fitzgibbon et al 1996; Motwani et al 1998]. Unlike LIMA grafts, 
SVGs are subject to intimal hyperplasia, atherosclerosis, progressive stenosis and 
occlusion [Motwani et al 1998]. During the first year 12-20 % of the SVGs occlude. 
Intimal hyperplasia occurs mainly one month to five years after surgery [Nwasokwa 
1995]. Atherosclerotic lesions that are also haemodynamically significant appear after 
about 3-5 years [Nwasokwa 1995; Goldman et al 2004]. At approximately 10 years, 
50 % of all SVGs are occluded, and half of the remaining grafts are expected to be 
severely narrowed due to atherosclerosis [Nwasokwa 1995; Fitzgibbon et al 1996; 
Motwani et al 1998]. Vein graft failures are believed to be the most common reason 
for recurrent coronary symptoms following CABG [Nwasokwa 1995; Fabricius et al 
2001; Goldman et al 2004].  
Numerous studies have shown that about 10 % of all LIMA grafts are 
occluded within 10-15 years. When LIMA occlusions occurs the mechanism seems to 
be different from vein graft occlusions [Nwasokwa 1995; Shimizu et al 2000; 
Goldman et al 2004; Berger et al 2004; Desai et al 2004; Sabik et al 2008]. A 
characteristic lesion observed in the LIMA is the “string phenomenon”, a longitudinal 
narrowing of the LIMA lumen to less than 1 mm over a length of 3-5 cm. The rate of 
the string phenomenon has not been ascertained yet, but it has been estimated to 
happen in 2 % of CABG patients [Villareal et al 2000]. Competitive flow in the 
LIMA is believed to cause the string phenomenon, which is considered an early sign 
of graft failure [Siebenmann et al 1993; Nasu et al 1995; Kawasuji et al 1996; 
Hashimoto et al 1996; Pagni et al 1997; Pagni et al 1997; Hirotani et al 2001; 
Gaudino et al 2002; Sabik et al 2003; Bezon et al 2003; Nakajima et al 2004; Berger 
et al 2004; Sabik et al 2005; Botman et al 2007; Sabik et al 2008].  
Biological properties of the LIMA graft are crucial determinants of its 
resistance to atherosclerosis. The LIMA is an elastic artery and has an enhanced 
endothelial function compared to vein grafts, as shown by greater production of 
vasodilating mediators like NO [Nishioka et al 1998]. The LIMA characteristic of 
higher basal release of vasodilating mediators is likely to play a vital role in 
maintaining the superior vascular patency. In that respect, a promising step in 
improving vein graft patency has been introduced by the so-called “no-touch” method 
during vein harvesting. Early reports on this technique have shown better early- and 
long-term graft patency compared to conventional vein harvesting [Souza et al 2002]. 
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 During conventional vein harvesting, the tissue around the saphenous vein is 
removed and often exposed to high-pressure distension to overcome spasm and 
leakages. The no-touch method involves harvesting the vein with minimal handling 
with the intention of conserving the perivascular adipose tissue. Conserving the 
perivascular tissue may protect the vein by reducing the circumferential stress 
[Kassab et al 2006] as well as maintain long-term sufficient endothelial function 
[Dashwood et al 2005]. Regarding the acute effects, conventional vein harvesting 
induces considerable endothelial injury and reduced NO production compared to the 
no-touch method [Dashwood et al 2005]. 
 As mentioned in chapter 4.2, the shear stress induced by blood flow on the 
endothelium triggers its biochemical responds; thus, it is a major contributor to 
endothelial function. An unfavourable WSS induces an endothelial dysfunction, 
which induces vascular disease such as intimal hyperplasia and atherosclerosis. In 
paper IV, we studied the WSS under competitive flow conditions. At high competitive 
flow, such as when a graft is placed distal to the non-significant coronary stenosis, 
very low and oscillatory WSS was found. This unfavourable WSS may explain the 
LIMA string phenomenon and reduced graft patency by competitive flow.  
The WSS pattern observed under partial competitive flow, simulating the 
clinical condition of a conduit grafted distal to the significant coronary stenosis, was 
comparable to the no competitive flow condition (Figure 17 and 18). We found very 
low and oscillatory WSS during high competitive flow, which simulates a non-
significant coronary stenosis. The WSS pattern during partial competitive flow, 
simulating significant coronary stenosis, was comparable to the condition with no 
competitive flow. Thus, the WSS pattern changed greatly upon the degree of 
competitive flow. Our findings indicate that bypass grafts may tolerate a certain 
degree of competitive flow, which is probably the most frequent situation. In contrast, 
the unfavourable WSS caused by high competitive flow probably has an adverse 
impact on graft patency. Thus, our findings are in line with other studies reporting the 
relationship of graft patency and competitive flow [Siebenmann et al 1993; Nasu et al 
1995; Kawasuji et al 1996; Hashimoto et al 1996; Pagni et al 1997; Pagni et al 1997; 
Hirotani et al 2001; Gaudino et al 2002; Sabik et al 2003; Bezon et al 2003; Nakajima 
et al 2004; Berger et al 2004; Sabik et al 2005; Botman et al 2007; Sabik et al 2008]. 
The consequences of low and oscillatory WSS may very likely be the LIMA string 
phenomenon and subsequent LIMA graft failure [Kassab et al 2006; Reneman et al 
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2006; Chatzizisis et al 2007; Stone et al 2007; John 2009; Davies 2009]. Moreover, 
another additional explanation for the changes seen at competitive flow conditions is 
based on the fact that WSS influences on homeostasis and vessel lumen dimensions 
[Gusic et al 2005; Kassab et al 2006]. The physiological responds may explain, in 
part, the aetiology of the string phenomenon of the LIMA graft: The endothelium 
maintains a sufficient WSS by affecting the vessel radius ( 3R
Q4
S
P W , radius R greatly 
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competitive flow, the vessel narrows in order to increase the WSS, and hence, the 
endothelial function. 
 
  45 
2006; Chatzizisis et al 2007; Stone et al 2007; John 2009; Davies 2009]. Moreover, 
another additional explanation for the changes seen at competitive flow conditions is 
based on the fact that WSS influences on homeostasis and vessel lumen dimensions 
[Gusic et al 2005; Kassab et al 2006]. The physiological responds may explain, in 
part, the aetiology of the string phenomenon of the LIMA graft: The endothelium 
maintains a sufficient WSS by affecting the vessel radius ( 3R
Q4
S
P W , radius R greatly 
LQIOXHQFHV:66 Ĳ 6HH&KDSWHU $W D ORZ DQG RVFLOODWRU\:66 DV XQGHU KLJK
competitive flow, the vessel narrows in order to increase the WSS, and hence, the 
endothelial function. 
 
  45 
2006; Chatzizisis et al 2007; Stone et al 2007; John 2009; Davies 2009]. Moreover, 
another additional explanation for the changes seen at competitive flow conditions is 
based on the fact that WSS influences on homeostasis and vessel lumen dimensions 
[Gusic et al 2005; Kassab et al 2006]. The physiological responds may explain, in 
part, the aetiology of the string phenomenon of the LIMA graft: The endothelium 
maintains a sufficient WSS by affecting the vessel radius ( 3R
Q4
S
P W , radius R greatly 
LQIOXHQFHV:66 Ĳ 6HH&KDSWHU $W D ORZ DQG RVFLOODWRU\:66 DV XQGHU KLJK
competitive flow, the vessel narrows in order to increase the WSS, and hence, the 
endothelial function. 
 
  45 
2006; Chatzizisis et al 2007; Stone et al 2007; John 2009; Davies 2009]. Moreover, 
another additional explanation for the changes seen at competitive flow conditions is 
based on the fact that WSS influences on homeostasis and vessel lumen dimensions 
[Gusic et al 2005; Kassab et al 2006]. The physiological responds may explain, in 
part, the aetiology of the string phenomenon of the LIMA graft: The endothelium 
maintains a sufficient WSS by affecting the vessel radius ( 3R
Q4
S
P W , radius R greatly 
LQIOXHQFHV:66 Ĳ 6HH&KDSWHU $W D ORZ DQG RVFLOODWRU\:66 DV XQGHU KLJK
competitive flow, the vessel narrows in order to increase the WSS, and hence, the 
endothelial function. 
 
  46 
9.  MAIN CONCLUSIONS 
 
-  The statistical analyses of the 1390 flow measurements concluded that the graft 
flow in vein grafts increase gradually from single to double and up to triple sequential 
bypasses. The PIs of vein grafts to the right coronary system were significantly higher 
than in grafts to the left coronary system. However, no PI differences exist between 
single, double and triple sequential vein grafts. In addition, higher graft flow should 
be expected in males compared to female patients.  
 
-  TTFMs cannot detect minor or moderate technical failures in the anastomoses 
because they are not haemodynamically significant. However, competitive flow 
influences the TTFMs early and substantially. During transit-time flowmetry the 
surgeon should particularly be aware of the severity of the coronary stenosis, the size 
of the target coronary vessel and the influence of competitive flow. These 
considerations are essential before final interpretations of TTFMs are made. 
 
- Although the transit-time flowmeters from MediStim ASA and Transonic Inc. have 
presented the same guidelines regarding the PI values, they are not directly 
comparable due to their different default filter settings. The level of filter settings in 
the flowmeter determines the shapes in the flow curves, which results in different PI 
values. Thus, it is important to refer to the type of flowmeter used when presenting 
transit-time flow values.  
 
- Competitive flow, which is known to influence negatively on graft patency, induces 
low and oscillatory wall shear stress (WSS).  The levels of WSS found in our 
computational fluid dynamics model are supposed to have damaging effects on the 
endothelium, inducing endothelial dysfunction. Thus, the low and oscillatory WSS 
seen during high competitive flow may explain the reduced long-term patency of 
bypass grafts and the LIMA “string phenomenon”.  A lower level of competitive flow 
may be better tolerated due to a higher and more unidirectional shear stress, similar to 
the ideal situation with no competitive flow. 
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10.  PROSPECTS OF FUTURE RESEARCH 
 
Further developments within intraoperative quality assessment in CABG 
There is a need for dedicated instruments designed for intraoperative quality 
assessment, for instance scanning areas prior to incisions. The widespread use of new 
technology will largely depend on the cost, ease and sensitivity of the method. 
Transit-time flowmetry may remain the cornerstone for intraoperative quality 
assessment of CABG, but using it in combination with ultrasound imaging may 
provide better and more reliable information in the future. This new approach with 
epicardial ultrasound and TTFMs needs to be validated in clinical studies. 
 
Graft patency  
Improvement of the long-term patency of grafts, especially vein grafts, must remain 
an important aim for future research. Preservation of endothelial function is probably 
essential for long-term patency. Thus, better knowledge of endothelial function, 
especially in vein grafts, is mandatory. Does the conventional way to harvest a vein 
by removing the surrounding tissue reduce the endothelial function and hence the 
long-term patency? A better understanding of WSS and endothelial function, 
atherosclerosis and intimal hyperplasia may lead us to improved operative strategies, 
for instance keeping the surrounding tissue around the vein grafts. Better knowledge 
may also guide us to a biological or pharmacological approach, such as gene therapy.    
There is a need for clinical studies on the impact of WSS and other biomechanical 
forces in different flow conditions and different bypass grafts. Changes in surgical 
practice will only occur if favourable results can be demonstrated in humans. 
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Transit-Time Blood Flow Measurements in
Sequential Saphenous Coronary Artery
Bypass Grafts
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Cardiothoracic Surgery, St. Olav University Hospital, Trondheim, and Institute of Surgical Sciences, The Medical Faculty,
University of Bergen, Norway
Background. Little information is available on transit-
time ﬂow measurements of sequential saphenous vein
grafts. The aim of the study was evaluation of mean
blood ﬂow and pulsatility index of sequential saphenous
vein grafts in a large population of patients operated on
with coronary artery bypass grafting.
Methods. In 581 patients 1,390 grafts were nested into
left internal mammary artery to left anterior descending
artery, single vein grafts, or double and triple sequential
vein grafts, and analyzed.
Results. Within the single vein graft group there were
no differences between ﬂow of grafts to different target
vessels except for diagonals (diagonal versus obtuse
marginal, p < 0.001; versus posterior descending artery,
p  0.035; versus right coronary artery, p  0.003). Flows
measured in single vein grafts were signiﬁcantly lower
than in double (p < 0.001) and triple sequential vein
grafts (p < 0.001). Flows were lower in double versus
triple sequential vein grafts (p  0.017) and higher in
men versus women (p < 0.001). Mean pulsatility index of
vein grafts were lower in the left versus the right coro-
nary system, 2.0  0.01 and 2.4  0.06, respectively (p <
0.001). Between sex and groups of vein grafts within
each coronary system, mean pulsatility index had sim-
ilar values.
Conclusions. Blood ﬂow increases from single to dou-
ble and up to triple sequential grafts. Single grafts
directed to diagonals have the lowest ﬂow. Graft blood
ﬂows are higher in male versus female patients. Single,
double, and triple saphenous vein grafts have similar
pulsatility indexes. Pulsatility index of grafts to the right
coronary system is signiﬁcantly higher than that of grafts
to the left coronary system.
(Ann Thorac Surg 2009;87:1409–15)
© 2009 by The Society of Thoracic Surgeons
Coronary artery bypass graft (CABG) surgery is anestablished treatment for angina pectoris of isch-
emic origin and can increase life quality and expectancy
as well as reduce ischemic complications [1, 2]. Long-
term results depend on the patency of grafts [3]. Vein
grafts show poor long-term patency and limit the long-
term success of CABG. Approximately 60% to 70% of
saphenous vein grafts (SVGs) will be narrowed or closed
down within a decade; in contrast, 90% of internal mam-
mary artery grafts remain patent at 10 years [4–6].
Angiography is still the gold standard for intraopera-
tive graft assessment, but it is rarely carried out routinely
because of logistics and lack of time. Nowadays, transit-
time ﬂow measurement is the most common method for
intraoperative assessment of CABG. Several studies have
reported blood ﬂows in arterial and saphenous vein graft
(SVG) by transit-time ﬂowmetry [7–12]. Nonetheless,
little information is available regarding sequential SVGs,
which together with left internal mammary artery
(LIMA) to left anterior descending artery (LAD), are
still the routine conduits for surgical myocardial
revascularization.
To assess the performance of sequential SVGs, a com-
parisons of mean blood ﬂows and pulsatility index (PI) of
single versus sequential SVGs was carried out by the
retrospective analysis of results obtained in a large pop-
ulation of patients operated on with CABG by a single
surgeon.
Material and Methods
From 2000 to 2005, 595 consecutive patients were oper-
ated on by the same senior surgeon (R.H.). Routine
transit-time ﬂow measurements of all grafts were carried
out at the end of the procedure as a quality control.
Patients’ clinical characteristics are presented in Table 1.
The grafts considered for analysis were LIMA to LAD,
single SVG, and double and triple sequential SVG. Alto-
gether, 347 (60%) patients received a sequential SVG.
Of the 595 patients, 14 patients (2%) were excluded
Accepted for publication Feb 9, 2009.
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Surgery, St. Olav University Hospital, Trondheim, N-7018, Norway;
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from the analysis because of missing data. In the remain-
ing 581 patients, a total of 1,552 grafts were constructed.
Of these, 162 grafts (10%) were excluded from further
analyses: 15 grafts with a mean ﬂow less than 15 mL/min
and PI greater than 5 as a result of a poor peripheral
vascular bed (2 sequential SVGs, 3 LIMA-LAD, 10 single
SVGs) [13], 10 grafts made of different (right internal
mammary artery, radial) or composite (Y graft, quadru-
ple sequential SVG) conduits, and 137 grafts with incom-
plete ﬂow data. Thus, the analysis was carried out on
1,390 grafts.
All data were entered into a single clinical database
according to the regulation of the Norwegian Social Science
Data Services. The local ethical committee granted ap-
proval to this study on the basis of a quality control;
therefore no informed consent was required.
Table 2. Mean Blood Flow and Pulsatility Index Values
Graft Target Vessel
Male Female
N (grafts) Flow (mL/min) PI N (grafts) Flow (mL/min) PI
Single LIMA LAD 386 34  22 2.4  0.9 109 27  15 2.2  0.8
Single SVG Diagonal 60 36  18 1.9  0.8 15 32  17 1.6  0.3
PDA 200 47  26 2.5  1.5 59 42  28 2.2  1.0
OM 78 54  29 2.1  1.0 24 48  26 2.0  0.7
RCA 37 56  32 2.3  1.6 19 49  22 2.1  1.1
Posterior-lateral 12 54  33 2.8  1.7 0 . . . . . .
LAD 20 56  25 2.1  0.8 9 51  23 1.9  0.9
Double SSVG PDA-posterior 33 62  32 2.3  1.0 8 50  26 3.0  1.5
OM-OM 57 62  33 2.1  0.9 13 44  20 1.9  0.5
Diagonal-diagonal 9 74  42 1.9  0.9 0 . . . . . .
OM-diagonal 153 73  33 1.9  0.9 43 56  28 2.1  1.2
Triple SSVG Left coronary
artery system
37 84  44 2.1  0.7 9 75  19 2.0  0.7
Mean values are  1 standard deviation.
LAD  left anterior descending artery; LIMA  left internal mammary artery; OM  obtuse marginal; PDA  posterior descending
artery; PI  pulsatility index; RCA  right coronary artery; SSVG  sequential saphenous vein graft; SVG  saphenous vein graft.
Table 1. Patients’ Clinical Characteristicsa
Variable Total Male Female p Value
Patients (N) 581 445 136 0.001b
Age (y) 66  10 65  10 70  9 0.001b
Coronary vessel disease 0.084b
1 VD 66 42 (9%) 24 (18%)
2 VD 97 73 (16%) 24 (18%)
3 VD 238 181 (42%) 57 (41%)
LMS only 8 7 (2%) 1 (1%)
1 VD  LMS 13 10 (2%) 3 (2%)
2 VD  LMS 42 33 (7%) 9 (7%)
3 VD  LMS 117 99 (22%) 18 (13%)
Unstable angina 230 (41%) 181 (40%) 49 (36%) 0.3c
Distal anastomoses 3.4  1.2 3.5  1.2 3.1  1.3 0.001c
Euroscore 5  3 4  3 6  3 0.001b
BMI (kg/m2) 27  4 27  4 26  5 0.6b
Left ventricular EF 0.63  0.15 0.62  0.14 0.65  0.16 0.049b
Redo 29 (5%) 23 (5%) 6 (4%) 0.7c
On-pump CABG 436 (75%) 353 (79%) 83 (61%) 0.001c
Off-pump CABG 61 (11%) 42 (9%) 19 (14%) 0.1c
CABG  AVR 73 (13%) 41 (9%) 32 (24%) 0.001c
CABG  MVR/ MVr 11 (2%) 8 (2%) 3 (2%) 0.8c
a Mean values are  1 standard deviation. Probability value refers to male versus female. b Student’s t test for equality of mean. c 2 test.
AVR  aortic valve replacement; BMI  body mass index; CABG  coronary artery bypass grafting; EF  ejection fraction; LMS  left
main stem stenosis; MVR  mitral valve replacement; MVr  mitral valve repair; VD  vessel disease.
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Operative Technique
The approach to the heart was through a median ster-
notomy in all cases. A pedicled LIMA was harvested by
diathermia. The greater saphenous vein was stored in
heparin solution with 0.05% papaverine after harvesting.
Cardiopulmonary bypass was performed with moderate
hypothermia (34°C). The heart was arrested by infusion
of antegrade and retrograde crystalloid or cold blood
cardioplegia. In off-pump operations the target vessel
was snared with 4-0 pledgeted polypropylene suture
(Prolene; Ethicon, Somerville, NJ) proximal to the coro-
nary arteriotomy. After 3 to 5 minutes of ischemic pre-
conditioning, the snare was released and an epicardial
stabilizer applied to pull the heart and immobilize the
vessel site chosen for grafting. After arteriotomy an
intracoronary shunt (CardioThoracic System, Cupertino,
CA) was positioned into the vessel lumen.
Grafting was attempted on all vessels measuring 1 mm
or more in diameter with a 50% or greater stenosis. The
surgical policy was to carry out sequential grafting any
time it was considered feasible. The LIMA was always
grafted to the LAD end-to-side. The single SVG anasto-
mosis was also constructed end-to-side, whereas in the
sequential SVG the distal end-to-side anastomosis was
constructed before the side-by-side anastomosis. All
LIMA and vein anastomoses were sutured with 7-0
Prolene. The proximal anastomoses were made after
release of the aortic cross-clamp and by applying a
side-biting clamp on the ascending aorta.
Transit-Time Flow Measurements
Grafts were assessed in stable hemodynamic conditions
10 to 15 minutes after cardiopulmonary bypass discon-
tinuation. In off-pump patients, the ﬂow measurements
were recorded after completion of all distal anastomoses.
Mean systemic arterial blood pressure during measure-
ments was 68  8 mm Hg.
Measurements were carried out by 3- or 4-mm ﬂow
probes connected to a transit-time ﬂowmeter (Medi-Stim
ASA, Oslo, Norway). Both for single and sequential SVGs
the ﬂow probe was placed about 2 cm below the proximal
anastomosis. The LIMA ﬂow was assessed by applying
the probe around a skeletonized distal site.
In all grafts the ﬂow measurements included mean
ﬂow and the PI. The PI is a dimensionless positive
number that is considered as an indicator of peripheral
vascular resistance. This is automatically calculated by
the ﬂowmeter according to the following formula: PI 
[maximum volumetric peak ﬂow  minimum volumetric
peak ﬂow]/mean volumetric ﬂow.
Based on work by Belboul and coworkers [14], mean
ﬂows and PIs were divided according to patients’ sex,
target vessel, and left and right coronary circulation. The
intermediate coronary branch was considered as diago-
nal. Because the posterior descending and posterior-
lateral branches originated from the right coronary artery
in most cases, they were considered part of the right
coronary system.
Table 3. Estimated Mean Flowsa
Males Females
Graft N Mean Flow (mL/min)
95% CI
N Mean Flow (mL/min)
95% CI
Low High Low High
LIMA to LAD 386 35 32 38 109 26 22 31
SVG to
Diagonal
60 42 36 49 15 34 26 41
Single SVG 347 50 47 53 111 42 37 46
Double SSVG 252 69 65 72 64 60 55 65
Triple SSVG 37 81 74 89 9 73 64 81
a Covariates appearing in the model are evaluated at the following values: age  66 years; left ventricular ejection fraction  0.63; mean arterial
pressure  68 mm Hg.
CI  conﬁdence interval; LAD  left anterior descending artery; LIMA  left internal mammary artery; SSVG  sequential saphenous vein
graft; SVG  saphenous vein graft.
Table 4. Factors Inﬂuencing Blood Flow in Coronary Artery
Bypass Graftsa
Factors
Flow
Estimate SEM t Ratio
p
Value
Male 8.7 2.4 3.7 0.001
EF 0.23 0.06 3.56 0.001
Age 0.21 0.10 2.12 0.034
LIMA to LAD 46 4 11.9 0.001
Single SVG 39 5 7.9 0.001
SVG to diagonal 31 4 7.9 0.001
Double SSVG 13 4 3.1 0.002
Triple SSVG 0
Intercept 61.3 11.9 5.2 0.001
a The table shows the ﬁxed factors inﬂuencing the ﬂow in all coronary
bypass grafts according to the linear mixed model. Triple SSVG is the
reference level (N  1,390).
EF  ejection fraction; LAD  left anterior descending artery;
LIMA  left internal mammary artery; SEM  standard error of the
mean; SSVG  sequential saphenous vein graft; SVG  saphe-
nous vein graft.
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Operative Technique
The approach to the heart was through a median ster-
notomy in all cases. A pedicled LIMA was harvested by
diathermia. The greater saphenous vein was stored in
heparin solution with 0.05% papaverine after harvesting.
Cardiopulmonary bypass was performed with moderate
hypothermia (34°C). The heart was arrested by infusion
of antegrade and retrograde crystalloid or cold blood
cardioplegia. In off-pump operations the target vessel
was snared with 4-0 pledgeted polypropylene suture
(Prolene; Ethicon, Somerville, NJ) proximal to the coro-
nary arteriotomy. After 3 to 5 minutes of ischemic pre-
conditioning, the snare was released and an epicardial
stabilizer applied to pull the heart and immobilize the
vessel site chosen for grafting. After arteriotomy an
intracoronary shunt (CardioThoracic System, Cupertino,
CA) was positioned into the vessel lumen.
Grafting was attempted on all vessels measuring 1 mm
or more in diameter with a 50% or greater stenosis. The
surgical policy was to carry out sequential grafting any
time it was considered feasible. The LIMA was always
grafted to the LAD end-to-side. The single SVG anasto-
mosis was also constructed end-to-side, whereas in the
sequential SVG the distal end-to-side anastomosis was
constructed before the side-by-side anastomosis. All
LIMA and vein anastomoses were sutured with 7-0
Prolene. The proximal anastomoses were made after
release of the aortic cross-clamp and by applying a
side-biting clamp on the ascending aorta.
Transit-Time Flow Measurements
Grafts were assessed in stable hemodynamic conditions
10 to 15 minutes after cardiopulmonary bypass discon-
tinuation. In off-pump patients, the ﬂow measurements
were recorded after completion of all distal anastomoses.
Mean systemic arterial blood pressure during measure-
ments was 68  8 mm Hg.
Measurements were carried out by 3- or 4-mm ﬂow
probes connected to a transit-time ﬂowmeter (Medi-Stim
ASA, Oslo, Norway). Both for single and sequential SVGs
the ﬂow probe was placed about 2 cm below the proximal
anastomosis. The LIMA ﬂow was assessed by applying
the probe around a skeletonized distal site.
In all grafts the ﬂow measurements included mean
ﬂow and the PI. The PI is a dimensionless positive
number that is considered as an indicator of peripheral
vascular resistance. This is automatically calculated by
the ﬂowmeter according to the following formula: PI 
[maximum volumetric peak ﬂow  minimum volumetric
peak ﬂow]/mean volumetric ﬂow.
Based on work by Belboul and coworkers [14], mean
ﬂows and PIs were divided according to patients’ sex,
target vessel, and left and right coronary circulation. The
intermediate coronary branch was considered as diago-
nal. Because the posterior descending and posterior-
lateral branches originated from the right coronary artery
in most cases, they were considered part of the right
coronary system.
Table 3. Estimated Mean Flowsa
Males Females
Graft N Mean Flow (mL/min)
95% CI
N Mean Flow (mL/min)
95% CI
Low High Low High
LIMA to LAD 386 35 32 38 109 26 22 31
SVG to
Diagonal
60 42 36 49 15 34 26 41
Single SVG 347 50 47 53 111 42 37 46
Double SSVG 252 69 65 72 64 60 55 65
Triple SSVG 37 81 74 89 9 73 64 81
a Covariates appearing in the model are evaluated at the following values: age  66 years; left ventricular ejection fraction  0.63; mean arterial
pressure  68 mm Hg.
CI  conﬁdence interval; LAD  left anterior descending artery; LIMA  left internal mammary artery; SSVG  sequential saphenous vein
graft; SVG  saphenous vein graft.
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Male 8.7 2.4 3.7 0.001
EF 0.23 0.06 3.56 0.001
Age 0.21 0.10 2.12 0.034
LIMA to LAD 46 4 11.9 0.001
Single SVG 39 5 7.9 0.001
SVG to diagonal 31 4 7.9 0.001
Double SSVG 13 4 3.1 0.002
Triple SSVG 0
Intercept 61.3 11.9 5.2 0.001
a The table shows the ﬁxed factors inﬂuencing the ﬂow in all coronary
bypass grafts according to the linear mixed model. Triple SSVG is the
reference level (N  1,390).
EF  ejection fraction; LAD  left anterior descending artery;
LIMA  left internal mammary artery; SEM  standard error of the
mean; SSVG  sequential saphenous vein graft; SVG  saphe-
nous vein graft.
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the ﬂow probe was placed about 2 cm below the proximal
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number that is considered as an indicator of peripheral
vascular resistance. This is automatically calculated by
the ﬂowmeter according to the following formula: PI 
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peak ﬂow]/mean volumetric ﬂow.
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ﬂows and PIs were divided according to patients’ sex,
target vessel, and left and right coronary circulation. The
intermediate coronary branch was considered as diago-
nal. Because the posterior descending and posterior-
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in most cases, they were considered part of the right
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Statistical Analysis
Data are presented as the mean  1 standard deviation.
All data were reviewed retrospectively. The grafts were
naturally nested into four groups: LIMA-LAD, and sin-
gle, double, and triple sequential SVGs. Comparison of
ﬂow values within these groups and overall comparison
among the groups were done using a linear mixed model.
Sex, age, blood pressure, and ejection fraction were
initially included in the model, and statistically nonsig-
niﬁcant terms were sequentially removed. The mixed
model also incorporated correlation of grafts within each
patient [15]. Pairwise post-hoc comparisons were ad-
justed for multiple comparisons using the Bonferroni
technique. Categorical variables were analyzed using a 2
test, and continuous variables using a two-tailed Stu-
dent’s t test with equal or unequal variances based on the
ﬁndings of an initial F test for equality of variance. A
probability value of less than 0.05 was considered signif-
icant. Statistical analysis was performed by SPSS for
Windows 15 (SPSS Inc, Chicago, IL).
Results
Of the 1,390 grafts constituting the study, 1,385 were
found satisfactory at the transit-time ﬂow measurements
control, whereas 5 grafts (0.4%; 2 LIMA-to-LADs, 3 single
SVGs to obtuse marginal, posterior descending, and
LAD) required revision of the anastomosis because of
unexpected low ﬂows and high PIs attributable to tech-
nical failure or incorrect placement of the anastomosis.
After revision both ﬂows and PI were within satisfactory
ranges.
Graft Flow
Mean ﬂow values of grafts directed to different target
vessels are shown in Table 2. In Figure 1, the box plots
depict ﬂow values when categorized in LIMA-to-LAD,
single SVG, and double and triple sequential SVGs,
whereas Table 3 shows the estimated mean values from
the statistical model. Within the single SVG group there
were no signiﬁcant differences between ﬂows in grafts
directed to different target vessels except for the diagonal
(diagonal versus obtuse marginal, p  0.001; diagonal ver-
sus posterior descending artery, p  0.035; diagonal versus
right coronary artery, p  0.003). This behavior was taken
into consideration for further analysis by grouping to-
gether all single SVGs, whereas those directed to the
diagonal were treated as an additional group. Within the
double sequential group the target vessels of the grafts
made no signiﬁcant difference (p  0.093).
Table 4 shows the ﬁxed factors inﬂuencing the ﬂow in
all CABGs according to the linear mixed model. Overall,
graft ﬂows were 9 mL/min higher for men than for
women (p  0.001). Age and left ventricular ejection
fraction also made signiﬁcant contributions to the model.
Flow was not signiﬁcantly inﬂuenced by the perfusion
pressure (p  0.115).
The pairwise post-hoc comparison showed ﬂows in
single SVGs were signiﬁcantly lower when compared
with double (p  0.001) and triple sequential SVGs (p 
0.001; Fig 1, Table 3). Flows in single SVG to diagonal
were signiﬁcantly lower than ﬂows in double and triple
sequential SVG (p  0.001, respectively). Flows in double
sequential SVGs were signiﬁcantly lower than those in
triple sequential SVGs (p  0.017).
Pulsatility Index
Mean PI values of grafts directed to different target
vessels are shown in Table 2. Figure 2 shows PI values in
single and sequential SVG to the left and right coronary
system. Overall, the mean PI  standard error of the
mean of SVG to the left or right coronary system were
2.0  0.05 and 2.4  0.06, respectively, with the difference
Fig 1. Transit-time blood ﬂows in different coronary bypass grafts
(581 patients; 1,390 grafts) in a box plot diagram. All triple sequen-
tial saphenous vein grafts (SSVGs) were directed to the left coronary
artery system. (LAD  left anterior descending artery; LIMA  left
internal mammary artery; SVG  saphenous vein graft.)
Fig 2. Pulsatility index (PI) in single saphenous vein grafts (SVGs)
and double and triple sequential saphenous vein grafts (SSVGs),
divided by right and left coronary system presented in a box plot
diagram. (SEM  standard error of the mean.)
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diagonal were treated as an additional group. Within the
double sequential group the target vessels of the grafts
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Table 4 shows the ﬁxed factors inﬂuencing the ﬂow in
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graft ﬂows were 9 mL/min higher for men than for
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fraction also made signiﬁcant contributions to the model.
Flow was not signiﬁcantly inﬂuenced by the perfusion
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sequential SVG (p  0.001, respectively). Flows in double
sequential SVGs were signiﬁcantly lower than those in
triple sequential SVGs (p  0.017).
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Mean PI values of grafts directed to different target
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single and sequential SVG to the left and right coronary
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model also incorporated correlation of grafts within each
patient [15]. Pairwise post-hoc comparisons were ad-
justed for multiple comparisons using the Bonferroni
technique. Categorical variables were analyzed using a 2
test, and continuous variables using a two-tailed Stu-
dent’s t test with equal or unequal variances based on the
ﬁndings of an initial F test for equality of variance. A
probability value of less than 0.05 was considered signif-
icant. Statistical analysis was performed by SPSS for
Windows 15 (SPSS Inc, Chicago, IL).
Results
Of the 1,390 grafts constituting the study, 1,385 were
found satisfactory at the transit-time ﬂow measurements
control, whereas 5 grafts (0.4%; 2 LIMA-to-LADs, 3 single
SVGs to obtuse marginal, posterior descending, and
LAD) required revision of the anastomosis because of
unexpected low ﬂows and high PIs attributable to tech-
nical failure or incorrect placement of the anastomosis.
After revision both ﬂows and PI were within satisfactory
ranges.
Graft Flow
Mean ﬂow values of grafts directed to different target
vessels are shown in Table 2. In Figure 1, the box plots
depict ﬂow values when categorized in LIMA-to-LAD,
single SVG, and double and triple sequential SVGs,
whereas Table 3 shows the estimated mean values from
the statistical model. Within the single SVG group there
were no signiﬁcant differences between ﬂows in grafts
directed to different target vessels except for the diagonal
(diagonal versus obtuse marginal, p  0.001; diagonal ver-
sus posterior descending artery, p  0.035; diagonal versus
right coronary artery, p  0.003). This behavior was taken
into consideration for further analysis by grouping to-
gether all single SVGs, whereas those directed to the
diagonal were treated as an additional group. Within the
double sequential group the target vessels of the grafts
made no signiﬁcant difference (p  0.093).
Table 4 shows the ﬁxed factors inﬂuencing the ﬂow in
all CABGs according to the linear mixed model. Overall,
graft ﬂows were 9 mL/min higher for men than for
women (p  0.001). Age and left ventricular ejection
fraction also made signiﬁcant contributions to the model.
Flow was not signiﬁcantly inﬂuenced by the perfusion
pressure (p  0.115).
The pairwise post-hoc comparison showed ﬂows in
single SVGs were signiﬁcantly lower when compared
with double (p  0.001) and triple sequential SVGs (p 
0.001; Fig 1, Table 3). Flows in single SVG to diagonal
were signiﬁcantly lower than ﬂows in double and triple
sequential SVG (p  0.001, respectively). Flows in double
sequential SVGs were signiﬁcantly lower than those in
triple sequential SVGs (p  0.017).
Pulsatility Index
Mean PI values of grafts directed to different target
vessels are shown in Table 2. Figure 2 shows PI values in
single and sequential SVG to the left and right coronary
system. Overall, the mean PI  standard error of the
mean of SVG to the left or right coronary system were
2.0  0.05 and 2.4  0.06, respectively, with the difference
Fig 1. Transit-time blood ﬂows in different coronary bypass grafts
(581 patients; 1,390 grafts) in a box plot diagram. All triple sequen-
tial saphenous vein grafts (SSVGs) were directed to the left coronary
artery system. (LAD  left anterior descending artery; LIMA  left
internal mammary artery; SVG  saphenous vein graft.)
Fig 2. Pulsatility index (PI) in single saphenous vein grafts (SVGs)
and double and triple sequential saphenous vein grafts (SSVGs),
divided by right and left coronary system presented in a box plot
diagram. (SEM  standard error of the mean.)
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being signiﬁcant (p  0.001). There were no signiﬁcant
differences between PI values for any type of grafts
within the single and double SVG group to the left or
right coronary system (p  0.001). Moreover, PI values of
single versus double versus triple SVG group within the
left coronary system were not signiﬁcantly different (p 
0.244). Similarly, PI values of single versus double SVGs
to the right coronary system were also not signiﬁcantly
different (p  0.126). Pulsatility index values were similar
for men and women (p  0.534).
Comment
Although several clinical series have demonstrated that
the sequential bypass grafting technique has excellent
long-term results [16–18], this technique remains a con-
troversial one. This is particularly true considering that
the majority of studies on sequential technique go back
at least a decade, when transit-time ﬂowmetry was
unavailable.
Our study analyzed routine recordings of intraopera-
tive transit-time ﬂow measurements of sequential SVGs
in a large population of patients operated on by one
surgeon. Thus, the same surgical technique of coronary
artery grafting and standard of measurements were ap-
plied in all patients, avoiding operator-related biases at
the time of statistical analysis of the outcome.
The ﬁrst ﬁnding was an increased blood ﬂow in se-
quential SVG compared with single SVG. This observa-
tion was consistent for both male and female patients,
with male patients exhibiting the highest ﬂows. Speciﬁ-
cally, male patients were predicted to have a graft blood
ﬂow 8.7 mL/min higher than women of the same age and
left ventricular ejection fraction. The blood ﬂow in-
creased according to the number of distal anastomoses:
from a lower ﬂow in single SVGs to a higher ﬂow in
double sequentials and up to the highest ﬂow in triple
sequentials. The trend was conﬁrmed by our linear
mixed model predicting that in patients of the same age,
sex, and left ventricular ejection fraction, a triple sequen-
tial graft has 13 and 39 mL/min ﬂow higher than double
sequential and single SVG, respectively. This behavior is
recognized to be caused by decreased total resistance,
better run-off, and minimized impedance difference.
The variables generally used for evaluation of the ﬂow
rate are graft quality and diameter, and the resistance
posed by the native coronary vessel. If one considers that
the diameters of SVGs are relatively constant for a given
patient, and the resistance posed by an SVG is negligible
when compared with that of its coronary counterpart, the
resistance of the native coronary vessels remains the
principal determinant of the ﬂow rate [17]. Therefore, if
individual resistances of the grafted coronaries are as-
sumed to be equivalent, a double sequential graft should
pose only half of the resistance of an individual graft.
Thus, the single SVGs are more resistant than sequential
conduits, and are expected to have a lower ﬂow com-
pared with the sequential ones. Although all the differ-
ences among the three ﬂow values reached statistical
signiﬁcance, ﬂows in double and triple sequential SVGs
were not twofold or threefold higher, respectively, com-
pared with ﬂows in single SVGs. This observation is
consistent with the conclusion by Gwozdziewicz and
coworkers [19] that blood ﬂow through an individual
bypass is comparable with that through the distal seg-
ment (end-to-side anastomosis) of a double sequential
bypass. A likely explanation may be the relation between
the capacity of the graft and the blood ﬂow velocity in the
graft. Although a sequential SVG would be able to
provide a blood supply two or three times larger than a
single SVG, this will not occur because blood ﬂow veloc-
ity should be similarly high. The native coronary blood
ﬂow velocity is relatively ﬁxed because it is dependent on
the cross-sectional area of the coronary lumen and re-
gional left ventricular mass [20].
Within the single SVG group, grafts directed to diag-
onal branches exhibited signiﬁcantly lower ﬂows than
those directed to other target vessels, and this held true
both for men and women. The explanation is that diag-
onals may be vessels of a smaller diameter and with less
peripheral ﬂow reserve, thus posing a higher coronary
resistance. Signiﬁcantly lower ﬂows of single grafts to
diagonals were also reported by Hassenein and col-
leagues [21]. Overall, ﬂows were signiﬁcantly higher in
men versus women because the former are assumed to
have coronary arteries of larger diameter than the latter
as well as larger ventricular mass [22].
Surprisingly, and in contrast to comparable studies
[9–12], we measured a lower ﬂow in the LIMA-LAD
grafts compared with vein grafts directed to the LAD. We
believe this may be caused by some degree of spasm of
the LIMA graft, as no vasodilators (eg, papaverine) were
used routinely.
With regard to the PI, our results show that single,
double, and triple SVGs all had similar PI values without
signiﬁcant differences among the three groups. The only
difference was the higher PI in the right coronary system
compared with the left, and this was true both for male
and female patients. These ﬁndings are opposite to what
one could expect as sequential grafts provide higher
ﬂows owing to a reduced peripheral vascular resistance.
Thus, sequential grafts should theoretically provide
lower PIs compared with single SVGs. Nonetheless, our
data indicate that the increased blood ﬂow from single to
sequential SVGs is not associated with a decrease of PI.
The likely explanation is that the shape of the ﬂow curves
of the single and sequential grafts are similar, resulting in
similar PI values. Thus PI, a dimensionless number
derived from an equation considering the maximum and
minimum peaks and mean ﬂow measurements, will
change concomitantly with marked changes of the ﬂow
curve. This is typically seen as a gross increase of resis-
tance in the bypass grafts (ie, technical failure of the
anastomosis, graft kinking or torsion) or coronary arteries
(ie, small diameter, poor runoff). This is in line with the
reports by Morota and coworkers [23], who showed a
large increase of PI as a consequence of a progressive
tightening of the LIMA-LAD graft in the pig causing a
reduced mean ﬂow. On the other hand, the right coro-
nary system had signiﬁcantly higher PI values com-
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being signiﬁcant (p  0.001). There were no signiﬁcant
differences between PI values for any type of grafts
within the single and double SVG group to the left or
right coronary system (p  0.001). Moreover, PI values of
single versus double versus triple SVG group within the
left coronary system were not signiﬁcantly different (p 
0.244). Similarly, PI values of single versus double SVGs
to the right coronary system were also not signiﬁcantly
different (p  0.126). Pulsatility index values were similar
for men and women (p  0.534).
Comment
Although several clinical series have demonstrated that
the sequential bypass grafting technique has excellent
long-term results [16–18], this technique remains a con-
troversial one. This is particularly true considering that
the majority of studies on sequential technique go back
at least a decade, when transit-time ﬂowmetry was
unavailable.
Our study analyzed routine recordings of intraopera-
tive transit-time ﬂow measurements of sequential SVGs
in a large population of patients operated on by one
surgeon. Thus, the same surgical technique of coronary
artery grafting and standard of measurements were ap-
plied in all patients, avoiding operator-related biases at
the time of statistical analysis of the outcome.
The ﬁrst ﬁnding was an increased blood ﬂow in se-
quential SVG compared with single SVG. This observa-
tion was consistent for both male and female patients,
with male patients exhibiting the highest ﬂows. Speciﬁ-
cally, male patients were predicted to have a graft blood
ﬂow 8.7 mL/min higher than women of the same age and
left ventricular ejection fraction. The blood ﬂow in-
creased according to the number of distal anastomoses:
from a lower ﬂow in single SVGs to a higher ﬂow in
double sequentials and up to the highest ﬂow in triple
sequentials. The trend was conﬁrmed by our linear
mixed model predicting that in patients of the same age,
sex, and left ventricular ejection fraction, a triple sequen-
tial graft has 13 and 39 mL/min ﬂow higher than double
sequential and single SVG, respectively. This behavior is
recognized to be caused by decreased total resistance,
better run-off, and minimized impedance difference.
The variables generally used for evaluation of the ﬂow
rate are graft quality and diameter, and the resistance
posed by the native coronary vessel. If one considers that
the diameters of SVGs are relatively constant for a given
patient, and the resistance posed by an SVG is negligible
when compared with that of its coronary counterpart, the
resistance of the native coronary vessels remains the
principal determinant of the ﬂow rate [17]. Therefore, if
individual resistances of the grafted coronaries are as-
sumed to be equivalent, a double sequential graft should
pose only half of the resistance of an individual graft.
Thus, the single SVGs are more resistant than sequential
conduits, and are expected to have a lower ﬂow com-
pared with the sequential ones. Although all the differ-
ences among the three ﬂow values reached statistical
signiﬁcance, ﬂows in double and triple sequential SVGs
were not twofold or threefold higher, respectively, com-
pared with ﬂows in single SVGs. This observation is
consistent with the conclusion by Gwozdziewicz and
coworkers [19] that blood ﬂow through an individual
bypass is comparable with that through the distal seg-
ment (end-to-side anastomosis) of a double sequential
bypass. A likely explanation may be the relation between
the capacity of the graft and the blood ﬂow velocity in the
graft. Although a sequential SVG would be able to
provide a blood supply two or three times larger than a
single SVG, this will not occur because blood ﬂow veloc-
ity should be similarly high. The native coronary blood
ﬂow velocity is relatively ﬁxed because it is dependent on
the cross-sectional area of the coronary lumen and re-
gional left ventricular mass [20].
Within the single SVG group, grafts directed to diag-
onal branches exhibited signiﬁcantly lower ﬂows than
those directed to other target vessels, and this held true
both for men and women. The explanation is that diag-
onals may be vessels of a smaller diameter and with less
peripheral ﬂow reserve, thus posing a higher coronary
resistance. Signiﬁcantly lower ﬂows of single grafts to
diagonals were also reported by Hassenein and col-
leagues [21]. Overall, ﬂows were signiﬁcantly higher in
men versus women because the former are assumed to
have coronary arteries of larger diameter than the latter
as well as larger ventricular mass [22].
Surprisingly, and in contrast to comparable studies
[9–12], we measured a lower ﬂow in the LIMA-LAD
grafts compared with vein grafts directed to the LAD. We
believe this may be caused by some degree of spasm of
the LIMA graft, as no vasodilators (eg, papaverine) were
used routinely.
With regard to the PI, our results show that single,
double, and triple SVGs all had similar PI values without
signiﬁcant differences among the three groups. The only
difference was the higher PI in the right coronary system
compared with the left, and this was true both for male
and female patients. These ﬁndings are opposite to what
one could expect as sequential grafts provide higher
ﬂows owing to a reduced peripheral vascular resistance.
Thus, sequential grafts should theoretically provide
lower PIs compared with single SVGs. Nonetheless, our
data indicate that the increased blood ﬂow from single to
sequential SVGs is not associated with a decrease of PI.
The likely explanation is that the shape of the ﬂow curves
of the single and sequential grafts are similar, resulting in
similar PI values. Thus PI, a dimensionless number
derived from an equation considering the maximum and
minimum peaks and mean ﬂow measurements, will
change concomitantly with marked changes of the ﬂow
curve. This is typically seen as a gross increase of resis-
tance in the bypass grafts (ie, technical failure of the
anastomosis, graft kinking or torsion) or coronary arteries
(ie, small diameter, poor runoff). This is in line with the
reports by Morota and coworkers [23], who showed a
large increase of PI as a consequence of a progressive
tightening of the LIMA-LAD graft in the pig causing a
reduced mean ﬂow. On the other hand, the right coro-
nary system had signiﬁcantly higher PI values com-
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being signiﬁcant (p  0.001). There were no signiﬁcant
differences between PI values for any type of grafts
within the single and double SVG group to the left or
right coronary system (p  0.001). Moreover, PI values of
single versus double versus triple SVG group within the
left coronary system were not signiﬁcantly different (p 
0.244). Similarly, PI values of single versus double SVGs
to the right coronary system were also not signiﬁcantly
different (p  0.126). Pulsatility index values were similar
for men and women (p  0.534).
Comment
Although several clinical series have demonstrated that
the sequential bypass grafting technique has excellent
long-term results [16–18], this technique remains a con-
troversial one. This is particularly true considering that
the majority of studies on sequential technique go back
at least a decade, when transit-time ﬂowmetry was
unavailable.
Our study analyzed routine recordings of intraopera-
tive transit-time ﬂow measurements of sequential SVGs
in a large population of patients operated on by one
surgeon. Thus, the same surgical technique of coronary
artery grafting and standard of measurements were ap-
plied in all patients, avoiding operator-related biases at
the time of statistical analysis of the outcome.
The ﬁrst ﬁnding was an increased blood ﬂow in se-
quential SVG compared with single SVG. This observa-
tion was consistent for both male and female patients,
with male patients exhibiting the highest ﬂows. Speciﬁ-
cally, male patients were predicted to have a graft blood
ﬂow 8.7 mL/min higher than women of the same age and
left ventricular ejection fraction. The blood ﬂow in-
creased according to the number of distal anastomoses:
from a lower ﬂow in single SVGs to a higher ﬂow in
double sequentials and up to the highest ﬂow in triple
sequentials. The trend was conﬁrmed by our linear
mixed model predicting that in patients of the same age,
sex, and left ventricular ejection fraction, a triple sequen-
tial graft has 13 and 39 mL/min ﬂow higher than double
sequential and single SVG, respectively. This behavior is
recognized to be caused by decreased total resistance,
better run-off, and minimized impedance difference.
The variables generally used for evaluation of the ﬂow
rate are graft quality and diameter, and the resistance
posed by the native coronary vessel. If one considers that
the diameters of SVGs are relatively constant for a given
patient, and the resistance posed by an SVG is negligible
when compared with that of its coronary counterpart, the
resistance of the native coronary vessels remains the
principal determinant of the ﬂow rate [17]. Therefore, if
individual resistances of the grafted coronaries are as-
sumed to be equivalent, a double sequential graft should
pose only half of the resistance of an individual graft.
Thus, the single SVGs are more resistant than sequential
conduits, and are expected to have a lower ﬂow com-
pared with the sequential ones. Although all the differ-
ences among the three ﬂow values reached statistical
signiﬁcance, ﬂows in double and triple sequential SVGs
were not twofold or threefold higher, respectively, com-
pared with ﬂows in single SVGs. This observation is
consistent with the conclusion by Gwozdziewicz and
coworkers [19] that blood ﬂow through an individual
bypass is comparable with that through the distal seg-
ment (end-to-side anastomosis) of a double sequential
bypass. A likely explanation may be the relation between
the capacity of the graft and the blood ﬂow velocity in the
graft. Although a sequential SVG would be able to
provide a blood supply two or three times larger than a
single SVG, this will not occur because blood ﬂow veloc-
ity should be similarly high. The native coronary blood
ﬂow velocity is relatively ﬁxed because it is dependent on
the cross-sectional area of the coronary lumen and re-
gional left ventricular mass [20].
Within the single SVG group, grafts directed to diag-
onal branches exhibited signiﬁcantly lower ﬂows than
those directed to other target vessels, and this held true
both for men and women. The explanation is that diag-
onals may be vessels of a smaller diameter and with less
peripheral ﬂow reserve, thus posing a higher coronary
resistance. Signiﬁcantly lower ﬂows of single grafts to
diagonals were also reported by Hassenein and col-
leagues [21]. Overall, ﬂows were signiﬁcantly higher in
men versus women because the former are assumed to
have coronary arteries of larger diameter than the latter
as well as larger ventricular mass [22].
Surprisingly, and in contrast to comparable studies
[9–12], we measured a lower ﬂow in the LIMA-LAD
grafts compared with vein grafts directed to the LAD. We
believe this may be caused by some degree of spasm of
the LIMA graft, as no vasodilators (eg, papaverine) were
used routinely.
With regard to the PI, our results show that single,
double, and triple SVGs all had similar PI values without
signiﬁcant differences among the three groups. The only
difference was the higher PI in the right coronary system
compared with the left, and this was true both for male
and female patients. These ﬁndings are opposite to what
one could expect as sequential grafts provide higher
ﬂows owing to a reduced peripheral vascular resistance.
Thus, sequential grafts should theoretically provide
lower PIs compared with single SVGs. Nonetheless, our
data indicate that the increased blood ﬂow from single to
sequential SVGs is not associated with a decrease of PI.
The likely explanation is that the shape of the ﬂow curves
of the single and sequential grafts are similar, resulting in
similar PI values. Thus PI, a dimensionless number
derived from an equation considering the maximum and
minimum peaks and mean ﬂow measurements, will
change concomitantly with marked changes of the ﬂow
curve. This is typically seen as a gross increase of resis-
tance in the bypass grafts (ie, technical failure of the
anastomosis, graft kinking or torsion) or coronary arteries
(ie, small diameter, poor runoff). This is in line with the
reports by Morota and coworkers [23], who showed a
large increase of PI as a consequence of a progressive
tightening of the LIMA-LAD graft in the pig causing a
reduced mean ﬂow. On the other hand, the right coro-
nary system had signiﬁcantly higher PI values com-
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being signiﬁcant (p  0.001). There were no signiﬁcant
differences between PI values for any type of grafts
within the single and double SVG group to the left or
right coronary system (p  0.001). Moreover, PI values of
single versus double versus triple SVG group within the
left coronary system were not signiﬁcantly different (p 
0.244). Similarly, PI values of single versus double SVGs
to the right coronary system were also not signiﬁcantly
different (p  0.126). Pulsatility index values were similar
for men and women (p  0.534).
Comment
Although several clinical series have demonstrated that
the sequential bypass grafting technique has excellent
long-term results [16–18], this technique remains a con-
troversial one. This is particularly true considering that
the majority of studies on sequential technique go back
at least a decade, when transit-time ﬂowmetry was
unavailable.
Our study analyzed routine recordings of intraopera-
tive transit-time ﬂow measurements of sequential SVGs
in a large population of patients operated on by one
surgeon. Thus, the same surgical technique of coronary
artery grafting and standard of measurements were ap-
plied in all patients, avoiding operator-related biases at
the time of statistical analysis of the outcome.
The ﬁrst ﬁnding was an increased blood ﬂow in se-
quential SVG compared with single SVG. This observa-
tion was consistent for both male and female patients,
with male patients exhibiting the highest ﬂows. Speciﬁ-
cally, male patients were predicted to have a graft blood
ﬂow 8.7 mL/min higher than women of the same age and
left ventricular ejection fraction. The blood ﬂow in-
creased according to the number of distal anastomoses:
from a lower ﬂow in single SVGs to a higher ﬂow in
double sequentials and up to the highest ﬂow in triple
sequentials. The trend was conﬁrmed by our linear
mixed model predicting that in patients of the same age,
sex, and left ventricular ejection fraction, a triple sequen-
tial graft has 13 and 39 mL/min ﬂow higher than double
sequential and single SVG, respectively. This behavior is
recognized to be caused by decreased total resistance,
better run-off, and minimized impedance difference.
The variables generally used for evaluation of the ﬂow
rate are graft quality and diameter, and the resistance
posed by the native coronary vessel. If one considers that
the diameters of SVGs are relatively constant for a given
patient, and the resistance posed by an SVG is negligible
when compared with that of its coronary counterpart, the
resistance of the native coronary vessels remains the
principal determinant of the ﬂow rate [17]. Therefore, if
individual resistances of the grafted coronaries are as-
sumed to be equivalent, a double sequential graft should
pose only half of the resistance of an individual graft.
Thus, the single SVGs are more resistant than sequential
conduits, and are expected to have a lower ﬂow com-
pared with the sequential ones. Although all the differ-
ences among the three ﬂow values reached statistical
signiﬁcance, ﬂows in double and triple sequential SVGs
were not twofold or threefold higher, respectively, com-
pared with ﬂows in single SVGs. This observation is
consistent with the conclusion by Gwozdziewicz and
coworkers [19] that blood ﬂow through an individual
bypass is comparable with that through the distal seg-
ment (end-to-side anastomosis) of a double sequential
bypass. A likely explanation may be the relation between
the capacity of the graft and the blood ﬂow velocity in the
graft. Although a sequential SVG would be able to
provide a blood supply two or three times larger than a
single SVG, this will not occur because blood ﬂow veloc-
ity should be similarly high. The native coronary blood
ﬂow velocity is relatively ﬁxed because it is dependent on
the cross-sectional area of the coronary lumen and re-
gional left ventricular mass [20].
Within the single SVG group, grafts directed to diag-
onal branches exhibited signiﬁcantly lower ﬂows than
those directed to other target vessels, and this held true
both for men and women. The explanation is that diag-
onals may be vessels of a smaller diameter and with less
peripheral ﬂow reserve, thus posing a higher coronary
resistance. Signiﬁcantly lower ﬂows of single grafts to
diagonals were also reported by Hassenein and col-
leagues [21]. Overall, ﬂows were signiﬁcantly higher in
men versus women because the former are assumed to
have coronary arteries of larger diameter than the latter
as well as larger ventricular mass [22].
Surprisingly, and in contrast to comparable studies
[9–12], we measured a lower ﬂow in the LIMA-LAD
grafts compared with vein grafts directed to the LAD. We
believe this may be caused by some degree of spasm of
the LIMA graft, as no vasodilators (eg, papaverine) were
used routinely.
With regard to the PI, our results show that single,
double, and triple SVGs all had similar PI values without
signiﬁcant differences among the three groups. The only
difference was the higher PI in the right coronary system
compared with the left, and this was true both for male
and female patients. These ﬁndings are opposite to what
one could expect as sequential grafts provide higher
ﬂows owing to a reduced peripheral vascular resistance.
Thus, sequential grafts should theoretically provide
lower PIs compared with single SVGs. Nonetheless, our
data indicate that the increased blood ﬂow from single to
sequential SVGs is not associated with a decrease of PI.
The likely explanation is that the shape of the ﬂow curves
of the single and sequential grafts are similar, resulting in
similar PI values. Thus PI, a dimensionless number
derived from an equation considering the maximum and
minimum peaks and mean ﬂow measurements, will
change concomitantly with marked changes of the ﬂow
curve. This is typically seen as a gross increase of resis-
tance in the bypass grafts (ie, technical failure of the
anastomosis, graft kinking or torsion) or coronary arteries
(ie, small diameter, poor runoff). This is in line with the
reports by Morota and coworkers [23], who showed a
large increase of PI as a consequence of a progressive
tightening of the LIMA-LAD graft in the pig causing a
reduced mean ﬂow. On the other hand, the right coro-
nary system had signiﬁcantly higher PI values com-
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pared with the left across all the graft types because of
a more spiky and systolic ﬂow pattern, indicating
higher vascular resistance in the right system. How-
ever, it is also known that blood ﬂow to the right
coronary artery takes place during systole as a result of
minor compression of the epicardial vessels during
right ventricular contraction [13].
The limitations of our study are, ﬁrst, that total ﬂow
measurements were taken in sequential grafts by apply-
ing the probe about 2 cm distal to the aortic anastomosis;
therefore the assessment of ﬂow characteristics such as
the systolic and diastolic patterns of each distal anasto-
mosis could not be carried out. On the other hand,
Gwozdziewicz and coworkers [19] reported that grafting
a sequential graft proximal to the larger artery in se-
quence did not appear to have a signiﬁcant effect on the
blood ﬂow in the distal segment of a sequential graft.
Second, coronary ﬂow reserve was not investigated as
injection of papaverine in the bypass grafts was not
carried out routinely. Third, exclusion of the few grafts
with PI greater than 5 and mean ﬂow less than 15 mL/min
was done because of poor runoff as assessed by the
combined information from the angiogram and the lim-
ited peripheral vascular bed seen in the surgical ﬁeld.
However, this issue was not conﬁrmed by postoperative
angiography as this was not performed routinely. A
follow-up angiography would have been needed to prove
the long-term outcome of sequential grafts.
On clinical grounds the reason to carry out transit-time
ﬂow measurements is as ﬁrst-line quality control of CABG,
with the aim to rule out all the likely causes of early graft
failures. Ideally ﬂow measurements should be followed
by an angiogram later in the patient’s follow-up. Unfor-
tunately an angiogram performed on a routine basis in a
patient without recurrent angina is just wishful thinking,
because it is costly, difﬁcult, and impractical owing to the
heavy caseloads of the catheterization laboratories. We
are aware that clear cutoff transit-time ﬂow values to
predict the patency for different types of grafts to differ-
ent target vessels have not been deﬁned, owing to a wide
variability among patients and among different grafts.
Nonetheless ﬂow measurements remain the most ap-
plied speciﬁc investigation readily available on graft
performance, and may be considered proof of a satisfac-
tory surgical job. In our unit transit-time ﬂow measure-
ments of each graft are part of the operation report.
In conclusion, at retrospective analysis, sequential
SVGs had a signiﬁcantly higher blood ﬂow compared
with single SVGs, with ﬂow increasing from single SVG
to double and triple sequential SVG. Single SVGs di-
rected to diagonals had the lowest ﬂow. Blood ﬂows in
single and sequential grafts were higher in men versus
women. Single, double, and triple SVGs had similar PIs.
The PI of grafts directed to the right coronary system was
signiﬁcantly higher compared with grafts to the left
coronary system.
We thank Siren Torsvik Oernes, MS, for statistical analysis of
data.
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ever, it is also known that blood ﬂow to the right
coronary artery takes place during systole as a result of
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measurements were taken in sequential grafts by apply-
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mosis could not be carried out. On the other hand,
Gwozdziewicz and coworkers [19] reported that grafting
a sequential graft proximal to the larger artery in se-
quence did not appear to have a signiﬁcant effect on the
blood ﬂow in the distal segment of a sequential graft.
Second, coronary ﬂow reserve was not investigated as
injection of papaverine in the bypass grafts was not
carried out routinely. Third, exclusion of the few grafts
with PI greater than 5 and mean ﬂow less than 15 mL/min
was done because of poor runoff as assessed by the
combined information from the angiogram and the lim-
ited peripheral vascular bed seen in the surgical ﬁeld.
However, this issue was not conﬁrmed by postoperative
angiography as this was not performed routinely. A
follow-up angiography would have been needed to prove
the long-term outcome of sequential grafts.
On clinical grounds the reason to carry out transit-time
ﬂow measurements is as ﬁrst-line quality control of CABG,
with the aim to rule out all the likely causes of early graft
failures. Ideally ﬂow measurements should be followed
by an angiogram later in the patient’s follow-up. Unfor-
tunately an angiogram performed on a routine basis in a
patient without recurrent angina is just wishful thinking,
because it is costly, difﬁcult, and impractical owing to the
heavy caseloads of the catheterization laboratories. We
are aware that clear cutoff transit-time ﬂow values to
predict the patency for different types of grafts to differ-
ent target vessels have not been deﬁned, owing to a wide
variability among patients and among different grafts.
Nonetheless ﬂow measurements remain the most ap-
plied speciﬁc investigation readily available on graft
performance, and may be considered proof of a satisfac-
tory surgical job. In our unit transit-time ﬂow measure-
ments of each graft are part of the operation report.
In conclusion, at retrospective analysis, sequential
SVGs had a signiﬁcantly higher blood ﬂow compared
with single SVGs, with ﬂow increasing from single SVG
to double and triple sequential SVG. Single SVGs di-
rected to diagonals had the lowest ﬂow. Blood ﬂows in
single and sequential grafts were higher in men versus
women. Single, double, and triple SVGs had similar PIs.
The PI of grafts directed to the right coronary system was
signiﬁcantly higher compared with grafts to the left
coronary system.
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a more spiky and systolic ﬂow pattern, indicating
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ever, it is also known that blood ﬂow to the right
coronary artery takes place during systole as a result of
minor compression of the epicardial vessels during
right ventricular contraction [13].
The limitations of our study are, ﬁrst, that total ﬂow
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ing the probe about 2 cm distal to the aortic anastomosis;
therefore the assessment of ﬂow characteristics such as
the systolic and diastolic patterns of each distal anasto-
mosis could not be carried out. On the other hand,
Gwozdziewicz and coworkers [19] reported that grafting
a sequential graft proximal to the larger artery in se-
quence did not appear to have a signiﬁcant effect on the
blood ﬂow in the distal segment of a sequential graft.
Second, coronary ﬂow reserve was not investigated as
injection of papaverine in the bypass grafts was not
carried out routinely. Third, exclusion of the few grafts
with PI greater than 5 and mean ﬂow less than 15 mL/min
was done because of poor runoff as assessed by the
combined information from the angiogram and the lim-
ited peripheral vascular bed seen in the surgical ﬁeld.
However, this issue was not conﬁrmed by postoperative
angiography as this was not performed routinely. A
follow-up angiography would have been needed to prove
the long-term outcome of sequential grafts.
On clinical grounds the reason to carry out transit-time
ﬂow measurements is as ﬁrst-line quality control of CABG,
with the aim to rule out all the likely causes of early graft
failures. Ideally ﬂow measurements should be followed
by an angiogram later in the patient’s follow-up. Unfor-
tunately an angiogram performed on a routine basis in a
patient without recurrent angina is just wishful thinking,
because it is costly, difﬁcult, and impractical owing to the
heavy caseloads of the catheterization laboratories. We
are aware that clear cutoff transit-time ﬂow values to
predict the patency for different types of grafts to differ-
ent target vessels have not been deﬁned, owing to a wide
variability among patients and among different grafts.
Nonetheless ﬂow measurements remain the most ap-
plied speciﬁc investigation readily available on graft
performance, and may be considered proof of a satisfac-
tory surgical job. In our unit transit-time ﬂow measure-
ments of each graft are part of the operation report.
In conclusion, at retrospective analysis, sequential
SVGs had a signiﬁcantly higher blood ﬂow compared
with single SVGs, with ﬂow increasing from single SVG
to double and triple sequential SVG. Single SVGs di-
rected to diagonals had the lowest ﬂow. Blood ﬂows in
single and sequential grafts were higher in men versus
women. Single, double, and triple SVGs had similar PIs.
The PI of grafts directed to the right coronary system was
signiﬁcantly higher compared with grafts to the left
coronary system.
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a more spiky and systolic ﬂow pattern, indicating
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ever, it is also known that blood ﬂow to the right
coronary artery takes place during systole as a result of
minor compression of the epicardial vessels during
right ventricular contraction [13].
The limitations of our study are, ﬁrst, that total ﬂow
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therefore the assessment of ﬂow characteristics such as
the systolic and diastolic patterns of each distal anasto-
mosis could not be carried out. On the other hand,
Gwozdziewicz and coworkers [19] reported that grafting
a sequential graft proximal to the larger artery in se-
quence did not appear to have a signiﬁcant effect on the
blood ﬂow in the distal segment of a sequential graft.
Second, coronary ﬂow reserve was not investigated as
injection of papaverine in the bypass grafts was not
carried out routinely. Third, exclusion of the few grafts
with PI greater than 5 and mean ﬂow less than 15 mL/min
was done because of poor runoff as assessed by the
combined information from the angiogram and the lim-
ited peripheral vascular bed seen in the surgical ﬁeld.
However, this issue was not conﬁrmed by postoperative
angiography as this was not performed routinely. A
follow-up angiography would have been needed to prove
the long-term outcome of sequential grafts.
On clinical grounds the reason to carry out transit-time
ﬂow measurements is as ﬁrst-line quality control of CABG,
with the aim to rule out all the likely causes of early graft
failures. Ideally ﬂow measurements should be followed
by an angiogram later in the patient’s follow-up. Unfor-
tunately an angiogram performed on a routine basis in a
patient without recurrent angina is just wishful thinking,
because it is costly, difﬁcult, and impractical owing to the
heavy caseloads of the catheterization laboratories. We
are aware that clear cutoff transit-time ﬂow values to
predict the patency for different types of grafts to differ-
ent target vessels have not been deﬁned, owing to a wide
variability among patients and among different grafts.
Nonetheless ﬂow measurements remain the most ap-
plied speciﬁc investigation readily available on graft
performance, and may be considered proof of a satisfac-
tory surgical job. In our unit transit-time ﬂow measure-
ments of each graft are part of the operation report.
In conclusion, at retrospective analysis, sequential
SVGs had a signiﬁcantly higher blood ﬂow compared
with single SVGs, with ﬂow increasing from single SVG
to double and triple sequential SVG. Single SVGs di-
rected to diagonals had the lowest ﬂow. Blood ﬂows in
single and sequential grafts were higher in men versus
women. Single, double, and triple SVGs had similar PIs.
The PI of grafts directed to the right coronary system was
signiﬁcantly higher compared with grafts to the left
coronary system.
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INVITED COMMENTARY
Sequential grafting techniques during coronary artery
bypass grafting (CABG) have been in use for decades and
have been adopted by different surgeons to varying extents.
Purported advantages have included efﬁcient use of avail-
able conduits, potentially improved graft patency rates
attributable to presumed higher ﬂow rates, and the need for
fewer proximal anastomoses for sequential aortocoronary
grafts. Intraoperative transit time graft ﬂow measurement
and calculation of the pulsatility index have likewise been
available for many years and have been adopted by some
surgeons as a quality control measure.
Nordgaard and coauthors [1] have provided a retro-
spective analysis of intraoperative transit time ﬂow mea-
surements from a consecutive cohort of CABG patients
operated on at a single center by a single surgeon using
a standardized technique during a 5-year time period.
The stated objective of this report was to compare the
mean ﬂow rates and the pulsatility indices in single grafts
with those of double and triple sequential grafts. Sequen-
tial grafting techniques were preferred and were used for
saphenous vein grafts (SVG) whenever feasible. Routine
transit time ﬂow measurements using a standardized
technique were used for quality control. Results were
tabulated for left internal mammary artery-left anterior
descending artery and for SVG-diagonal, other single
SVG grafts, and double and triple sequential grafts.
There were 581 evaluable patients with a total of 1552
grafts, of which 1390 were evaluated. Some patients and
some grafts were excluded from analysis, most often
because of inadequate data. Nordgaard and coauthors
based their analysis on previous authors’ ﬁndings, divid-
ing the data according to gender, target vessel, and left or
right coronary systems.
Among the pertinent ﬁndings were that measured
mean graft ﬂows increased with the number of recipient
vessels. Single grafts had the lowest mean ﬂows, followed
by double sequential grafts, whereas triple sequential
grafts had the highest mean ﬂows. These ﬁndings per-
sisted after statistically controlling for gender, recipient
vessel, and left or right coronary system grafting. Inter-
estingly, the magnitude of increased ﬂow compared with
single grafts was less than double for double grafts or
triple for triple sequential grafts. The authors offer some
theoretical geometric and physiologic explanations for
this ﬁnding.
The authors have provided a thorough analysis of a
considerable amount of mean ﬂow and pulsatility index
data from a consecutive cohort of patients in which
surgeon and technique biases were minimized. The ﬁnd-
ings suggest that sequential grafts do result in higher
proximal vein ﬂows and that triple sequential grafts carry
the highest proximal ﬂows.
The authors also correctly point out several limitations
to their study: Some patients and some grafts were not
included, and the technique used only measured total
graft ﬂow, so nothing could be said about the relative
proportions of ﬂow into each recipient vessel. Flow
reserve was not evaluated. Follow-up angiographic data
and patient outcome data that would indicate the ade-
quacy or durability of revascularization are not provided.
The authors do suggest that from their experience, transit
time mean ﬂow and pulsatility index measurement might
be considered as useful intraoperative graft quality con-
trol measures.
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Abstract
Objective: To assess whether coronary graft ﬂow patterns are affected differently by native coronary competitive ﬂow or by stenosis of the
coronary anastomosis. Methods: Nine pigs (65—70 kg) underwent off-pump grafting of the left internal mammary artery to the left anterior
descending artery (LAD). Transit-time ﬂow patterns in the mammary grafts were recorded under four different conditions: (1) baseline ﬂow
(proximal LAD occluded), (2) full competitive ﬂow, (3) partial competitive ﬂow and (4) after creation of a stenosis in the anastomosis. Competitive
ﬂow was achieved by an adjustable occluder on the left anterior descending artery. The mean luminal stenosis of the anastomosis was 75  11%,
calculated by epicardial ultrasound. Mean ﬂow, systolic and diastolic antegrade and retrograde ﬂow during different ﬂow conditions were
calculated as ratios of baseline ﬂow and compared. Different derived ﬂow indexes were calculated and compared in the samemanner. Friedman’s
test and post hoc analyses by Wilcoxon signed-ranks were performed without correction for multiple comparisons. Results: Mean graft ﬂow was
more reduced by competitive ﬂow than by a stenotic anastomosis of 75  11%. Competitive ﬂow signiﬁcantly decreased diastolic antegrade ﬂow
and both diastolic and systolic maximum peak ﬂows, but increased retrograde ﬂow, compared with baseline and stenosis. Furthermore,
competitive ﬂow and stenosis could be distinguished by analysis of several derived indexes. Pulsatility index (maximum  minimum ﬂow/mean
ﬂow) and insufﬁciency percent (retrograde ﬂow as fraction of total ﬂow) was increased signiﬁcantly more by competitive ﬂow than by stenosis.
Diastolic ﬁlling percent was signiﬁcantly reduced at competitive ﬂow comparedwith stenosis and baseline. Conclusions: Themammary graft ﬂow
was signiﬁcantly reduced by native coronary competitive ﬂow, but marginally decreased by a stenotic anastomosis of 75% mean luminal stenosis.
Reduction of graft ﬂow due to competition was particularly evident in diastole. A detailed ﬂow pattern analysis may differentiate between
competitive ﬂow and stenosis of the anastomosis.
# 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
Keywords: Heart surgery; CABG; Anastomosis; Coronary graft assessment; Transit-time ﬂow measurement; Epicardial ultrasound
1. Introduction
Transit-timebloodﬂowmeasurement has gainedpopularity
for assessing patency of coronary bypass grafts. It is easy and
convenient for intra-operative use and provides accurate graft
ﬂow measurements with few sources of technical error [1].
However, clear cut-off values to predict the patency for
different types of grafts to different target vessels have not
been reported because of a wide variability among patients
and grafts. Generally, a mean graft ﬂow of under 10—15 ml/
min, pulsatility index>5 and a poor diastolic ﬂowpattern have
been accepted as indicating poor graft performance, necessi-
tating further investigation of the graft and the anastomosis
[2]. When interpreting transit-time ﬂow measurements, it is
important to take thehemodynamic conditionsof the coronary
system into consideration. Thus low ﬂow within bypass grafts
might havenumerous causes, such as high coronary resistance,
small target vessels, kinking, dissection or spasm in the graft,
competitive ﬂow and anastomotic failure. Hence the use of
graft ﬂow for assessing the anastomosis may give unreliable
results and lead to unnecessary revisions.
This study aimed to assess the impairment of graft ﬂows
due to competitive ﬂow from the coronary artery or stenosis
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European Journal of Cardio-thoracic Surgery 36 (2009) 137—142
§ Presented at the 22nd Annual Meeting of the European Association for
Cardio-thoracic Surgery, Lisbon, Portugal, September 14—17, 2008.
§§ Disclosure: GE Vingmed Ultrasound and Medi-Stim ASA, Norway, provided
ﬁnancial support for equipment and disposables. Conﬂict of interest state-
ment: The Department of Circulation and Medical Imaging, Norwegian
University of Science and Technology, has a corporate partnership with GE
Vingmed Ultrasound and Medi-Stim ASA.
* Corresponding author. Tel.: +47 91717994; fax: +47 73867029.
E-mail address: haavardnordgaard@gmail.com (H. Nordgaard).
1010-7940/$ — see front matter # 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
doi:10.1016/j.ejcts.2009.02.036
Different graft ﬂow patterns due to competitive ﬂow or stenosis
in the coronary anastomosis assessed by transit-time ﬂowmetry
in a porcine model§,§§
Ha˚vard Nordgaard a,*, Dag Nordhaug a,b, Idar Kirkeby-Garstad b,
Lasse Løvstakken a, Nicola Vitale a, Rune Haaverstad a,c
aDepartment of Circulation and Medical Imaging, Norwegian University of Science and Technology, N-7489 Trondheim, Norway
bDepartment of Cardiothoracic Surgery, St. Olavs University Hospital, Trondheim, Norway
c Institute of Surgical Sciences, The Medical Faculty, University of Bergen, Bergen, Norway
Received 31 August 2008; received in revised form 17 February 2009; accepted 23 February 2009; Available online 18 April 2009
Abstract
Objective: To assess whether coronary graft ﬂow patterns are affected differently by native coronary competitive ﬂow or by stenosis of the
coronary anastomosis. Methods: Nine pigs (65—70 kg) underwent off-pump grafting of the left internal mammary artery to the left anterior
descending artery (LAD). Transit-time ﬂow patterns in the mammary grafts were recorded under four different conditions: (1) baseline ﬂow
(proximal LAD occluded), (2) full competitive ﬂow, (3) partial competitive ﬂow and (4) after creation of a stenosis in the anastomosis. Competitive
ﬂow was achieved by an adjustable occluder on the left anterior descending artery. The mean luminal stenosis of the anastomosis was 75  11%,
calculated by epicardial ultrasound. Mean ﬂow, systolic and diastolic antegrade and retrograde ﬂow during different ﬂow conditions were
calculated as ratios of baseline ﬂow and compared. Different derived ﬂow indexes were calculated and compared in the samemanner. Friedman’s
test and post hoc analyses by Wilcoxon signed-ranks were performed without correction for multiple comparisons. Results: Mean graft ﬂow was
more reduced by competitive ﬂow than by a stenotic anastomosis of 75  11%. Competitive ﬂow signiﬁcantly decreased diastolic antegrade ﬂow
and both diastolic and systolic maximum peak ﬂows, but increased retrograde ﬂow, compared with baseline and stenosis. Furthermore,
competitive ﬂow and stenosis could be distinguished by analysis of several derived indexes. Pulsatility index (maximum  minimum ﬂow/mean
ﬂow) and insufﬁciency percent (retrograde ﬂow as fraction of total ﬂow) was increased signiﬁcantly more by competitive ﬂow than by stenosis.
Diastolic ﬁlling percent was signiﬁcantly reduced at competitive ﬂow comparedwith stenosis and baseline. Conclusions: Themammary graft ﬂow
was signiﬁcantly reduced by native coronary competitive ﬂow, but marginally decreased by a stenotic anastomosis of 75% mean luminal stenosis.
Reduction of graft ﬂow due to competition was particularly evident in diastole. A detailed ﬂow pattern analysis may differentiate between
competitive ﬂow and stenosis of the anastomosis.
# 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
Keywords: Heart surgery; CABG; Anastomosis; Coronary graft assessment; Transit-time ﬂow measurement; Epicardial ultrasound
1. Introduction
Transit-timebloodﬂowmeasurement has gainedpopularity
for assessing patency of coronary bypass grafts. It is easy and
convenient for intra-operative use and provides accurate graft
ﬂow measurements with few sources of technical error [1].
However, clear cut-off values to predict the patency for
different types of grafts to different target vessels have not
been reported because of a wide variability among patients
and grafts. Generally, a mean graft ﬂow of under 10—15 ml/
min, pulsatility index>5 and a poor diastolic ﬂowpattern have
been accepted as indicating poor graft performance, necessi-
tating further investigation of the graft and the anastomosis
[2]. When interpreting transit-time ﬂow measurements, it is
important to take thehemodynamic conditionsof the coronary
system into consideration. Thus low ﬂow within bypass grafts
might havenumerous causes, such as high coronary resistance,
small target vessels, kinking, dissection or spasm in the graft,
competitive ﬂow and anastomotic failure. Hence the use of
graft ﬂow for assessing the anastomosis may give unreliable
results and lead to unnecessary revisions.
This study aimed to assess the impairment of graft ﬂows
due to competitive ﬂow from the coronary artery or stenosis
www.elsevier.com/locate/ejcts
European Journal of Cardio-thoracic Surgery 36 (2009) 137—142
§ Presented at the 22nd Annual Meeting of the European Association for
Cardio-thoracic Surgery, Lisbon, Portugal, September 14—17, 2008.
§§ Disclosure: GE Vingmed Ultrasound and Medi-Stim ASA, Norway, provided
ﬁnancial support for equipment and disposables. Conﬂict of interest state-
ment: The Department of Circulation and Medical Imaging, Norwegian
University of Science and Technology, has a corporate partnership with GE
Vingmed Ultrasound and Medi-Stim ASA.
* Corresponding author. Tel.: +47 91717994; fax: +47 73867029.
E-mail address: haavardnordgaard@gmail.com (H. Nordgaard).
1010-7940/$ — see front matter # 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
doi:10.1016/j.ejcts.2009.02.036
Different graft ﬂow patterns due to competitive ﬂow or stenosis
in the coronary anastomosis assessed by transit-time ﬂowmetry
in a porcine model§,§§
Ha˚vard Nordgaard a,*, Dag Nordhaug a,b, Idar Kirkeby-Garstad b,
Lasse Løvstakken a, Nicola Vitale a, Rune Haaverstad a,c
aDepartment of Circulation and Medical Imaging, Norwegian University of Science and Technology, N-7489 Trondheim, Norway
bDepartment of Cardiothoracic Surgery, St. Olavs University Hospital, Trondheim, Norway
c Institute of Surgical Sciences, The Medical Faculty, University of Bergen, Bergen, Norway
Received 31 August 2008; received in revised form 17 February 2009; accepted 23 February 2009; Available online 18 April 2009
Abstract
Objective: To assess whether coronary graft ﬂow patterns are affected differently by native coronary competitive ﬂow or by stenosis of the
coronary anastomosis. Methods: Nine pigs (65—70 kg) underwent off-pump grafting of the left internal mammary artery to the left anterior
descending artery (LAD). Transit-time ﬂow patterns in the mammary grafts were recorded under four different conditions: (1) baseline ﬂow
(proximal LAD occluded), (2) full competitive ﬂow, (3) partial competitive ﬂow and (4) after creation of a stenosis in the anastomosis. Competitive
ﬂow was achieved by an adjustable occluder on the left anterior descending artery. The mean luminal stenosis of the anastomosis was 75  11%,
calculated by epicardial ultrasound. Mean ﬂow, systolic and diastolic antegrade and retrograde ﬂow during different ﬂow conditions were
calculated as ratios of baseline ﬂow and compared. Different derived ﬂow indexes were calculated and compared in the samemanner. Friedman’s
test and post hoc analyses by Wilcoxon signed-ranks were performed without correction for multiple comparisons. Results: Mean graft ﬂow was
more reduced by competitive ﬂow than by a stenotic anastomosis of 75  11%. Competitive ﬂow signiﬁcantly decreased diastolic antegrade ﬂow
and both diastolic and systolic maximum peak ﬂows, but increased retrograde ﬂow, compared with baseline and stenosis. Furthermore,
competitive ﬂow and stenosis could be distinguished by analysis of several derived indexes. Pulsatility index (maximum  minimum ﬂow/mean
ﬂow) and insufﬁciency percent (retrograde ﬂow as fraction of total ﬂow) was increased signiﬁcantly more by competitive ﬂow than by stenosis.
Diastolic ﬁlling percent was signiﬁcantly reduced at competitive ﬂow comparedwith stenosis and baseline. Conclusions: Themammary graft ﬂow
was signiﬁcantly reduced by native coronary competitive ﬂow, but marginally decreased by a stenotic anastomosis of 75% mean luminal stenosis.
Reduction of graft ﬂow due to competition was particularly evident in diastole. A detailed ﬂow pattern analysis may differentiate between
competitive ﬂow and stenosis of the anastomosis.
# 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
Keywords: Heart surgery; CABG; Anastomosis; Coronary graft assessment; Transit-time ﬂow measurement; Epicardial ultrasound
1. Introduction
Transit-timebloodﬂowmeasurement has gainedpopularity
for assessing patency of coronary bypass grafts. It is easy and
convenient for intra-operative use and provides accurate graft
ﬂow measurements with few sources of technical error [1].
However, clear cut-off values to predict the patency for
different types of grafts to different target vessels have not
been reported because of a wide variability among patients
and grafts. Generally, a mean graft ﬂow of under 10—15 ml/
min, pulsatility index>5 and a poor diastolic ﬂowpattern have
been accepted as indicating poor graft performance, necessi-
tating further investigation of the graft and the anastomosis
[2]. When interpreting transit-time ﬂow measurements, it is
important to take thehemodynamic conditionsof the coronary
system into consideration. Thus low ﬂow within bypass grafts
might havenumerous causes, such as high coronary resistance,
small target vessels, kinking, dissection or spasm in the graft,
competitive ﬂow and anastomotic failure. Hence the use of
graft ﬂow for assessing the anastomosis may give unreliable
results and lead to unnecessary revisions.
This study aimed to assess the impairment of graft ﬂows
due to competitive ﬂow from the coronary artery or stenosis
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Abstract
Objective: To assess whether coronary graft ﬂow patterns are affected differently by native coronary competitive ﬂow or by stenosis of the
coronary anastomosis. Methods: Nine pigs (65—70 kg) underwent off-pump grafting of the left internal mammary artery to the left anterior
descending artery (LAD). Transit-time ﬂow patterns in the mammary grafts were recorded under four different conditions: (1) baseline ﬂow
(proximal LAD occluded), (2) full competitive ﬂow, (3) partial competitive ﬂow and (4) after creation of a stenosis in the anastomosis. Competitive
ﬂow was achieved by an adjustable occluder on the left anterior descending artery. The mean luminal stenosis of the anastomosis was 75  11%,
calculated by epicardial ultrasound. Mean ﬂow, systolic and diastolic antegrade and retrograde ﬂow during different ﬂow conditions were
calculated as ratios of baseline ﬂow and compared. Different derived ﬂow indexes were calculated and compared in the samemanner. Friedman’s
test and post hoc analyses by Wilcoxon signed-ranks were performed without correction for multiple comparisons. Results: Mean graft ﬂow was
more reduced by competitive ﬂow than by a stenotic anastomosis of 75  11%. Competitive ﬂow signiﬁcantly decreased diastolic antegrade ﬂow
and both diastolic and systolic maximum peak ﬂows, but increased retrograde ﬂow, compared with baseline and stenosis. Furthermore,
competitive ﬂow and stenosis could be distinguished by analysis of several derived indexes. Pulsatility index (maximum  minimum ﬂow/mean
ﬂow) and insufﬁciency percent (retrograde ﬂow as fraction of total ﬂow) was increased signiﬁcantly more by competitive ﬂow than by stenosis.
Diastolic ﬁlling percent was signiﬁcantly reduced at competitive ﬂow comparedwith stenosis and baseline. Conclusions: Themammary graft ﬂow
was signiﬁcantly reduced by native coronary competitive ﬂow, but marginally decreased by a stenotic anastomosis of 75% mean luminal stenosis.
Reduction of graft ﬂow due to competition was particularly evident in diastole. A detailed ﬂow pattern analysis may differentiate between
competitive ﬂow and stenosis of the anastomosis.
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1. Introduction
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convenient for intra-operative use and provides accurate graft
ﬂow measurements with few sources of technical error [1].
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different types of grafts to different target vessels have not
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of the coronary anastomosis, as well as the extent of their
impact. Transit-time ﬂow patterns were measured at four
different ﬂow conditions in a left internal mammary artery
(LIMA) to left anterior descending coronary artery (LAD) in a
porcine model.
2. Materials and methods
Ten Noroc pigs (hybrid of 1/4 Duroc, 1/4 Yorkshire and 1/2
Norwegian landrace, weight 65—70 kg) underwent off-pump
coronary artery bypass grafting (OPCAB) with LIMA-to-LAD
anastomosis through a median sternotomy. One pig was
excluded from the study because of hemodynamic instability
throughout the study so that nine animals were included in
the ﬁnal analysis. The animals received good care in
accordance with the European convention on animal care
and Norwegian national regulations. Approval was given by
the Norwegian ethics committee on animal research. All
animals were treated by the same anesthesiologist and
surgical team. At completion of the experiments, the animals
were killed with an intravenous injection of high dose
pentobarbital and potassium chloride.
2.1. Anesthesia and surgical technique
All pigs received premedication with intramuscular
azaperone 4 mg/kg and ketamine 0.20 mg/kg. Anesthesia
was induced with intravenous atropine 1 mg, fentanyl
0.01 mg/kg and pentobarbital 10 mg/kg. General anesthesia
was maintained by infusions of fentanyl 0.02 mg/kg/h and
midazolam 0.3 mg/kg/h. Amiodarone 150 mg and hexam-
ethonium chloride 20 mg/kg were given to avoid arrhyth-
mias. Full heparinization was achieved with heparin 10—
20 000 IE intravenously. The pigs were ventilated with room
air through a tracheotomy tube, and ventilator settings were
adjusted according to blood gas measurements. Central
venous catheters were introduced into both internal jugular
veins for infusions and measurements of central venous
pressure. A catheter was placed in the descending thoracic
aorta for continuous measurement of arterial pressure. The
bladder was drained through a cystotomy. After median
sternotomy, the LIMAwas harvested with its pedicle. A 16 mm
ﬂow transit-time ﬂow probe (VeriQ ﬂowmeter, Medi-Stim
ASA, Oslo, Norway) was placed around the pulmonary trunk
to measure cardiac output. ECG leads were connected to the
ﬂowmeter. An Axius vacuum stabilizer (Guidant, Santa Clara,
CA) was applied to immobilize the LAD at the site chosen for
grafting. A 2 or 3 mm ﬂow probe was placed immediately
proximal to the coronary arteriotomy to assess native
coronary ﬂow. Adjacent to this ﬂow probe, an adjustable
vascular occluder (In Vivo Metric, US) was applied to create
either occlusion of the LAD or partial competitive ﬂow
(Figs. 1 and 3). Full competitive ﬂow was achieved by
complete pressure release of the vascular occluder. Ischemic
preconditioning was performed by ﬁve repeated cycles of
30 s of LAD occlusion with 30 s of reperfusion in between.
After arteriotomy of the LAD, an intracoronary shunt was
placed in the vessel lumen. The LIMA—LAD anastomosis was
then sutured with a continuous 7-0 Prolene to create patent
anastomoses without technical failures. Patency of the
anastomosis was conﬁrmed with epicardial ultrasound
imaging. At completion of the anastomosis, a 3 mm ﬂow
probe was also placed on the LIMA graft to assess graft ﬂow
(Figs. 1 and 3).
2.2. Epicardial ultrasound imaging
The status of the anastomosis was assessed by epicardial
ultrasound imaging before and after constructing a stenosis
of the anastomosis, and with or without competitive ﬂow.
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Fig. 1. Layout of the four ﬂow conditions with typical corresponding ﬂow
curves. (A) Baseline ﬂow with proximal LAD totally occluded. (B) Full compe-
titive ﬂow with no snaring of the proximal LAD. (C) Partial competitive ﬂow
with partial occlusion of LAD (approximately 50% of full competitive ﬂow). (D)
Stenotic anastomosis with no competitive ﬂow.
Fig. 2. B-mode ultrasound images of the same LIMA—LAD anastomosis. (A)
Fully patent anastomosis. (B) Stenotic anastomosis after placement of a deep
stitch at the toe.
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The ultrasound imaging was performed with a GE Vivid 7
scanner (GE Vingmed, Norway) equipped with an i13L linear
array probe (GE Healthcare, Waukesha, WI), capable of
operating at frequencies from 7 to 14 MHz. Ultrasound gel
was applied in the ﬁeld of the anastomosis to get a proper
stand-off, suitable for better images. The anastomosis was
visualized in transverse and longitudinal scan planes using B-
mode tissue imaging and a new ultrasound ﬂow imaging
modality termed ‘blood ﬂow imaging’ (BFI). The BFI modality
is based on conventional color Doppler imaging and can
visualize blood ﬂow in any direction of the two-dimensional
image plane without limitations imposed by aliases [3]
(Videos 1 and 2). The luminal stenosis was estimated with the
use of MATLAB v7.0 (Mathworks Inc., USA).
2.3. Experimental protocol
Transit-time ﬂow patterns in the LIMA grafts were
recorded under four different conditions: (A) baseline ﬂow:
the proximal LAD was totally occluded; (B) full competitive
ﬂow: no occlusion of the proximal LAD; (C) partial
competitive ﬂow: partial occlusion of the LAD to roughly
half its competitive ﬂow; (D) stenotic anastomosis (Fig. 1).
After a fully patent anastomosis was constructed and
controlled by epicardial ultrasound, a stenosis of the
anastomosis was made by placing a deep stitch at the
anastomotic toe with the aim to reduce its cross sectional
area (Fig. 2). The calculated mean degree of stenosis was
75  11% as measured by epicardial ultrasound [3].
All ﬂow and ultrasound measurements were made after
30 min stabilization and at similar and stable hemodynamic
conditions (heart rate, cardiac output and blood pressure)
after removal of the stabilizer from the epicardial surface.
All recordings of ﬂow values in the LAD, LIMA and pulmonary
trunkwere obtained simultaneously and stored in a database.
The ﬂow curves were analyzed off-line using the Medi-Stim
2.0 VeriQ software. The LAD ﬂow represented the compe-
titive ﬂow (Figs. 1 and 3) (Videos 1 and 2).
For each ﬂow condition ﬁve consecutive stable wavelets
from each recording probe were stored for further analysis.
The ﬂow in the pulmonary trunk deﬁned the systolic and
diastolic ﬂow phase. The following ﬂow values were
calculated in the LIMA graft under all four conditions:
diastolic antegrade ﬂow, systolic antegrade ﬂow, total
retrograde ﬂow, diastolic maximum peak ﬂow, and systolic
maximum peak ﬂow. The following values were used to
calculate the following derived indexes:
2.4. Statistics
Data were analyzed using SPSS, version 15.0 (SPSS Inc.,
Chicago, IL) and expressed as mean  1 standard deviation
for normally distributed data and as median with range for
data not normally distributed. Friedman’s tests for non-
normally distributed variables were applied. If the Fried-
man’s test revealed signiﬁcant changes, post hoc analyses by
Wilcoxon signed-ranks were performed without correction
for multiple comparisons. To compare the ﬂow measure-
ments between individual pigs, ratio values to baseline ﬂow
were calculated. A p value <0.05 was considered signiﬁcant.
3. Results
The overall blood pressure, heart rate and cardiac output
were 94  14 mmHg, 102  19/min and 7.0  1.6 l/min,
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Table 1
True values of mean ﬂow and derived indexes. Median and range (n = 9).
Name Baseline Full competitive ﬂow Partial competitive ﬂow Stenosis of anastomosis p
Mean ﬂow 48 (35—50) 29 (3—38)*,y 38 (18—52) * 41 (19—60) 0.001
Pulsatility index 3.3 (1.6—10.1) 5.8 (2.2—12.8) * 4.0 (2.0—9.7) 3.9 (1.5—10.1) 0.006
Diastolic ﬁlling% 67 (56—85) 46 (31—58)*,y 56 (40—71) * 61 (46—75) <0.001
Insufﬁciency% 2.3 (0—13.1) 9.4 (0.21—37.0)*,y 5.1 (0—14.5) 2.0 (0—14.6) 0.002
p refers to Friedman’s test.
* p < 0.05 refers to comparison with baseline condition analyzed by post hoc test.
y p < 0.05 refers to comparison with a luminal LIMA—LAD stenosis of 75  11%, analyzed by post hoc test.
Fig. 3. Layout showing the position of the three ﬂow probes during experi-
ments and their corresponding ﬂow curves by the Medi-Stim VeriQ ﬂowmeter.
(A) Pulmonary trunk ﬂow. (B) LAD ﬂow. (C) LIMA ﬂow. The vascular occluder
was applied around the proximal LAD to adjust competitive ﬂow. These ﬂow
curves were recorded at full competitive ﬂow; light gray represents diastolic
ﬂow, dark gray is the systolic ﬂow. Antegrade and retrograde ﬂow is the ﬂow
above and below the zero line, respectively.
Mean flow ¼ antegrade retrograde flow
Insufficiency ð%Þ ¼ ðretrograde flow=antegrade flowÞ  100
Diastolic filling ð%Þ ¼ ðdiastolic flow=ðsystolicþ diastolic flowÞ  100
Pulsatility index ðPIÞ ¼ ðmaximum peak flowminimum peak flowÞ=mean flow:
This is automatically calculated by the flowmeter:
The ultrasound imaging was performed with a GE Vivid 7
scanner (GE Vingmed, Norway) equipped with an i13L linear
array probe (GE Healthcare, Waukesha, WI), capable of
operating at frequencies from 7 to 14 MHz. Ultrasound gel
was applied in the ﬁeld of the anastomosis to get a proper
stand-off, suitable for better images. The anastomosis was
visualized in transverse and longitudinal scan planes using B-
mode tissue imaging and a new ultrasound ﬂow imaging
modality termed ‘blood ﬂow imaging’ (BFI). The BFI modality
is based on conventional color Doppler imaging and can
visualize blood ﬂow in any direction of the two-dimensional
image plane without limitations imposed by aliases [3]
(Videos 1 and 2). The luminal stenosis was estimated with the
use of MATLAB v7.0 (Mathworks Inc., USA).
2.3. Experimental protocol
Transit-time ﬂow patterns in the LIMA grafts were
recorded under four different conditions: (A) baseline ﬂow:
the proximal LAD was totally occluded; (B) full competitive
ﬂow: no occlusion of the proximal LAD; (C) partial
competitive ﬂow: partial occlusion of the LAD to roughly
half its competitive ﬂow; (D) stenotic anastomosis (Fig. 1).
After a fully patent anastomosis was constructed and
controlled by epicardial ultrasound, a stenosis of the
anastomosis was made by placing a deep stitch at the
anastomotic toe with the aim to reduce its cross sectional
area (Fig. 2). The calculated mean degree of stenosis was
75  11% as measured by epicardial ultrasound [3].
All ﬂow and ultrasound measurements were made after
30 min stabilization and at similar and stable hemodynamic
conditions (heart rate, cardiac output and blood pressure)
after removal of the stabilizer from the epicardial surface.
All recordings of ﬂow values in the LAD, LIMA and pulmonary
trunkwere obtained simultaneously and stored in a database.
The ﬂow curves were analyzed off-line using the Medi-Stim
2.0 VeriQ software. The LAD ﬂow represented the compe-
titive ﬂow (Figs. 1 and 3) (Videos 1 and 2).
For each ﬂow condition ﬁve consecutive stable wavelets
from each recording probe were stored for further analysis.
The ﬂow in the pulmonary trunk deﬁned the systolic and
diastolic ﬂow phase. The following ﬂow values were
calculated in the LIMA graft under all four conditions:
diastolic antegrade ﬂow, systolic antegrade ﬂow, total
retrograde ﬂow, diastolic maximum peak ﬂow, and systolic
maximum peak ﬂow. The following values were used to
calculate the following derived indexes:
2.4. Statistics
Data were analyzed using SPSS, version 15.0 (SPSS Inc.,
Chicago, IL) and expressed as mean  1 standard deviation
for normally distributed data and as median with range for
data not normally distributed. Friedman’s tests for non-
normally distributed variables were applied. If the Fried-
man’s test revealed signiﬁcant changes, post hoc analyses by
Wilcoxon signed-ranks were performed without correction
for multiple comparisons. To compare the ﬂow measure-
ments between individual pigs, ratio values to baseline ﬂow
were calculated. A p value <0.05 was considered signiﬁcant.
3. Results
The overall blood pressure, heart rate and cardiac output
were 94  14 mmHg, 102  19/min and 7.0  1.6 l/min,
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Table 1
True values of mean ﬂow and derived indexes. Median and range (n = 9).
Name Baseline Full competitive ﬂow Partial competitive ﬂow Stenosis of anastomosis p
Mean ﬂow 48 (35—50) 29 (3—38)*,y 38 (18—52) * 41 (19—60) 0.001
Pulsatility index 3.3 (1.6—10.1) 5.8 (2.2—12.8) * 4.0 (2.0—9.7) 3.9 (1.5—10.1) 0.006
Diastolic ﬁlling% 67 (56—85) 46 (31—58)*,y 56 (40—71) * 61 (46—75) <0.001
Insufﬁciency% 2.3 (0—13.1) 9.4 (0.21—37.0)*,y 5.1 (0—14.5) 2.0 (0—14.6) 0.002
p refers to Friedman’s test.
* p < 0.05 refers to comparison with baseline condition analyzed by post hoc test.
y p < 0.05 refers to comparison with a luminal LIMA—LAD stenosis of 75  11%, analyzed by post hoc test.
Fig. 3. Layout showing the position of the three ﬂow probes during experi-
ments and their corresponding ﬂow curves by the Medi-Stim VeriQ ﬂowmeter.
(A) Pulmonary trunk ﬂow. (B) LAD ﬂow. (C) LIMA ﬂow. The vascular occluder
was applied around the proximal LAD to adjust competitive ﬂow. These ﬂow
curves were recorded at full competitive ﬂow; light gray represents diastolic
ﬂow, dark gray is the systolic ﬂow. Antegrade and retrograde ﬂow is the ﬂow
above and below the zero line, respectively.
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Insufficiency ð%Þ ¼ ðretrograde flow=antegrade flowÞ  100
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Pulsatility index ðPIÞ ¼ ðmaximum peak flowminimum peak flowÞ=mean flow:
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The ultrasound imaging was performed with a GE Vivid 7
scanner (GE Vingmed, Norway) equipped with an i13L linear
array probe (GE Healthcare, Waukesha, WI), capable of
operating at frequencies from 7 to 14 MHz. Ultrasound gel
was applied in the ﬁeld of the anastomosis to get a proper
stand-off, suitable for better images. The anastomosis was
visualized in transverse and longitudinal scan planes using B-
mode tissue imaging and a new ultrasound ﬂow imaging
modality termed ‘blood ﬂow imaging’ (BFI). The BFI modality
is based on conventional color Doppler imaging and can
visualize blood ﬂow in any direction of the two-dimensional
image plane without limitations imposed by aliases [3]
(Videos 1 and 2). The luminal stenosis was estimated with the
use of MATLAB v7.0 (Mathworks Inc., USA).
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Transit-time ﬂow patterns in the LIMA grafts were
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ﬂow: no occlusion of the proximal LAD; (C) partial
competitive ﬂow: partial occlusion of the LAD to roughly
half its competitive ﬂow; (D) stenotic anastomosis (Fig. 1).
After a fully patent anastomosis was constructed and
controlled by epicardial ultrasound, a stenosis of the
anastomosis was made by placing a deep stitch at the
anastomotic toe with the aim to reduce its cross sectional
area (Fig. 2). The calculated mean degree of stenosis was
75  11% as measured by epicardial ultrasound [3].
All ﬂow and ultrasound measurements were made after
30 min stabilization and at similar and stable hemodynamic
conditions (heart rate, cardiac output and blood pressure)
after removal of the stabilizer from the epicardial surface.
All recordings of ﬂow values in the LAD, LIMA and pulmonary
trunkwere obtained simultaneously and stored in a database.
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maximum peak ﬂow. The following values were used to
calculate the following derived indexes:
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Data were analyzed using SPSS, version 15.0 (SPSS Inc.,
Chicago, IL) and expressed as mean  1 standard deviation
for normally distributed data and as median with range for
data not normally distributed. Friedman’s tests for non-
normally distributed variables were applied. If the Fried-
man’s test revealed signiﬁcant changes, post hoc analyses by
Wilcoxon signed-ranks were performed without correction
for multiple comparisons. To compare the ﬂow measure-
ments between individual pigs, ratio values to baseline ﬂow
were calculated. A p value <0.05 was considered signiﬁcant.
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H. Nordgaard et al. / European Journal of Cardio-thoracic Surgery 36 (2009) 137—142 139
Table 1
True values of mean ﬂow and derived indexes. Median and range (n = 9).
Name Baseline Full competitive ﬂow Partial competitive ﬂow Stenosis of anastomosis p
Mean ﬂow 48 (35—50) 29 (3—38)*,y 38 (18—52) * 41 (19—60) 0.001
Pulsatility index 3.3 (1.6—10.1) 5.8 (2.2—12.8) * 4.0 (2.0—9.7) 3.9 (1.5—10.1) 0.006
Diastolic ﬁlling% 67 (56—85) 46 (31—58)*,y 56 (40—71) * 61 (46—75) <0.001
Insufﬁciency% 2.3 (0—13.1) 9.4 (0.21—37.0)*,y 5.1 (0—14.5) 2.0 (0—14.6) 0.002
p refers to Friedman’s test.
* p < 0.05 refers to comparison with baseline condition analyzed by post hoc test.
y p < 0.05 refers to comparison with a luminal LIMA—LAD stenosis of 75  11%, analyzed by post hoc test.
Fig. 3. Layout showing the position of the three ﬂow probes during experi-
ments and their corresponding ﬂow curves by the Medi-Stim VeriQ ﬂowmeter.
(A) Pulmonary trunk ﬂow. (B) LAD ﬂow. (C) LIMA ﬂow. The vascular occluder
was applied around the proximal LAD to adjust competitive ﬂow. These ﬂow
curves were recorded at full competitive ﬂow; light gray represents diastolic
ﬂow, dark gray is the systolic ﬂow. Antegrade and retrograde ﬂow is the ﬂow
above and below the zero line, respectively.
Mean flow ¼ antegrade retrograde flow
Insufficiency ð%Þ ¼ ðretrograde flow=antegrade flowÞ  100
Diastolic filling ð%Þ ¼ ðdiastolic flow=ðsystolicþ diastolic flowÞ  100
Pulsatility index ðPIÞ ¼ ðmaximum peak flowminimum peak flowÞ=mean flow:
This is automatically calculated by the flowmeter:
The ultrasound imaging was performed with a GE Vivid 7
scanner (GE Vingmed, Norway) equipped with an i13L linear
array probe (GE Healthcare, Waukesha, WI), capable of
operating at frequencies from 7 to 14 MHz. Ultrasound gel
was applied in the ﬁeld of the anastomosis to get a proper
stand-off, suitable for better images. The anastomosis was
visualized in transverse and longitudinal scan planes using B-
mode tissue imaging and a new ultrasound ﬂow imaging
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use of MATLAB v7.0 (Mathworks Inc., USA).
2.3. Experimental protocol
Transit-time ﬂow patterns in the LIMA grafts were
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ﬂow: no occlusion of the proximal LAD; (C) partial
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half its competitive ﬂow; (D) stenotic anastomosis (Fig. 1).
After a fully patent anastomosis was constructed and
controlled by epicardial ultrasound, a stenosis of the
anastomosis was made by placing a deep stitch at the
anastomotic toe with the aim to reduce its cross sectional
area (Fig. 2). The calculated mean degree of stenosis was
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All ﬂow and ultrasound measurements were made after
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after removal of the stabilizer from the epicardial surface.
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maximum peak ﬂow. The following values were used to
calculate the following derived indexes:
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Data were analyzed using SPSS, version 15.0 (SPSS Inc.,
Chicago, IL) and expressed as mean  1 standard deviation
for normally distributed data and as median with range for
data not normally distributed. Friedman’s tests for non-
normally distributed variables were applied. If the Fried-
man’s test revealed signiﬁcant changes, post hoc analyses by
Wilcoxon signed-ranks were performed without correction
for multiple comparisons. To compare the ﬂow measure-
ments between individual pigs, ratio values to baseline ﬂow
were calculated. A p value <0.05 was considered signiﬁcant.
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The overall blood pressure, heart rate and cardiac output
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Fig. 3. Layout showing the position of the three ﬂow probes during experi-
ments and their corresponding ﬂow curves by the Medi-Stim VeriQ ﬂowmeter.
(A) Pulmonary trunk ﬂow. (B) LAD ﬂow. (C) LIMA ﬂow. The vascular occluder
was applied around the proximal LAD to adjust competitive ﬂow. These ﬂow
curves were recorded at full competitive ﬂow; light gray represents diastolic
ﬂow, dark gray is the systolic ﬂow. Antegrade and retrograde ﬂow is the ﬂow
above and below the zero line, respectively.
Mean flow ¼ antegrade retrograde flow
Insufficiency ð%Þ ¼ ðretrograde flow=antegrade flowÞ  100
Diastolic filling ð%Þ ¼ ðdiastolic flow=ðsystolicþ diastolic flowÞ  100
Pulsatility index ðPIÞ ¼ ðmaximum peak flowminimum peak flowÞ=mean flow:
This is automatically calculated by the flowmeter:
respectively. The ﬂow values and derived indexes at all four
ﬂow conditions are presented in Tables 1 and 2. A dot plot
diagram (Fig. 4) illustrates the ﬂow ratios under the four ﬂow
conditions.
The most important ﬁndings were the reduction of
diastolic ﬂow determined by full and partial competitive
ﬂow compared with baseline ﬂow ( p = 0.008 and 0.021,
respectively), whilst the stenotic anastomoses inﬂuenced
either the diastolic or the mean ﬂow ( p = 0.314 and 0.285,
respectively) (Fig. 4; Tables 1 and 2). The mean ﬂow was
reduced during both full and partial competitive ﬂow
compared with baseline ﬂow ( p = 0.008 and 0.051, respec-
tively). The systolic antegrade ﬂowwas not inﬂuenced by any
of the ﬂow conditions ( p = 0.481) (Fig. 3). The PI and
percentage of insufﬁciency increased only under full
competitive ﬂow ( p = 0.008, both indexes) (Table 1). The
diastolic ﬁlling % was lower in full and partial competitive
ﬂow compared with baseline ( p = 0.008 and 0.011, respec-
tively). Retrograde ﬂow occurred in early systole under all
four ﬂow conditions, but was signiﬁcantly increased only
during full competitive ﬂow ( p = 0.008), (Table 2). The
diastolic and systolic maximum peak ﬂows were both reduced
at competitive ﬂow ( p = 0.008 and 0.011, respectively),
whilst a 75% anastomotic stenosis did not affect maximum
peak ﬂows ( p = 0.086 and 0.314, respectively) (Table 2).
4. Discussion
Our study produced four major ﬁndings. Firstly, compe-
titive ﬂow led to a signiﬁcant reduction of blood ﬂow within
the LIMA graft, mainly because of a considerable decrease
of the diastolic ﬂow. Secondly, the graft ﬂow was not
signiﬁcantly decreased despite a major (75%) stenosis of the
anastomoses. Thirdly, higher PI was observed at full
competitive ﬂow because lower mean ﬂows were recorded.
Finally, partial competitive ﬂow generally had the same
effect as full competitive ﬂow on both the mean and
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Fig. 4. Dot plots presenting ﬂow values at four different ﬂow conditions, expressed as ratio of baseline ﬂow (=1). (a) Mean ﬂow, (b) diastolic antegrade ﬂow, (c)
systolic antegrade ﬂow and (d) retrograde ﬂow.
Table 2
Flow values as ratios to baseline (=1). Baseline ﬂow is deﬁned as patent anastomosis with no competitive ﬂow. Median and range (n = 9).
Flow Full competitive ﬂow Partial competitive ﬂow Stenosis p
Mean 0.63 (0.08—0.81)*,y 0.76 (0.51—1.17) * 0.88 (0.54—1.25) 0.001
Diastolic antegrade 0.52 (0.13—0.77)*,y 0.56 (0.50—1.07) * 0.83 (0.43—1.86) 0.008
Systolic antegrade 1.06 (0.39—1.40) 1.16 (0.49—1.54) 0.96 (0.67—2.54) 0.481
Diastolic maximum peak 0.59 (0.34—0.78)*,y 0.72 (0.40—1.08) * 0.83 (0.37—1.83) <0.001
Systolic maximum peak 0.77 (0.50—1.04)*,y 0.76 (0.54—0.96)*,y 1.07 (0.71—2.83) 0.001
Retrograde 2.30 (1.15—10.55)*,y 1.37 (0.46—8.00) 0.60 (0.14—10.6) 0.018
p refers to Friedman’s test.
* p < 0.05 refers to comparison with baseline conditions analyzed by post hoc test.
y p < 0.05 refers to comparison with stenosis analyzed by post hoc test.
respectively. The ﬂow values and derived indexes at all four
ﬂow conditions are presented in Tables 1 and 2. A dot plot
diagram (Fig. 4) illustrates the ﬂow ratios under the four ﬂow
conditions.
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either the diastolic or the mean ﬂow ( p = 0.314 and 0.285,
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tively). The systolic antegrade ﬂowwas not inﬂuenced by any
of the ﬂow conditions ( p = 0.481) (Fig. 3). The PI and
percentage of insufﬁciency increased only under full
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tively). Retrograde ﬂow occurred in early systole under all
four ﬂow conditions, but was signiﬁcantly increased only
during full competitive ﬂow ( p = 0.008), (Table 2). The
diastolic and systolic maximum peak ﬂows were both reduced
at competitive ﬂow ( p = 0.008 and 0.011, respectively),
whilst a 75% anastomotic stenosis did not affect maximum
peak ﬂows ( p = 0.086 and 0.314, respectively) (Table 2).
4. Discussion
Our study produced four major ﬁndings. Firstly, compe-
titive ﬂow led to a signiﬁcant reduction of blood ﬂow within
the LIMA graft, mainly because of a considerable decrease
of the diastolic ﬂow. Secondly, the graft ﬂow was not
signiﬁcantly decreased despite a major (75%) stenosis of the
anastomoses. Thirdly, higher PI was observed at full
competitive ﬂow because lower mean ﬂows were recorded.
Finally, partial competitive ﬂow generally had the same
effect as full competitive ﬂow on both the mean and
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Fig. 4. Dot plots presenting ﬂow values at four different ﬂow conditions, expressed as ratio of baseline ﬂow (=1). (a) Mean ﬂow, (b) diastolic antegrade ﬂow, (c)
systolic antegrade ﬂow and (d) retrograde ﬂow.
Table 2
Flow values as ratios to baseline (=1). Baseline ﬂow is deﬁned as patent anastomosis with no competitive ﬂow. Median and range (n = 9).
Flow Full competitive ﬂow Partial competitive ﬂow Stenosis p
Mean 0.63 (0.08—0.81)*,y 0.76 (0.51—1.17) * 0.88 (0.54—1.25) 0.001
Diastolic antegrade 0.52 (0.13—0.77)*,y 0.56 (0.50—1.07) * 0.83 (0.43—1.86) 0.008
Systolic antegrade 1.06 (0.39—1.40) 1.16 (0.49—1.54) 0.96 (0.67—2.54) 0.481
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Systolic maximum peak 0.77 (0.50—1.04)*,y 0.76 (0.54—0.96)*,y 1.07 (0.71—2.83) 0.001
Retrograde 2.30 (1.15—10.55)*,y 1.37 (0.46—8.00) 0.60 (0.14—10.6) 0.018
p refers to Friedman’s test.
* p < 0.05 refers to comparison with baseline conditions analyzed by post hoc test.
y p < 0.05 refers to comparison with stenosis analyzed by post hoc test.
respectively. The ﬂow values and derived indexes at all four
ﬂow conditions are presented in Tables 1 and 2. A dot plot
diagram (Fig. 4) illustrates the ﬂow ratios under the four ﬂow
conditions.
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either the diastolic or the mean ﬂow ( p = 0.314 and 0.285,
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reduced during both full and partial competitive ﬂow
compared with baseline ﬂow ( p = 0.008 and 0.051, respec-
tively). The systolic antegrade ﬂowwas not inﬂuenced by any
of the ﬂow conditions ( p = 0.481) (Fig. 3). The PI and
percentage of insufﬁciency increased only under full
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ﬂow compared with baseline ( p = 0.008 and 0.011, respec-
tively). Retrograde ﬂow occurred in early systole under all
four ﬂow conditions, but was signiﬁcantly increased only
during full competitive ﬂow ( p = 0.008), (Table 2). The
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* p < 0.05 refers to comparison with baseline conditions analyzed by post hoc test.
y p < 0.05 refers to comparison with stenosis analyzed by post hoc test.
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diagram (Fig. 4) illustrates the ﬂow ratios under the four ﬂow
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reduced during both full and partial competitive ﬂow
compared with baseline ﬂow ( p = 0.008 and 0.051, respec-
tively). The systolic antegrade ﬂowwas not inﬂuenced by any
of the ﬂow conditions ( p = 0.481) (Fig. 3). The PI and
percentage of insufﬁciency increased only under full
competitive ﬂow ( p = 0.008, both indexes) (Table 1). The
diastolic ﬁlling % was lower in full and partial competitive
ﬂow compared with baseline ( p = 0.008 and 0.011, respec-
tively). Retrograde ﬂow occurred in early systole under all
four ﬂow conditions, but was signiﬁcantly increased only
during full competitive ﬂow ( p = 0.008), (Table 2). The
diastolic and systolic maximum peak ﬂows were both reduced
at competitive ﬂow ( p = 0.008 and 0.011, respectively),
whilst a 75% anastomotic stenosis did not affect maximum
peak ﬂows ( p = 0.086 and 0.314, respectively) (Table 2).
4. Discussion
Our study produced four major ﬁndings. Firstly, compe-
titive ﬂow led to a signiﬁcant reduction of blood ﬂow within
the LIMA graft, mainly because of a considerable decrease
of the diastolic ﬂow. Secondly, the graft ﬂow was not
signiﬁcantly decreased despite a major (75%) stenosis of the
anastomoses. Thirdly, higher PI was observed at full
competitive ﬂow because lower mean ﬂows were recorded.
Finally, partial competitive ﬂow generally had the same
effect as full competitive ﬂow on both the mean and
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Fig. 4. Dot plots presenting ﬂow values at four different ﬂow conditions, expressed as ratio of baseline ﬂow (=1). (a) Mean ﬂow, (b) diastolic antegrade ﬂow, (c)
systolic antegrade ﬂow and (d) retrograde ﬂow.
Table 2
Flow values as ratios to baseline (=1). Baseline ﬂow is deﬁned as patent anastomosis with no competitive ﬂow. Median and range (n = 9).
Flow Full competitive ﬂow Partial competitive ﬂow Stenosis p
Mean 0.63 (0.08—0.81)*,y 0.76 (0.51—1.17) * 0.88 (0.54—1.25) 0.001
Diastolic antegrade 0.52 (0.13—0.77)*,y 0.56 (0.50—1.07) * 0.83 (0.43—1.86) 0.008
Systolic antegrade 1.06 (0.39—1.40) 1.16 (0.49—1.54) 0.96 (0.67—2.54) 0.481
Diastolic maximum peak 0.59 (0.34—0.78)*,y 0.72 (0.40—1.08) * 0.83 (0.37—1.83) <0.001
Systolic maximum peak 0.77 (0.50—1.04)*,y 0.76 (0.54—0.96)*,y 1.07 (0.71—2.83) 0.001
Retrograde 2.30 (1.15—10.55)*,y 1.37 (0.46—8.00) 0.60 (0.14—10.6) 0.018
p refers to Friedman’s test.
* p < 0.05 refers to comparison with baseline conditions analyzed by post hoc test.
y p < 0.05 refers to comparison with stenosis analyzed by post hoc test.
diastolic ﬂow, whereas retrograde ﬂow, PI and insufﬁciency
were signiﬁcantly inﬂuenced only under full competitive
ﬂow.
Our various experimental settings evoked three different
ﬂow conditions often encountered by the surgeon in practice.
Full competitive ﬂow mimics the situation of a graft placed
distal to a less than critical stenosis of the coronary vessel.
This may occur when coronary vessels with less than 50—70%
stenosis are grafted, although such stenosis has no hemody-
namic consequences at rest. Partial competitive ﬂow occurs
when a coronary artery is grafted distal to a signiﬁcant
stenosis providing about half the volume ﬂow compared with
the full value. The third condition was no-ﬂow, an ideal
situation for placing the graft distally on a totally occluded
coronary.
This study showed that the LIMA graft was much
inﬂuenced by competitive ﬂow, as both the full and partial
competitive ﬂow conditions signiﬁcantly altered the ﬂow
patterns. Despite the superior long-term patency of
mammary grafts, the effect of competitive ﬂow on the
patency of LIMA grafts is still controversial [4—15]. The
narrowing phenomenon (string sign) of the distal mammary
graft is believed to be associated with competitive ﬂow
[4,7,16], because the blood ﬂow within the mammary
artery is so low that it cannot meet the metabolic
requirements of its cell walls, causing the graft to narrow
and eventually fail.
Clinical studies of competitive ﬂow do not measure ﬂows
because they are retrospective and based on angiographic
data. The occurrence of competitive ﬂow has been inferred
from the concomitant presence of a non-signiﬁcant stenosis
of the grafted vessel [7,9,17]. Furthermore, other studies
suggest that arterial grafts such as LIMA are more inﬂuenced
by competitive ﬂow than are saphenous vein grafts [4,7,10—
16]. The non-muscular saphenous vein grafts cannot adjust
their lumens in response to metabolic requirements as much
as arterial grafts. Thus, the response of vein grafts to low ﬂow
is limited.
To consider the effects of stenotic anastomoses we found
that a 75% luminal stenosis of the anastomosis did not reduce
blood ﬂow through the grafts. This supports the ﬁndings of
Morota et al. [18] and Jaber et al. [19], who also showed that
blood ﬂowmeasurements remained stable when anastomotic
stenoses varied from mild (<25%) to moderately severe
(<75%).
Our results are in line with the patho-physiological
principles underlining blood ﬂow in stenotic vessels described
by Poiseuille’s law. Nonetheless, this effect of a stenosis on
blood ﬂow is reduced in the LAD because of the autoregula-
tion within the peripheral vascular bed. The LAD is
characterized by the largest lumen and most extensive
peripheral vascular bed of all coronary arteries. Therefore to
reduce the LAD perfusion ﬂow by stenosis, the vessel lumen
must be considerably restricted (e.g. from 80 to 90%). With
such narrowing autoregulation will soon be exhausted, and
any subsequent small reduction will have major hemody-
namic consequences [20]. Clinically, a stenosis of the LAD
<75% will reduce maximal ﬂow capacity, causing ischemic
induced chest pain during exertion. During rest a stenosis
>75% may signiﬁcantly reduce blood ﬂow, which can lead to
chronic myocardial hypoxia.
A practical question raised by our ﬁndings is how to
distinguish between competitive ﬂows from a stenotic
anastomosis, whenever low ﬂows are recorded after CABG,
since both conditions may decrease blood ﬂow.We found that
competitive ﬂow altered mainly the diastolic phase of graft
ﬂow, whereas the systolic ﬂow remained unchanged.
Additionally, a smoother ﬂow pattern might be present,
because the maximum peaks in systole and diastole decrease
during competitive ﬂow in LIMA—LAD anastomoses. Thus, a
careful analysis of ﬂow patterns and their timing should
always be carried out in situations with low graft ﬂow. If the
ﬂow pattern is still difﬁcult to interpret then snaring the
coronary artery proximal to the anastomotic site might be of
further help. Thus D’Ancona et al. strongly recommended
that graft ﬂow should bemeasured with andwithout proximal
snaring of the coronary artery [2]. With competitive ﬂow, as
we found, occlusion of the coronary artery will increase graft
ﬂow; conversely, with a ﬂow decrease an obstruction distal to
the graft may be suspected (i.e. stenotic anastomosis,
coronary stenosis distal to the anastomotic site or poor run-
off). Temporary clamping of grafts directed to collateral
coronaries may also aid in the interpretation of blood ﬂow.
Hangler et al. strongly warned against the use of occluders
during CABG, as they found evidence of coronary endothelial
injury on electron microscopy after different occluding
techniques [21]. To avoid vessel snaring, many surgeons
measure the ﬂow in the LIMA graft before removing the aortic
cross clamp. Alternatively, as we have reported, epicardial
ultrasound is fast and efﬁcient for assessing coronary graft
anastomoses [22]. In the present study the new blood ﬂow
imaging modality was used to evaluate the patency of the
anastomosis by looking at its morphology and function, and
particularly the degree of stenosis [3]. We believe that this
technique has a great part to play in the intra-operative
assessment of CABG as it is non-invasive and can easily detect
stenoses and competitive ﬂow [22].
The main limitations of this study were that the pigs had
normal coronary arteries with good run-off, and that the
animal model may not be directly comparable to patients
with advanced coronary disease. The measured ﬂow values
may also be different in different species. Thus, the true ﬂow
values and derived indexes may not be directly applicable to
humans, although the 75% degree of anastomotic stenosis in
our model still represented a failed anastomosis likely to
cause stable angina. The consequences of an even tighter
stenosis on graft ﬂow were not investigated. Finally, the
statistical limitations were the multiple comparisons and a
limited number of measurements. The widely used Bonfer-
roni correction for multiple comparisons is designed for use
with independent multiple measurements and does not fully
apply to this situation. We instead report uncorrected p
values for the Wilcoxon signed-ranks, which the readers may
themselves more easily assess the relevance of the statistical
differences described.
In conclusion, in a porcine model, the LIMA ﬂow was
signiﬁcantly reduced by native coronary artery competitive
ﬂow but marginally decreased by an anastomotic mean
luminal stenosis of 75%. Reduction of graft ﬂow due to
competitive ﬂow was particularly evident in diastole. Thus a
careful analysis of ﬂow patterns may help to discriminate
between competitive ﬂow and an anastomotic stenosis. A
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diastolic ﬂow, whereas retrograde ﬂow, PI and insufﬁciency
were signiﬁcantly inﬂuenced only under full competitive
ﬂow.
Our various experimental settings evoked three different
ﬂow conditions often encountered by the surgeon in practice.
Full competitive ﬂow mimics the situation of a graft placed
distal to a less than critical stenosis of the coronary vessel.
This may occur when coronary vessels with less than 50—70%
stenosis are grafted, although such stenosis has no hemody-
namic consequences at rest. Partial competitive ﬂow occurs
when a coronary artery is grafted distal to a signiﬁcant
stenosis providing about half the volume ﬂow compared with
the full value. The third condition was no-ﬂow, an ideal
situation for placing the graft distally on a totally occluded
coronary.
This study showed that the LIMA graft was much
inﬂuenced by competitive ﬂow, as both the full and partial
competitive ﬂow conditions signiﬁcantly altered the ﬂow
patterns. Despite the superior long-term patency of
mammary grafts, the effect of competitive ﬂow on the
patency of LIMA grafts is still controversial [4—15]. The
narrowing phenomenon (string sign) of the distal mammary
graft is believed to be associated with competitive ﬂow
[4,7,16], because the blood ﬂow within the mammary
artery is so low that it cannot meet the metabolic
requirements of its cell walls, causing the graft to narrow
and eventually fail.
Clinical studies of competitive ﬂow do not measure ﬂows
because they are retrospective and based on angiographic
data. The occurrence of competitive ﬂow has been inferred
from the concomitant presence of a non-signiﬁcant stenosis
of the grafted vessel [7,9,17]. Furthermore, other studies
suggest that arterial grafts such as LIMA are more inﬂuenced
by competitive ﬂow than are saphenous vein grafts [4,7,10—
16]. The non-muscular saphenous vein grafts cannot adjust
their lumens in response to metabolic requirements as much
as arterial grafts. Thus, the response of vein grafts to low ﬂow
is limited.
To consider the effects of stenotic anastomoses we found
that a 75% luminal stenosis of the anastomosis did not reduce
blood ﬂow through the grafts. This supports the ﬁndings of
Morota et al. [18] and Jaber et al. [19], who also showed that
blood ﬂowmeasurements remained stable when anastomotic
stenoses varied from mild (<25%) to moderately severe
(<75%).
Our results are in line with the patho-physiological
principles underlining blood ﬂow in stenotic vessels described
by Poiseuille’s law. Nonetheless, this effect of a stenosis on
blood ﬂow is reduced in the LAD because of the autoregula-
tion within the peripheral vascular bed. The LAD is
characterized by the largest lumen and most extensive
peripheral vascular bed of all coronary arteries. Therefore to
reduce the LAD perfusion ﬂow by stenosis, the vessel lumen
must be considerably restricted (e.g. from 80 to 90%). With
such narrowing autoregulation will soon be exhausted, and
any subsequent small reduction will have major hemody-
namic consequences [20]. Clinically, a stenosis of the LAD
<75% will reduce maximal ﬂow capacity, causing ischemic
induced chest pain during exertion. During rest a stenosis
>75% may signiﬁcantly reduce blood ﬂow, which can lead to
chronic myocardial hypoxia.
A practical question raised by our ﬁndings is how to
distinguish between competitive ﬂows from a stenotic
anastomosis, whenever low ﬂows are recorded after CABG,
since both conditions may decrease blood ﬂow.We found that
competitive ﬂow altered mainly the diastolic phase of graft
ﬂow, whereas the systolic ﬂow remained unchanged.
Additionally, a smoother ﬂow pattern might be present,
because the maximum peaks in systole and diastole decrease
during competitive ﬂow in LIMA—LAD anastomoses. Thus, a
careful analysis of ﬂow patterns and their timing should
always be carried out in situations with low graft ﬂow. If the
ﬂow pattern is still difﬁcult to interpret then snaring the
coronary artery proximal to the anastomotic site might be of
further help. Thus D’Ancona et al. strongly recommended
that graft ﬂow should bemeasured with andwithout proximal
snaring of the coronary artery [2]. With competitive ﬂow, as
we found, occlusion of the coronary artery will increase graft
ﬂow; conversely, with a ﬂow decrease an obstruction distal to
the graft may be suspected (i.e. stenotic anastomosis,
coronary stenosis distal to the anastomotic site or poor run-
off). Temporary clamping of grafts directed to collateral
coronaries may also aid in the interpretation of blood ﬂow.
Hangler et al. strongly warned against the use of occluders
during CABG, as they found evidence of coronary endothelial
injury on electron microscopy after different occluding
techniques [21]. To avoid vessel snaring, many surgeons
measure the ﬂow in the LIMA graft before removing the aortic
cross clamp. Alternatively, as we have reported, epicardial
ultrasound is fast and efﬁcient for assessing coronary graft
anastomoses [22]. In the present study the new blood ﬂow
imaging modality was used to evaluate the patency of the
anastomosis by looking at its morphology and function, and
particularly the degree of stenosis [3]. We believe that this
technique has a great part to play in the intra-operative
assessment of CABG as it is non-invasive and can easily detect
stenoses and competitive ﬂow [22].
The main limitations of this study were that the pigs had
normal coronary arteries with good run-off, and that the
animal model may not be directly comparable to patients
with advanced coronary disease. The measured ﬂow values
may also be different in different species. Thus, the true ﬂow
values and derived indexes may not be directly applicable to
humans, although the 75% degree of anastomotic stenosis in
our model still represented a failed anastomosis likely to
cause stable angina. The consequences of an even tighter
stenosis on graft ﬂow were not investigated. Finally, the
statistical limitations were the multiple comparisons and a
limited number of measurements. The widely used Bonfer-
roni correction for multiple comparisons is designed for use
with independent multiple measurements and does not fully
apply to this situation. We instead report uncorrected p
values for the Wilcoxon signed-ranks, which the readers may
themselves more easily assess the relevance of the statistical
differences described.
In conclusion, in a porcine model, the LIMA ﬂow was
signiﬁcantly reduced by native coronary artery competitive
ﬂow but marginally decreased by an anastomotic mean
luminal stenosis of 75%. Reduction of graft ﬂow due to
competitive ﬂow was particularly evident in diastole. Thus a
careful analysis of ﬂow patterns may help to discriminate
between competitive ﬂow and an anastomotic stenosis. A
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diastolic ﬂow, whereas retrograde ﬂow, PI and insufﬁciency
were signiﬁcantly inﬂuenced only under full competitive
ﬂow.
Our various experimental settings evoked three different
ﬂow conditions often encountered by the surgeon in practice.
Full competitive ﬂow mimics the situation of a graft placed
distal to a less than critical stenosis of the coronary vessel.
This may occur when coronary vessels with less than 50—70%
stenosis are grafted, although such stenosis has no hemody-
namic consequences at rest. Partial competitive ﬂow occurs
when a coronary artery is grafted distal to a signiﬁcant
stenosis providing about half the volume ﬂow compared with
the full value. The third condition was no-ﬂow, an ideal
situation for placing the graft distally on a totally occluded
coronary.
This study showed that the LIMA graft was much
inﬂuenced by competitive ﬂow, as both the full and partial
competitive ﬂow conditions signiﬁcantly altered the ﬂow
patterns. Despite the superior long-term patency of
mammary grafts, the effect of competitive ﬂow on the
patency of LIMA grafts is still controversial [4—15]. The
narrowing phenomenon (string sign) of the distal mammary
graft is believed to be associated with competitive ﬂow
[4,7,16], because the blood ﬂow within the mammary
artery is so low that it cannot meet the metabolic
requirements of its cell walls, causing the graft to narrow
and eventually fail.
Clinical studies of competitive ﬂow do not measure ﬂows
because they are retrospective and based on angiographic
data. The occurrence of competitive ﬂow has been inferred
from the concomitant presence of a non-signiﬁcant stenosis
of the grafted vessel [7,9,17]. Furthermore, other studies
suggest that arterial grafts such as LIMA are more inﬂuenced
by competitive ﬂow than are saphenous vein grafts [4,7,10—
16]. The non-muscular saphenous vein grafts cannot adjust
their lumens in response to metabolic requirements as much
as arterial grafts. Thus, the response of vein grafts to low ﬂow
is limited.
To consider the effects of stenotic anastomoses we found
that a 75% luminal stenosis of the anastomosis did not reduce
blood ﬂow through the grafts. This supports the ﬁndings of
Morota et al. [18] and Jaber et al. [19], who also showed that
blood ﬂowmeasurements remained stable when anastomotic
stenoses varied from mild (<25%) to moderately severe
(<75%).
Our results are in line with the patho-physiological
principles underlining blood ﬂow in stenotic vessels described
by Poiseuille’s law. Nonetheless, this effect of a stenosis on
blood ﬂow is reduced in the LAD because of the autoregula-
tion within the peripheral vascular bed. The LAD is
characterized by the largest lumen and most extensive
peripheral vascular bed of all coronary arteries. Therefore to
reduce the LAD perfusion ﬂow by stenosis, the vessel lumen
must be considerably restricted (e.g. from 80 to 90%). With
such narrowing autoregulation will soon be exhausted, and
any subsequent small reduction will have major hemody-
namic consequences [20]. Clinically, a stenosis of the LAD
<75% will reduce maximal ﬂow capacity, causing ischemic
induced chest pain during exertion. During rest a stenosis
>75% may signiﬁcantly reduce blood ﬂow, which can lead to
chronic myocardial hypoxia.
A practical question raised by our ﬁndings is how to
distinguish between competitive ﬂows from a stenotic
anastomosis, whenever low ﬂows are recorded after CABG,
since both conditions may decrease blood ﬂow.We found that
competitive ﬂow altered mainly the diastolic phase of graft
ﬂow, whereas the systolic ﬂow remained unchanged.
Additionally, a smoother ﬂow pattern might be present,
because the maximum peaks in systole and diastole decrease
during competitive ﬂow in LIMA—LAD anastomoses. Thus, a
careful analysis of ﬂow patterns and their timing should
always be carried out in situations with low graft ﬂow. If the
ﬂow pattern is still difﬁcult to interpret then snaring the
coronary artery proximal to the anastomotic site might be of
further help. Thus D’Ancona et al. strongly recommended
that graft ﬂow should bemeasured with andwithout proximal
snaring of the coronary artery [2]. With competitive ﬂow, as
we found, occlusion of the coronary artery will increase graft
ﬂow; conversely, with a ﬂow decrease an obstruction distal to
the graft may be suspected (i.e. stenotic anastomosis,
coronary stenosis distal to the anastomotic site or poor run-
off). Temporary clamping of grafts directed to collateral
coronaries may also aid in the interpretation of blood ﬂow.
Hangler et al. strongly warned against the use of occluders
during CABG, as they found evidence of coronary endothelial
injury on electron microscopy after different occluding
techniques [21]. To avoid vessel snaring, many surgeons
measure the ﬂow in the LIMA graft before removing the aortic
cross clamp. Alternatively, as we have reported, epicardial
ultrasound is fast and efﬁcient for assessing coronary graft
anastomoses [22]. In the present study the new blood ﬂow
imaging modality was used to evaluate the patency of the
anastomosis by looking at its morphology and function, and
particularly the degree of stenosis [3]. We believe that this
technique has a great part to play in the intra-operative
assessment of CABG as it is non-invasive and can easily detect
stenoses and competitive ﬂow [22].
The main limitations of this study were that the pigs had
normal coronary arteries with good run-off, and that the
animal model may not be directly comparable to patients
with advanced coronary disease. The measured ﬂow values
may also be different in different species. Thus, the true ﬂow
values and derived indexes may not be directly applicable to
humans, although the 75% degree of anastomotic stenosis in
our model still represented a failed anastomosis likely to
cause stable angina. The consequences of an even tighter
stenosis on graft ﬂow were not investigated. Finally, the
statistical limitations were the multiple comparisons and a
limited number of measurements. The widely used Bonfer-
roni correction for multiple comparisons is designed for use
with independent multiple measurements and does not fully
apply to this situation. We instead report uncorrected p
values for the Wilcoxon signed-ranks, which the readers may
themselves more easily assess the relevance of the statistical
differences described.
In conclusion, in a porcine model, the LIMA ﬂow was
signiﬁcantly reduced by native coronary artery competitive
ﬂow but marginally decreased by an anastomotic mean
luminal stenosis of 75%. Reduction of graft ﬂow due to
competitive ﬂow was particularly evident in diastole. Thus a
careful analysis of ﬂow patterns may help to discriminate
between competitive ﬂow and an anastomotic stenosis. A
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diastolic ﬂow, whereas retrograde ﬂow, PI and insufﬁciency
were signiﬁcantly inﬂuenced only under full competitive
ﬂow.
Our various experimental settings evoked three different
ﬂow conditions often encountered by the surgeon in practice.
Full competitive ﬂow mimics the situation of a graft placed
distal to a less than critical stenosis of the coronary vessel.
This may occur when coronary vessels with less than 50—70%
stenosis are grafted, although such stenosis has no hemody-
namic consequences at rest. Partial competitive ﬂow occurs
when a coronary artery is grafted distal to a signiﬁcant
stenosis providing about half the volume ﬂow compared with
the full value. The third condition was no-ﬂow, an ideal
situation for placing the graft distally on a totally occluded
coronary.
This study showed that the LIMA graft was much
inﬂuenced by competitive ﬂow, as both the full and partial
competitive ﬂow conditions signiﬁcantly altered the ﬂow
patterns. Despite the superior long-term patency of
mammary grafts, the effect of competitive ﬂow on the
patency of LIMA grafts is still controversial [4—15]. The
narrowing phenomenon (string sign) of the distal mammary
graft is believed to be associated with competitive ﬂow
[4,7,16], because the blood ﬂow within the mammary
artery is so low that it cannot meet the metabolic
requirements of its cell walls, causing the graft to narrow
and eventually fail.
Clinical studies of competitive ﬂow do not measure ﬂows
because they are retrospective and based on angiographic
data. The occurrence of competitive ﬂow has been inferred
from the concomitant presence of a non-signiﬁcant stenosis
of the grafted vessel [7,9,17]. Furthermore, other studies
suggest that arterial grafts such as LIMA are more inﬂuenced
by competitive ﬂow than are saphenous vein grafts [4,7,10—
16]. The non-muscular saphenous vein grafts cannot adjust
their lumens in response to metabolic requirements as much
as arterial grafts. Thus, the response of vein grafts to low ﬂow
is limited.
To consider the effects of stenotic anastomoses we found
that a 75% luminal stenosis of the anastomosis did not reduce
blood ﬂow through the grafts. This supports the ﬁndings of
Morota et al. [18] and Jaber et al. [19], who also showed that
blood ﬂowmeasurements remained stable when anastomotic
stenoses varied from mild (<25%) to moderately severe
(<75%).
Our results are in line with the patho-physiological
principles underlining blood ﬂow in stenotic vessels described
by Poiseuille’s law. Nonetheless, this effect of a stenosis on
blood ﬂow is reduced in the LAD because of the autoregula-
tion within the peripheral vascular bed. The LAD is
characterized by the largest lumen and most extensive
peripheral vascular bed of all coronary arteries. Therefore to
reduce the LAD perfusion ﬂow by stenosis, the vessel lumen
must be considerably restricted (e.g. from 80 to 90%). With
such narrowing autoregulation will soon be exhausted, and
any subsequent small reduction will have major hemody-
namic consequences [20]. Clinically, a stenosis of the LAD
<75% will reduce maximal ﬂow capacity, causing ischemic
induced chest pain during exertion. During rest a stenosis
>75% may signiﬁcantly reduce blood ﬂow, which can lead to
chronic myocardial hypoxia.
A practical question raised by our ﬁndings is how to
distinguish between competitive ﬂows from a stenotic
anastomosis, whenever low ﬂows are recorded after CABG,
since both conditions may decrease blood ﬂow.We found that
competitive ﬂow altered mainly the diastolic phase of graft
ﬂow, whereas the systolic ﬂow remained unchanged.
Additionally, a smoother ﬂow pattern might be present,
because the maximum peaks in systole and diastole decrease
during competitive ﬂow in LIMA—LAD anastomoses. Thus, a
careful analysis of ﬂow patterns and their timing should
always be carried out in situations with low graft ﬂow. If the
ﬂow pattern is still difﬁcult to interpret then snaring the
coronary artery proximal to the anastomotic site might be of
further help. Thus D’Ancona et al. strongly recommended
that graft ﬂow should bemeasured with andwithout proximal
snaring of the coronary artery [2]. With competitive ﬂow, as
we found, occlusion of the coronary artery will increase graft
ﬂow; conversely, with a ﬂow decrease an obstruction distal to
the graft may be suspected (i.e. stenotic anastomosis,
coronary stenosis distal to the anastomotic site or poor run-
off). Temporary clamping of grafts directed to collateral
coronaries may also aid in the interpretation of blood ﬂow.
Hangler et al. strongly warned against the use of occluders
during CABG, as they found evidence of coronary endothelial
injury on electron microscopy after different occluding
techniques [21]. To avoid vessel snaring, many surgeons
measure the ﬂow in the LIMA graft before removing the aortic
cross clamp. Alternatively, as we have reported, epicardial
ultrasound is fast and efﬁcient for assessing coronary graft
anastomoses [22]. In the present study the new blood ﬂow
imaging modality was used to evaluate the patency of the
anastomosis by looking at its morphology and function, and
particularly the degree of stenosis [3]. We believe that this
technique has a great part to play in the intra-operative
assessment of CABG as it is non-invasive and can easily detect
stenoses and competitive ﬂow [22].
The main limitations of this study were that the pigs had
normal coronary arteries with good run-off, and that the
animal model may not be directly comparable to patients
with advanced coronary disease. The measured ﬂow values
may also be different in different species. Thus, the true ﬂow
values and derived indexes may not be directly applicable to
humans, although the 75% degree of anastomotic stenosis in
our model still represented a failed anastomosis likely to
cause stable angina. The consequences of an even tighter
stenosis on graft ﬂow were not investigated. Finally, the
statistical limitations were the multiple comparisons and a
limited number of measurements. The widely used Bonfer-
roni correction for multiple comparisons is designed for use
with independent multiple measurements and does not fully
apply to this situation. We instead report uncorrected p
values for the Wilcoxon signed-ranks, which the readers may
themselves more easily assess the relevance of the statistical
differences described.
In conclusion, in a porcine model, the LIMA ﬂow was
signiﬁcantly reduced by native coronary artery competitive
ﬂow but marginally decreased by an anastomotic mean
luminal stenosis of 75%. Reduction of graft ﬂow due to
competitive ﬂow was particularly evident in diastole. Thus a
careful analysis of ﬂow patterns may help to discriminate
between competitive ﬂow and an anastomotic stenosis. A
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detailed knowledge of different ﬂow patterns by the surgeon
is mandatory for a reliable interpretation of transit-time
ﬂowmetry. In a near future epicardial tissue and Doppler
imaging assessment may be performed together with transit-
time ﬂowmetry because the combined information supplied
by each technique might potentially improve intra-operative
evaluation of coronary grafts.
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Dr B. Walpoth (Geneva, Switzerland): Thank you for presenting an
interesting experimental assessment of this new device from MediStim.
Basically there are some problems with what you showed. First of all, it has
been shown before, secondly, it is well known to all cardiac surgeons that you
will never have full competitive ﬂow. You need a relevant stenosis in order to
make a bypass. And as you have shown and which was known that if you have a
stenosis of the native vessels which is not in excess of 75 to 80%, you will not
have major changes in your ﬂow measurement.
However, I fully agree with you that the addition of imaging technique is an
important feature, because sometimes you measure low-ﬂow situations in
grafts without any obvious reasons, but if imaging is available it can help on-
site in the operating room to make a decision.
My question is the following. You said with 75% stenosis at the toe of your
anastomosis you didn’t see major ﬂow changes. You saw some changes but not
as much as you would have expected. How did you assess the 75% stenosis? To
obtain a correct degree of stenosis you need a biplanar angiographic evaluation
and 75% might not be sufﬁcient.
Dr Nordgaard: We used our ultrasound images of the anastomoses. The
images were afterwards analyzed using the MatLab software. Several
diameters of each LIMA—LAD anastomosis were measured for calculation of
the degree of luminal stenosis. In the operation ﬁeld we assessed the
anastomosis using ultrasound imaging since our aim was creating a stenosis of a
signiﬁcant degree at the toe of the anastomosis.
I do not agree with your comment that full competitive ﬂow doesn’t exist
in coronary surgery. Often surgeons do graft vessels with about 50% luminal
stenosis. Then the hemodynamic still acts as full competitive ﬂow because the
blood ﬂow is not inﬂuenced at this degree of stenosis.
Dr Walpoth: This is correct, yes.
Dr A. Pavie (Paris, France): On your presentation I would like to make a
small comment, and I am a little provocative. You suggest that it is more
important to have good indication to avoid competitive ﬂow, but it is still very
important to do good surgery. I am not sure that we can follow you. It is
certainly important to do a good indication, but if we do good surgery, it is
probably better.
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Supplementary data associated with this article can be found, in the online
version, at doi:10.1016/j.ejcts.2009.02.036.
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detailed knowledge of different ﬂow patterns by the surgeon
is mandatory for a reliable interpretation of transit-time
ﬂowmetry. In a near future epicardial tissue and Doppler
imaging assessment may be performed together with transit-
time ﬂowmetry because the combined information supplied
by each technique might potentially improve intra-operative
evaluation of coronary grafts.
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Appendix A. Conference discussion
Dr B. Walpoth (Geneva, Switzerland): Thank you for presenting an
interesting experimental assessment of this new device from MediStim.
Basically there are some problems with what you showed. First of all, it has
been shown before, secondly, it is well known to all cardiac surgeons that you
will never have full competitive ﬂow. You need a relevant stenosis in order to
make a bypass. And as you have shown and which was known that if you have a
stenosis of the native vessels which is not in excess of 75 to 80%, you will not
have major changes in your ﬂow measurement.
However, I fully agree with you that the addition of imaging technique is an
important feature, because sometimes you measure low-ﬂow situations in
grafts without any obvious reasons, but if imaging is available it can help on-
site in the operating room to make a decision.
My question is the following. You said with 75% stenosis at the toe of your
anastomosis you didn’t see major ﬂow changes. You saw some changes but not
as much as you would have expected. How did you assess the 75% stenosis? To
obtain a correct degree of stenosis you need a biplanar angiographic evaluation
and 75% might not be sufﬁcient.
Dr Nordgaard: We used our ultrasound images of the anastomoses. The
images were afterwards analyzed using the MatLab software. Several
diameters of each LIMA—LAD anastomosis were measured for calculation of
the degree of luminal stenosis. In the operation ﬁeld we assessed the
anastomosis using ultrasound imaging since our aim was creating a stenosis of a
signiﬁcant degree at the toe of the anastomosis.
I do not agree with your comment that full competitive ﬂow doesn’t exist
in coronary surgery. Often surgeons do graft vessels with about 50% luminal
stenosis. Then the hemodynamic still acts as full competitive ﬂow because the
blood ﬂow is not inﬂuenced at this degree of stenosis.
Dr Walpoth: This is correct, yes.
Dr A. Pavie (Paris, France): On your presentation I would like to make a
small comment, and I am a little provocative. You suggest that it is more
important to have good indication to avoid competitive ﬂow, but it is still very
important to do good surgery. I am not sure that we can follow you. It is
certainly important to do a good indication, but if we do good surgery, it is
probably better.
Appendix B. Supplementary data
Supplementary data associated with this article can be found, in the online
version, at doi:10.1016/j.ejcts.2009.02.036.
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1. Introduction
Intra-operative assessment of graft patency is an impor-
tant aspect of coronary artery bypass grafting (CABG).
Transit-time ﬂow measurement (TTFM) has been in clinical
use for more than a decade and is the most applied technique
for intra-operative coronary graft assessment. Transit-time
technology has proven to have a high reliability and accuracy
with few sources of technical errors and provides volumetric
ﬂow patterns and derived indexes, such as the pulsatility
index (PI) [1—4].
The PI is considered a non-invasive method for the
assessment of peripheral vascular resistance of coronary
arteries [5—9], as well as in arteries of other organs (i.e.
brain, kidney, placenta, eye, and so on) [5]. It was ﬁrst
introduced by Gosling and King [6], and was originally deﬁned
as the peak-to-peak height of the waveform divided by the
mean height during a single cardiac cycle, as assessed by
Doppler ultrasound. With the introduction of TTFM, the
deﬁnition of PI was replaced and simpliﬁed, and at present
the following formula is applied: PI = [maximum volumetric
peak ﬂow  minimum volumetric peak ﬂow]/mean volu-
metric ﬂow.
The two most commonly used transit-time ﬂowmeters
are manufactured by MediStim ASA (Oslo, Norway) and
Transonic Systems Inc. (Ithaca, NY, USA) and have different
default ﬁlter settings of 20 and 10 Hz, respectively.
Since the level of ﬁlter settings in a ﬂowmeter may
inﬂuence the wave form, different maximum and minimum
peak ﬂows may be registered and inﬂuence the PI values
[10].
The aim of this study was to assess the potential
variability of the PI as calculated by the MediStim and
Transonic ﬂowmeters, and to investigate whether increase
in ﬁltering of the ﬂowmeter signals inﬂuences ﬂow curves
and PI values.
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2. Material and methods
The idea to carry out this study came to us while
studying two clinical series of patients operated upon with
CABG, each of them assessed by TTFM of coronary grafts by
the MediStim or the Transonic ﬂowmeter, respectively (see
Table 1). The ﬁrst series was operated on by RH at the
University Hospital of Trondheim, Norway, whereas the
second series came from the University Hospital of
Catanzaro, Italy, being operated upon by AR. All single
and sequential saphenous vein grafts (SVGs), and left
internal mammary artery (LIMA) grafts were included. All
ﬂow measurements were carried out after weaning of
cardiopulmonary bypass and after administration of
protamine. Factors such subclavian artery stenosis or
spasm of the LIMA graft were not taken into consideration.
We observed that the PI calculated by the Transonic was
generally lower than the PI by MediStim. This difference
was either due to a real difference between the two
ﬂowmeters (i.e. different levels of ﬁlter setting), or it was
determined by the intrinsic biases associated with a
comparison between different patient populations and
surgeons. Moreover, we decided to search the literature for
the largest clinical series reporting PI data of coronary
grafts calculated by the MediStim or Transonic ﬂowmeters,
to ﬁnd out whether the trend of different PI values
calculated by the two machines were consistent in other
series as well (see Table 2). Most of the relevant data
available were obtained by the MediStim ﬂowmeter [11—
16], whereas just two series presented by the same
investigators were found reporting PI values by Transonic
[17,18]. Despite differences in the amount of data, we
noted a trend towards lower PI values provided by the
Transonic ﬂowmeter versus the MediStim ﬂowmeter. Thus,
we decided to carry out the following study to ascertain
whether this observation held true based on the technical
characteristics of transit-time ﬂowmeters.
2.1. Digital signal processing technology in transit-time
ﬂowmeters
The transit-time ﬂowmeters measure the time differ-
ence between an upstream and downstream ultrasonic
pulse when transmitted and received by two spatially
separated transducers in the ﬂow probe. This time-delay
difference can be converted to volume ﬂow, which is
displayed on-screen as a digitised signal. The ﬂow is
recorded as analogue signals that are initially digitally
sampled at a sufﬁciently high frequency according to the
Nyquist—Shannon sampling theorem [19]. Further, the
ﬂowmeter typically uses a low-pass ﬁlter to smooth the
signal and attenuate noise. MediStim and Transonic
ﬂowmeters use default low-pass ﬁlters at 20 and 10 Hz,
respectively. In other words, the ﬂowmeters ﬁlter the
signals differently, which may determine different ﬂow
curve patterns.
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Table 1
Mean PI of two patient populations assessed by MediStim and Transonic ﬂowmeter, respectively.
Graft Group A Group B
N Mean 95% CI N Mean 95% CI p
Lower Upper Lower Upper
LIMA-LAD 482 2.1 2.1 2.2 100 1.7 1.6 1.8 <0.001
Single SVG to LCA 198 1.8 1.7 1.9 36 1.7 1.5 2.0 0.52
Double SSVG to LCA 264 1.8 1.7 1.9 19 1.4 1.0 1.8 0.03
Single SVG to RCA 317 2.1 1.9 2.2 25 1.6 1.3 2.0 0.03
Double SSVG to RCA 41 2.2 1.9 2.5 61 1.7 1.5 1.9 0.001
Group A: MediStim ﬂowmeter; Group B: Transonic ﬂowmeter; CI: conﬁdence interval; LCA: left coronary artery; RCA: right coronary artery; SSVG: sequential
saphenous vein graft; and SVG: saphenous vein graft.
Table 2
Mean PI from different published studies.
Flowmeter Author Type of graft (N) PI  SD
MediStim Becit [11] LIMA-LAD (102) 2.32  0.88
SVG to Diagonal (48) 2.26  0.81
SVG to OM (80) 2.51  0.94
SVG to RCA (73) 2.23  0.94
Goel* [12] LIMA-LAD (162) 2.71  0.95
SVG overall (224) 2.48  1.04
Gwozdziewicz [13] SSVG (50) 1.8  0.4
Kim*** [14] To LCA (67) 2.4  1.3
To RCA (36) 3.1  1.6
Hassanein [15] LIMA-LAD (421) 1.98  1.08
SVG to Diagonal (69) 1.72  0.58
SVG to OM (71) 1.88  0.86
SVG to RCA (107) 1.80  1.82
Nordgaard** [16] LIMA-LAD (495) 2.4  0.9
SVG to LCA (527)y 2.0 (0.05 SEM)
SVG to RCA (368)y 2.4 (0.06 SEM)
Transonic Onorati [17] LIMA-LAD (199) 1.53  0.62
SVG to RCA (102) 1.67  1.20
SVG to OM (61) 2.06  0.89
SVG to Diag (25) 2.25  1.25
Onorati [18] LIMA-LAD (45)a 1.2  0.4
LIMA-LAD (45)b 1.0  0.7
SVG to OMa 1.46  0.9
SSVG to OMb 0.71  0.4
a Single SVG group.
b Sequential SVG group.
* OPCAB in 36% of cases.
** OPCAB in 11% of cases.
*** Only arterial grafts were used: mammary (n = 78), gastroepiploic (n = 38)
and radial artery (n = 1).
y Includes values from single and sequential SVG as no PI difference was
found between the groups [16].
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protamine. Factors such subclavian artery stenosis or
spasm of the LIMA graft were not taken into consideration.
We observed that the PI calculated by the Transonic was
generally lower than the PI by MediStim. This difference
was either due to a real difference between the two
ﬂowmeters (i.e. different levels of ﬁlter setting), or it was
determined by the intrinsic biases associated with a
comparison between different patient populations and
surgeons. Moreover, we decided to search the literature for
the largest clinical series reporting PI data of coronary
grafts calculated by the MediStim or Transonic ﬂowmeters,
to ﬁnd out whether the trend of different PI values
calculated by the two machines were consistent in other
series as well (see Table 2). Most of the relevant data
available were obtained by the MediStim ﬂowmeter [11—
16], whereas just two series presented by the same
investigators were found reporting PI values by Transonic
[17,18]. Despite differences in the amount of data, we
noted a trend towards lower PI values provided by the
Transonic ﬂowmeter versus the MediStim ﬂowmeter. Thus,
we decided to carry out the following study to ascertain
whether this observation held true based on the technical
characteristics of transit-time ﬂowmeters.
2.1. Digital signal processing technology in transit-time
ﬂowmeters
The transit-time ﬂowmeters measure the time differ-
ence between an upstream and downstream ultrasonic
pulse when transmitted and received by two spatially
separated transducers in the ﬂow probe. This time-delay
difference can be converted to volume ﬂow, which is
displayed on-screen as a digitised signal. The ﬂow is
recorded as analogue signals that are initially digitally
sampled at a sufﬁciently high frequency according to the
Nyquist—Shannon sampling theorem [19]. Further, the
ﬂowmeter typically uses a low-pass ﬁlter to smooth the
signal and attenuate noise. MediStim and Transonic
ﬂowmeters use default low-pass ﬁlters at 20 and 10 Hz,
respectively. In other words, the ﬂowmeters ﬁlter the
signals differently, which may determine different ﬂow
curve patterns.
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Table 1
Mean PI of two patient populations assessed by MediStim and Transonic ﬂowmeter, respectively.
Graft Group A Group B
N Mean 95% CI N Mean 95% CI p
Lower Upper Lower Upper
LIMA-LAD 482 2.1 2.1 2.2 100 1.7 1.6 1.8 <0.001
Single SVG to LCA 198 1.8 1.7 1.9 36 1.7 1.5 2.0 0.52
Double SSVG to LCA 264 1.8 1.7 1.9 19 1.4 1.0 1.8 0.03
Single SVG to RCA 317 2.1 1.9 2.2 25 1.6 1.3 2.0 0.03
Double SSVG to RCA 41 2.2 1.9 2.5 61 1.7 1.5 1.9 0.001
Group A: MediStim ﬂowmeter; Group B: Transonic ﬂowmeter; CI: conﬁdence interval; LCA: left coronary artery; RCA: right coronary artery; SSVG: sequential
saphenous vein graft; and SVG: saphenous vein graft.
Table 2
Mean PI from different published studies.
Flowmeter Author Type of graft (N) PI  SD
MediStim Becit [11] LIMA-LAD (102) 2.32  0.88
SVG to Diagonal (48) 2.26  0.81
SVG to OM (80) 2.51  0.94
SVG to RCA (73) 2.23  0.94
Goel* [12] LIMA-LAD (162) 2.71  0.95
SVG overall (224) 2.48  1.04
Gwozdziewicz [13] SSVG (50) 1.8  0.4
Kim*** [14] To LCA (67) 2.4  1.3
To RCA (36) 3.1  1.6
Hassanein [15] LIMA-LAD (421) 1.98  1.08
SVG to Diagonal (69) 1.72  0.58
SVG to OM (71) 1.88  0.86
SVG to RCA (107) 1.80  1.82
Nordgaard** [16] LIMA-LAD (495) 2.4  0.9
SVG to LCA (527)y 2.0 (0.05 SEM)
SVG to RCA (368)y 2.4 (0.06 SEM)
Transonic Onorati [17] LIMA-LAD (199) 1.53  0.62
SVG to RCA (102) 1.67  1.20
SVG to OM (61) 2.06  0.89
SVG to Diag (25) 2.25  1.25
Onorati [18] LIMA-LAD (45)a 1.2  0.4
LIMA-LAD (45)b 1.0  0.7
SVG to OMa 1.46  0.9
SSVG to OMb 0.71  0.4
a Single SVG group.
b Sequential SVG group.
* OPCAB in 36% of cases.
** OPCAB in 11% of cases.
*** Only arterial grafts were used: mammary (n = 78), gastroepiploic (n = 38)
and radial artery (n = 1).
y Includes values from single and sequential SVG as no PI difference was
found between the groups [16].
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The study protocol was divided into two steps:
(1) Controlled comparison of PI as calculated by the
MediStim and Transonic ﬂowmeters applied simulta-
neously on the same coronary grafts;
(2) Evaluation of changes in the ﬂow curves and PI with
different ﬁlter settings.
2.1.1. Assessment of PI in the same graft by MediStim and
Transonic ﬂowmeters
The two ﬂowmeters were simultaneously compared in 19
coronary bypass grafts (10 single and ﬁve sequential SVGs,
and four LIMA grafts) in 10 patients who were operated on by
the same surgeon (RA) in the same unit (Trondheim). Two
4 mm ﬂow probes, each connected to the respective
MediStim or Transonic ﬂowmeter, were placed next to each
other on the middle segment of the grafts. Each measure-
ment was done at a stable haemodynamic condition after
weaning from cardiopulmonary bypass, and good acoustical
coupling was obtained between the ﬂow probe and the graft.
2.1.2. Assessment of PI during different ﬁlter settings
Finally, to investigate the inﬂuence of different ﬁlter
settings on the ﬂow curves, eight grafts in four patients, who
were operated on by the same surgeon (RA), were assessed by
gradually increasing the ﬁlter setting of the ﬂowmeter from
5 Hz to 10, 20, 30, 50 and 100 Hz. To accomplish this, the
MediStim VeriQ ﬂowmeter was used since it is ﬁtted to adjust
the ﬁlter level. After discontinuation of the cardiopulmonary
bypass and at stable haemodynamic conditions, the ﬂow
patterns of the grafts were recorded for 5—10 s at each ﬁlter
level. The analysis of the ﬂow curves was carried out using
the MediStim VeriQ 2.0 software.
The complete study protocol was approved by the
Regional Medical Ethics Committee on Human Research at
both institutions. All data were entered into a single clinical
database according to the regulations of the Norwegian
Social Science Data Services.
2.2. Statistical methods
The grafts were nested into LIMA-LAD, single and
double sequential SVGs to the left and right coronary
arteries, respectively. In Table 1, a logarithmic transforma-
tion of the ﬂow data was performed to achieve
normal distribution. The comparisons between grafts from
the two cardiac centres were performed using two sample t-
tests except for the single SVGs to the left coronary artery,
where a random effects model with random intercept using
the ‘xtreg’ command in STATA was used. A random effects
model was used to account for repeated measurements as
several patients got more than one single SVG to the left
coronary artery system. AWilcoxon signed rank test was used
to compare the simultaneous ﬂow assessments in the same
grafts. Bland—Altman plots of the simultaneous ﬂow
measurements were made in Excel. The PI values are
expressed as geometric mean and 95% conﬁdence interval.
p < 0.05 was considered signiﬁcant. Statistical analysis was
performed using SPSS for Windows version 15 (SPSS Inc.,
Chicago, IL, USA) and STATA for Windows version 10
(StataCorp, College Station, TX, USA).
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Fig. 1. Simultaneous graft ﬂow measurements on the same graft with the
MediStim and Transonic ﬂowmeter. The upper panel shows a LIMA-LAD graft
with ‘spiky’ ﬂow curves. The PI values are 5.5 and 3.2 as calculated by the
MediStim and Transonic ﬂowmeters, respectively. The lower panel shows SVG
to posterior descending artery (PDA). The PI values are lower and the ﬂow
curves are similar in both ﬂowmeters PI 1.3 and 1.2 in the MediStim and
Transonic ﬂowmeter, respectively.
Fig. 2. Bland—Altman plots of simultaneous measurements in 19 coronary
bypass grafts by the MediStim and Transonic ﬂowmeters. The upper and lower
graphs show the ﬂow (ml/min) and PI values, respectively. Measurements
(dots) above the zero line are those that the MediStim ﬂowmeter records
higher than the Transonic. The values below the zero line are measurements
that the Transonic records higher than the MediStim ﬂowmeter. There is a
trend towards higher ﬂow values in the MediStim ﬂowmeter (p = 0.053;
Wilcoxon sign ranks test). On the PI chart, all values were above the zero
line meaning that the MediStim ﬂowmeter always records higher PI values than
the Transonic (p < 0.001; Wilcoxon sign ranks test). Of note, the PI differences
between the two ﬂowmeters become greater as the PI increases.
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to posterior descending artery (PDA). The PI values are lower and the ﬂow
curves are similar in both ﬂowmeters PI 1.3 and 1.2 in the MediStim and
Transonic ﬂowmeter, respectively.
Fig. 2. Bland—Altman plots of simultaneous measurements in 19 coronary
bypass grafts by the MediStim and Transonic ﬂowmeters. The upper and lower
graphs show the ﬂow (ml/min) and PI values, respectively. Measurements
(dots) above the zero line are those that the MediStim ﬂowmeter records
higher than the Transonic. The values below the zero line are measurements
that the Transonic records higher than the MediStim ﬂowmeter. There is a
trend towards higher ﬂow values in the MediStim ﬂowmeter (p = 0.053;
Wilcoxon sign ranks test). On the PI chart, all values were above the zero
line meaning that the MediStim ﬂowmeter always records higher PI values than
the Transonic (p < 0.001; Wilcoxon sign ranks test). Of note, the PI differences
between the two ﬂowmeters become greater as the PI increases.
The study protocol was divided into two steps:
(1) Controlled comparison of PI as calculated by the
MediStim and Transonic ﬂowmeters applied simulta-
neously on the same coronary grafts;
(2) Evaluation of changes in the ﬂow curves and PI with
different ﬁlter settings.
2.1.1. Assessment of PI in the same graft by MediStim and
Transonic ﬂowmeters
The two ﬂowmeters were simultaneously compared in 19
coronary bypass grafts (10 single and ﬁve sequential SVGs,
and four LIMA grafts) in 10 patients who were operated on by
the same surgeon (RA) in the same unit (Trondheim). Two
4 mm ﬂow probes, each connected to the respective
MediStim or Transonic ﬂowmeter, were placed next to each
other on the middle segment of the grafts. Each measure-
ment was done at a stable haemodynamic condition after
weaning from cardiopulmonary bypass, and good acoustical
coupling was obtained between the ﬂow probe and the graft.
2.1.2. Assessment of PI during different ﬁlter settings
Finally, to investigate the inﬂuence of different ﬁlter
settings on the ﬂow curves, eight grafts in four patients, who
were operated on by the same surgeon (RA), were assessed by
gradually increasing the ﬁlter setting of the ﬂowmeter from
5 Hz to 10, 20, 30, 50 and 100 Hz. To accomplish this, the
MediStim VeriQ ﬂowmeter was used since it is ﬁtted to adjust
the ﬁlter level. After discontinuation of the cardiopulmonary
bypass and at stable haemodynamic conditions, the ﬂow
patterns of the grafts were recorded for 5—10 s at each ﬁlter
level. The analysis of the ﬂow curves was carried out using
the MediStim VeriQ 2.0 software.
The complete study protocol was approved by the
Regional Medical Ethics Committee on Human Research at
both institutions. All data were entered into a single clinical
database according to the regulations of the Norwegian
Social Science Data Services.
2.2. Statistical methods
The grafts were nested into LIMA-LAD, single and
double sequential SVGs to the left and right coronary
arteries, respectively. In Table 1, a logarithmic transforma-
tion of the ﬂow data was performed to achieve
normal distribution. The comparisons between grafts from
the two cardiac centres were performed using two sample t-
tests except for the single SVGs to the left coronary artery,
where a random effects model with random intercept using
the ‘xtreg’ command in STATA was used. A random effects
model was used to account for repeated measurements as
several patients got more than one single SVG to the left
coronary artery system. AWilcoxon signed rank test was used
to compare the simultaneous ﬂow assessments in the same
grafts. Bland—Altman plots of the simultaneous ﬂow
measurements were made in Excel. The PI values are
expressed as geometric mean and 95% conﬁdence interval.
p < 0.05 was considered signiﬁcant. Statistical analysis was
performed using SPSS for Windows version 15 (SPSS Inc.,
Chicago, IL, USA) and STATA for Windows version 10
(StataCorp, College Station, TX, USA).
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bypass grafts by the MediStim and Transonic ﬂowmeters. The upper and lower
graphs show the ﬂow (ml/min) and PI values, respectively. Measurements
(dots) above the zero line are those that the MediStim ﬂowmeter records
higher than the Transonic. The values below the zero line are measurements
that the Transonic records higher than the MediStim ﬂowmeter. There is a
trend towards higher ﬂow values in the MediStim ﬂowmeter (p = 0.053;
Wilcoxon sign ranks test). On the PI chart, all values were above the zero
line meaning that the MediStim ﬂowmeter always records higher PI values than
the Transonic (p < 0.001; Wilcoxon sign ranks test). Of note, the PI differences
between the two ﬂowmeters become greater as the PI increases.
3. Results
3.1. Assessment of PI by MediStim versus Transonic
ﬂowmeter in the same grafts
The MediStim and Transonic ﬂowmeter provided mean
PI and standard deviations of 2.7  1.2 and 1.8  0.6,
respectively ( p < 0.001; Wilcoxon signed ranks test). Fig. 1
clearly demonstrates the difference between the two
ﬂowmeters. The Transonic ﬂowmeter achieved system-
atically lower PI values. The degree of difference
depended on the ﬂow pattern. In a spiky ﬂow curve
pattern the resultant PI was high, with remarkable
differences between the two ﬂowmeters. However, with
a smoother ﬂow pattern the PI was low, and the two
ﬂowmeters produced similar values, demonstrating that
the difference between the ﬂowmeters becomes greater as
PI increases (Fig. 2).
3.2. Assessment of PI under different ﬁlter settings
Typical changes in the ﬂow pattern occurred under
different ﬁlter settings. At low-ﬁlter setting, a smoother
ﬂow pattern appeared with no sharp ﬂow spikes. By
increasing the ﬁlter setting, a ‘noisier’ ﬂow pattern appeared
which produced higher PIs. Fig. 3 visualises the different ﬂow
curves at different ﬁlter settings with the MediStim VeriQ
ﬂowmeter, and in this case as well, the difference between
ﬁlter settings becomes greater as PI increases.
4. Discussion
This study identiﬁed important differences between the
two most frequently used TTFMs. Because of a lower ﬁlter
setting, the Transonic ﬂowmeter produced smoother ﬂow
curves than the MediStim, which inﬂuenced the calculation
of the PIs. Speciﬁcally, PIs calculated by Transonic are lower
than those calculated by MediStim.
Direct comparisons of ﬂow and PI results of the same grafts
by the two ﬂowmeters provided evidence that the Transonic
produced a lower PI than the MediStim, which was observed
consistently during the testing of 19 grafts. Furthermore, PI
differences between the two ﬂowmeters seemed to be more
pronounced at higher PI values, as shown in Fig. 1.
The next step in our analysis was to ﬁnd out whether a
lower PI was achieved by applying a lower ﬁlter setting,
which produced smoother ﬂow curves. We discovered that a
constant increase in PI value occurred in concomitance with
an increase in the ﬁlter setting, and that higher ﬁlter settings
are characterised by a pronounced spiky pattern that
determined very high maximum and low minimum peaks
on the ﬂow charts, resulting in increased PI values.
The PI is calculated automatically by the ﬂowmeters. The
MediStim ﬂowmeter and the Transonic ﬂowmeter measure the
higher and lower peaks during a blood ﬂow recording time of 2
and 8 s, respectively. Therefore, one would expect higher and
lower peaks, resulting in higher PIs, to most likely be recorded
by the Transonic ﬂowmeter, rather than the MediStim because
of its longer recording time. Interestingly, but still of unknown
H.B. Nordgaard et al. / European Journal of Cardio-thoracic Surgery 37 (2010) 1063—10671066
Fig. 3. The upper panel shows PI values of eight different grafts measured under various ﬁlter settings (5, 10, 20, 30, 50 and 100 Hz, respectively). The proportion of
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present a greater increase in PI values due to higher ﬁlter settings. The lower ﬂow curves of a sequential saphenous vein graft (SSVG) to obtuse marginal (OM) and
diagonal (D) show a more moderate change in PI values due to lower ﬁlter settings. Increased ﬁlter settings lead to a spikier ﬂow pattern, causing higher PIs. Lower
ﬁlter setting results in a smoother ﬂow pattern, and consequently a lower PI. PDA: posterior descending artery. RCA: right coronary artery.
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reason, this was not the case since the Transonic produces
systematically lower PIs due to its lower ﬁlter setting.
Similar outcomes, which document the differences
between these two ﬂowmeters, have only previously
been published in an abstract.1 Fifty-ﬁve grafts from 23
patients were assessed intra-operatively by both devices. On
the one hand, a signiﬁcantly higher PI of 2.7 was shown with
the MediStim as compared with a PI of 2.2 by the Transonic.
On the other hand, the differences in mean ﬂow were also
signiﬁcant: it was 45.6 ml min1 using the MediStim as
compared with 62.1 ml min1 with the Transonic. Unfortu-
nately, the authors did not comment on these ﬁndings.
In vitro and in vivo comparisons of TTFMs have both shown
a high accuracy and precision in regard to volumetric ﬂow
[1,3,20]. To the best of our knowledge, this variation in ﬂow
pattern as seen in different ﬂowmeters has not been
previously described, although it is highly relevant. The
simultaneous comparison of the two ﬂowmeters conﬁrmed
the differences seen clinically as presented in Table 1.
On clinical grounds, the difference in waveforms due to
different ﬁlter settings may have important repercussions.
The shape of the ﬂow curve is an element which comes into
play when assessing grafts that are difﬁcult to interpret (low
ﬂows and high PI). In cases involving a failed anastomosis or a
graft directed to coronary arteries with high peripheral
vascular resistance, the waveform will present multiple
spikes that will be higher than expected. On the one hand, a
device equipped with a high ﬁlter setting will produce very
spiky ﬂow curves, making it difﬁcult to evaluate the graft
ﬂow. On the other hand, a device with a low ﬁlter setting will
smooth out most of the spikes, making the graft assessment
appear to be better than it actually is.
Unfortunately, there are no clear cut-off values of mean
ﬂow and PI that allow surgeons to adequately establish the
quality of a coronary graft. There has been much debate over
the identiﬁcation of these cut-off values, but so far, no general
agreement has been reached due to the many variables
involved in graft assessment [14,21,22]. The important issueof
having separate cut-off values for different ﬂowmeters has not
been discussed. Therefore, based on the results of our
investigation, it is important to refer to the type of ﬂowmeter
used when presenting ﬂow values.
In conclusion, MediStim and Transonic TTFMs are
not directly comparable because of their ﬁlter settings at
20 and 10 Hz, respectively. Different levels of ﬁlter settings in
the ﬂowmeters determine different shapes in the ﬂow
curves, which results in different PI values. In particular,
more pronounced differences in PIs were noted when the PI
was around 3. Thus, the type of ﬂowmeter should always be
reported together with the graft ﬂows and PI.
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reason, this was not the case since the Transonic produces
systematically lower PIs due to its lower ﬁlter setting.
Similar outcomes, which document the differences
between these two ﬂowmeters, have only previously
been published in an abstract.1 Fifty-ﬁve grafts from 23
patients were assessed intra-operatively by both devices. On
the one hand, a signiﬁcantly higher PI of 2.7 was shown with
the MediStim as compared with a PI of 2.2 by the Transonic.
On the other hand, the differences in mean ﬂow were also
signiﬁcant: it was 45.6 ml min1 using the MediStim as
compared with 62.1 ml min1 with the Transonic. Unfortu-
nately, the authors did not comment on these ﬁndings.
In vitro and in vivo comparisons of TTFMs have both shown
a high accuracy and precision in regard to volumetric ﬂow
[1,3,20]. To the best of our knowledge, this variation in ﬂow
pattern as seen in different ﬂowmeters has not been
previously described, although it is highly relevant. The
simultaneous comparison of the two ﬂowmeters conﬁrmed
the differences seen clinically as presented in Table 1.
On clinical grounds, the difference in waveforms due to
different ﬁlter settings may have important repercussions.
The shape of the ﬂow curve is an element which comes into
play when assessing grafts that are difﬁcult to interpret (low
ﬂows and high PI). In cases involving a failed anastomosis or a
graft directed to coronary arteries with high peripheral
vascular resistance, the waveform will present multiple
spikes that will be higher than expected. On the one hand, a
device equipped with a high ﬁlter setting will produce very
spiky ﬂow curves, making it difﬁcult to evaluate the graft
ﬂow. On the other hand, a device with a low ﬁlter setting will
smooth out most of the spikes, making the graft assessment
appear to be better than it actually is.
Unfortunately, there are no clear cut-off values of mean
ﬂow and PI that allow surgeons to adequately establish the
quality of a coronary graft. There has been much debate over
the identiﬁcation of these cut-off values, but so far, no general
agreement has been reached due to the many variables
involved in graft assessment [14,21,22]. The important issueof
having separate cut-off values for different ﬂowmeters has not
been discussed. Therefore, based on the results of our
investigation, it is important to refer to the type of ﬂowmeter
used when presenting ﬂow values.
In conclusion, MediStim and Transonic TTFMs are
not directly comparable because of their ﬁlter settings at
20 and 10 Hz, respectively. Different levels of ﬁlter settings in
the ﬂowmeters determine different shapes in the ﬂow
curves, which results in different PI values. In particular,
more pronounced differences in PIs were noted when the PI
was around 3. Thus, the type of ﬂowmeter should always be
reported together with the graft ﬂows and PI.
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reason, this was not the case since the Transonic produces
systematically lower PIs due to its lower ﬁlter setting.
Similar outcomes, which document the differences
between these two ﬂowmeters, have only previously
been published in an abstract.1 Fifty-ﬁve grafts from 23
patients were assessed intra-operatively by both devices. On
the one hand, a signiﬁcantly higher PI of 2.7 was shown with
the MediStim as compared with a PI of 2.2 by the Transonic.
On the other hand, the differences in mean ﬂow were also
signiﬁcant: it was 45.6 ml min1 using the MediStim as
compared with 62.1 ml min1 with the Transonic. Unfortu-
nately, the authors did not comment on these ﬁndings.
In vitro and in vivo comparisons of TTFMs have both shown
a high accuracy and precision in regard to volumetric ﬂow
[1,3,20]. To the best of our knowledge, this variation in ﬂow
pattern as seen in different ﬂowmeters has not been
previously described, although it is highly relevant. The
simultaneous comparison of the two ﬂowmeters conﬁrmed
the differences seen clinically as presented in Table 1.
On clinical grounds, the difference in waveforms due to
different ﬁlter settings may have important repercussions.
The shape of the ﬂow curve is an element which comes into
play when assessing grafts that are difﬁcult to interpret (low
ﬂows and high PI). In cases involving a failed anastomosis or a
graft directed to coronary arteries with high peripheral
vascular resistance, the waveform will present multiple
spikes that will be higher than expected. On the one hand, a
device equipped with a high ﬁlter setting will produce very
spiky ﬂow curves, making it difﬁcult to evaluate the graft
ﬂow. On the other hand, a device with a low ﬁlter setting will
smooth out most of the spikes, making the graft assessment
appear to be better than it actually is.
Unfortunately, there are no clear cut-off values of mean
ﬂow and PI that allow surgeons to adequately establish the
quality of a coronary graft. There has been much debate over
the identiﬁcation of these cut-off values, but so far, no general
agreement has been reached due to the many variables
involved in graft assessment [14,21,22]. The important issueof
having separate cut-off values for different ﬂowmeters has not
been discussed. Therefore, based on the results of our
investigation, it is important to refer to the type of ﬂowmeter
used when presenting ﬂow values.
In conclusion, MediStim and Transonic TTFMs are
not directly comparable because of their ﬁlter settings at
20 and 10 Hz, respectively. Different levels of ﬁlter settings in
the ﬂowmeters determine different shapes in the ﬂow
curves, which results in different PI values. In particular,
more pronounced differences in PIs were noted when the PI
was around 3. Thus, the type of ﬂowmeter should always be
reported together with the graft ﬂows and PI.
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reason, this was not the case since the Transonic produces
systematically lower PIs due to its lower ﬁlter setting.
Similar outcomes, which document the differences
between these two ﬂowmeters, have only previously
been published in an abstract.1 Fifty-ﬁve grafts from 23
patients were assessed intra-operatively by both devices. On
the one hand, a signiﬁcantly higher PI of 2.7 was shown with
the MediStim as compared with a PI of 2.2 by the Transonic.
On the other hand, the differences in mean ﬂow were also
signiﬁcant: it was 45.6 ml min1 using the MediStim as
compared with 62.1 ml min1 with the Transonic. Unfortu-
nately, the authors did not comment on these ﬁndings.
In vitro and in vivo comparisons of TTFMs have both shown
a high accuracy and precision in regard to volumetric ﬂow
[1,3,20]. To the best of our knowledge, this variation in ﬂow
pattern as seen in different ﬂowmeters has not been
previously described, although it is highly relevant. The
simultaneous comparison of the two ﬂowmeters conﬁrmed
the differences seen clinically as presented in Table 1.
On clinical grounds, the difference in waveforms due to
different ﬁlter settings may have important repercussions.
The shape of the ﬂow curve is an element which comes into
play when assessing grafts that are difﬁcult to interpret (low
ﬂows and high PI). In cases involving a failed anastomosis or a
graft directed to coronary arteries with high peripheral
vascular resistance, the waveform will present multiple
spikes that will be higher than expected. On the one hand, a
device equipped with a high ﬁlter setting will produce very
spiky ﬂow curves, making it difﬁcult to evaluate the graft
ﬂow. On the other hand, a device with a low ﬁlter setting will
smooth out most of the spikes, making the graft assessment
appear to be better than it actually is.
Unfortunately, there are no clear cut-off values of mean
ﬂow and PI that allow surgeons to adequately establish the
quality of a coronary graft. There has been much debate over
the identiﬁcation of these cut-off values, but so far, no general
agreement has been reached due to the many variables
involved in graft assessment [14,21,22]. The important issueof
having separate cut-off values for different ﬂowmeters has not
been discussed. Therefore, based on the results of our
investigation, it is important to refer to the type of ﬂowmeter
used when presenting ﬂow values.
In conclusion, MediStim and Transonic TTFMs are
not directly comparable because of their ﬁlter settings at
20 and 10 Hz, respectively. Different levels of ﬁlter settings in
the ﬂowmeters determine different shapes in the ﬂow
curves, which results in different PI values. In particular,
more pronounced differences in PIs were noted when the PI
was around 3. Thus, the type of ﬂowmeter should always be
reported together with the graft ﬂows and PI.
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